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Abstract 
HC03- plays a vital role in the ailWays, as mucus viscosity and ciliary beat have both 
been shown to be dependent upon the pH of the ailWay surface liquid. In cystic 
fibrosis (CF), reduced HC03- and fluid secretion produce dehydrated mucus, which 
impairs ailWay defence and predisposes the ailWays to bacterial infection. Calu-3 cells 
are used as a model of the serous cells of human tra~heobronchial submucosal glands 
which are involved in CFTR (cystic fibrosis transmembrane conductance regulator)-
dependent HC03- secretion. CFTR is widely regarded as the sole mediator of apical 
cr and HC03 - secretion in Calu-3 cells and human serous ailWay cells. However, the 
discovery ofSLC26 Cr/HC03- exchange activity linked to the expression ofCFTR in 
tracheal epithelial cells, as well as a functional interaction between apically co-
localised SLC26 exchangers and CFTR in mediating HC03- secretion in many HC03-
secreting epithelia including the pancreas and gastrointestinal tract, has led to some 
doubt over this hypothesis. The aim of this work was to investigate the potential role 
of SLC26 anion exchange (A E) in HC03- secretion from Calu-3 cells and its 
dependence on CFTR. AE activity was assessed by real time measurements of 
intracellular pH (PHi) using the pH-sensitive dye BCECF-AM, from cells grown as 
monolayers on semi-permeable supports. 
Calu-3 cells under non-stimulated conditions displayed Na + -dependent basolateral cr 
IHC03- exchange, which was abolished by HrDIDS. No apical AE activity could be 
detected under resting conditions. Stimulation of cells with a cAMP agonist 
(forskolin, adenosine, VIP) produced a switch in AE activity, activating an apical AE 
and completely inhibiting the basolateral AE. The cAMP-activated apical AE activity 
was Na+-independent, H2-DIDS-insensitive and could transport a range of monovalent 
anions in exchange for HC03- with the selectivity profile: Iodide=Br->Cr=Formate 
=N03-=SCN-. The profile of this anion exchanger corresponds with Pendrin 
(SLC26A4), which quantitative RT-PCR analysis showed to be expressed in these 
Calu-3 cells. Consistent with this, Pendrin knockdown (KD) Calu-3 cells had a 
reduced rate of AE activity, compared to wild-type (WT) cells. Protein phosphatase 1 
inhibition by okadaic acid activated an apical AE under non-stimulated conditions 
with a similar profile to Pendrin, which CFTR inhibitor studies demonstrated to be 
CPTR-independent. Interestingly, fluid secretion studies established that Calu-3 cells 
produced a more alkali fluid when treated with okadaic acid, consistent with enhanced 
HC03- secretion. The role of CFTR in CrlHC03- AE activity was assessed using 
CFTR inhibitors and CFTR KD Calu-3 cells. Although apical AE activity in WT 
Calu-3 cells could be abolished by inhibiting CFTR (with either CFTRinh-172 or 
GlyH-lOl), it could be restored by the addition of basolateral H2-DIDS, suggesting 
that the CFTR inhibition reveals a H2-DIDS-sensitive basolateral transport process 
which masks the effects of apical AE on pHi, rather than abolishing apical AE activity 
itself. In CFTR KD Calu-3 cells the rate of apical AE activity was significantly 
decreased compared to WT cells. These results suggest a role for CFTR in regulating 
apical CrlHC03- exchange activity and/or contributing to Cr-dependent HC03-
transport. Similarly cAMP inhibition of the basolateral AE was also found to be 
mediated via a CFTR-dependent mechanism, highlighting the importance of CFTR in 
the cAMP-dependent switch in Calu-3 AE activity. Such a switch in AE activity by 
cAMP, would favour bicarbonate secretion, consistent with the finding that cAMP 
enhances HC03 --dependent fluid secretion from Calu-3 cells. Apical AE activity was 
also observed in human bronchial epithelial cells (HBECs), which could not be 
blocked by GlyH-101, but was absent in CF HBECs. 
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1. Introduction 
1.1 Airway surface liquid: submucosal glands to airway lumen 
The human airways are lined by mucus, a salt-rich fluid containing antioxidants, 
antiproteases, antimicrobials and mucins. Mucus traps and inactivates inhaled 
particles and pathogens. These infectious particles are then removed from the airways 
by mucociliary clearance, maintaining the sterility of the lungs. The primary source of 
airway mucus is the submucosal glands, which are estimated to produce 
approximately 95% of upper airway mucus in healthy individuals (Reid, 1960). 
Submucosal glands are comprised of ":'61 % serous and -39% mucous cells by volume 
(Basbaum et aI, 1990). Much of the contents of airway mucus, such as water, salts 
and antibacterial compounds, are produced by serous cells, whereas the mucous (and 
goblet) cells provide most of the mucins. Each gland contains a series of 
interconnecting tubules that feed into a collecting duct, which narrows into a ciliated 
duct that is continuous with the airway lumen (Meyrick & Reid, 1970). Fluid 
secretions from the submucosal glands travel through the series of tubules and ducts, 
along the way being supplemented with further mucosal secretions, finally reaching 
the bronchial lumen, where the fluid maintains the airway surface liquid (ASL). 
The ASL is divided into a well-defined periciliary liquid (peL) layer and a mucus 
layer. The underlying peL is responsible for maintaining the mucus layer at an 
optimum distance from the airway surface epithelia, in order to sustain efficient 
mucus clearance via ciliary action (mucociliary clearance; Tarran, 2004). In normal 
airways, the peL is approximately the length of the outstretched cilia (-7 J.lm), 
whereas the mucus layer varies considerably in height (7 to 70 J.lm in vivo; Jayaraman 
et aI, 2001c). The volume and composition of the ASL is tightly regulated, to ensure 
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that the mucus layer is sufficiently hydrated. Airway surface epithelial ion transport is 
thought to play an important role in the regulation of the volume and composition of 
the PCL, through balanced Na + absorption (via epithelial sodium channels- ENaC) 
and cr secretion (via the cystic fibrosis transmembrane conductance regulator-
CFTR) , thus providing the driving force for transepithelial fluid movement (see 
section 5.5 for further discussion). This can be seen in patients with 
Pseudohypoaldosteronism, who exhibit loss-of-function mutations in ENaC and have 
an excess of ASL due to reduced Na + absorption (Kerem et ai, 1999). The osmotic 
gradient generated by the surface epithelium maintains the height of the PCL 
necessary for mucociliary clearance, as well as the salt concentration to provide 
optimum conditions for the activity of antimicrobial molecules (Smith et ai, 1996; 
Travis et ai, 2001). 
The homeostasis of the ASL is of particular interest in cystic fibrosis (CF), as CF is 
associated with defective mucociliary clearance, due to the dehydrated viscous 
composition of the secreted mucus. In CF, defective submucosal gland (SMG) 
secretion, together with abnormal airway surface epithelial function, produces ASL 
dehydration (Matsui et ai, 1998). This allows pathogens to remain in the airways, 
leading to infection, inflammation and tissue damage (see Figure 1.01). 
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Figure 1.01 - Proposed mechanism of lung disease in CF. Schematic of airway submucosal gland 
showing watery fluid secreted by CFTR-expressing serous acini (indicated by blue arrow), addition of 
glycoprpteins by mucous tubules (red arrow), and passage of fluid onto the airway surface through a 
collecting duct. Defective CFTR in serous glandular epithelial cells results in secretion of a reduced 
amount of a hyperviscous solution, which impairs bacterial clearance mechanisms leading to chronic 
airway infection, inflammation, and destruction. Yellow blocks represent sites of apical CFTR 
expression. Red blocks represent sites ofbasolateral CrIHC03' exchanger expression. Reproduced from 
Salinas et ai, 2005. 
1.2 CFTR 
CF is caused by mutations in the gene encoding for the cystic fibrosis transmembrane 
conductance regulator (CFTR). At the time of writing, more than 1700 CFTR gene 
mutations have been discovered (according to the cystic fibrosis mutation database*)' 
Deletion of phenylalanine at position 508 (deltaF508) is the most common CFTR 
mutation, affecting around 70% of CF sufferers (Davis, 2006). In cells containing the 
deltaF508 mutation, mature fully glycosylated CFTR proteins are not present in the 
membrane, as the protein does not fold normally, resulting in the retention of CFTR in 
the endoplasmic reticulum (ER), where it is ubiquitinated and retrotranslocated to the 
cytosol for proteasomal degradation (Cheng et aI, 1990; Gelman et aI, 2002). CF is 
*http://www.genet.sickkids.on.caicftr 
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characterised by the dysfunction of exocrine secretions, predominantly affecting the 
airways, intestine and pancreas, and is associated with a profound decline In 
transmembrane cr conductance in these organs (Quinton, 1990; Welsh, 1990). 
CFTR is a cAMP,..dependent phosphorylation-regulated, ATP-gated, cr channel 
, 
which is primarily located on the apical membrane of epithelial cells of many organs 
including the liver, pancreas, digestive tract, reproductive tract and the airways. It is 
also found in several non-epithelial tissues including cardiac myocytes (Nagel et al 
, 
1992), smooth muscle (Robert et ai, 2005), skeletal muscle (Diavangahi et ai, 2009), 
endothelia (Tousson et ai, 1998) and erythrocytes (Sprague et ai, 1998). This ATP-
binding cassette (ABC) transporter-class protein conducts the movement of cr and 
other monovalent anions, which together with the movement of Na +, dominates the 
epithelial cell, resulting in the movement of water by osmosis towards the lumen. 
Initially, following the discovery of the gene encoding CFTR (Riordan et ai, 1989), it 
was unclear whether CFTR regulated a cr conductance or was itself a cr channel. CF 
was associated with a low cr penneability (Quinton, 1983) and cAMP was found to 
open apical cr channels in nonnal but not CF airway epithelial cells (Schoumacher et 
ai, 1987; Li et ai, 1988). However, the disease also manifested in increased Na+ 
absorption by CF airway epithelia (Boucher et ai, 1986). It was subsequently 
discovered, following cloning of the CFTR gene, that CFTR was an A TP-regulated 
cr channel, with a 9-11 pS single-channel conductance and the penneability sequence: 
Br>Cr>f>F (Anderson et ai, 1991 a&b; Bear et ai, 1991). Patch clamp experiments 
in pancreatic duct cells showed that CFTR could also conduct HC03 -, although with a 
much lower penneability than cr (HC03-/Cr penneability ratio of 0.11-0.25; Grayet 
ai, 1990). In addition, studies have since shown that CFTR not only functions as an 
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anion channel, but can interact with and regulate other ion channels, including Na+ 
channels (Stutts et ai, 1995) and outwardly rectifying chloride channels (ORCCs; 
Egan et ai, 1992), as well as various other transport proteins including CrIHC03-
exchangers (see section 1.5). 
To date the structure of CFTR has not been fully detennined, as the substantial 
hydrophobic regions present in the CFTR protein are difficult to crystallise, rendering 
X-ray crystallography of the protein extremely challenging. However, by comparing 
the CFTR amino acid sequence with that of other members of the ABC transporter 
family, a general model of the structure of CFTR was proposed by Riordan and 
colleagues (Riordan et ai, 1989). CFTR consists of five domains: two membrane-
spanning domains (MSDI and MSD2) that together fonn the ion channel; two 
nucleotide-binding domains (NBDI and NBD2) that bind and hydrolyze ATP; and a 
regulatory (R) domain that is unique to CFTR (not found in other ABC transporters or 
other proteins). Each MSD consists of six hydrophobic a helices, which are connected 
to the cytoplasmic NBD, with the two homologous halves of CFTR linked by the R 
domain to give the overall structural organisation: MSDI-NBDI-R-MSD2-NBD2. 
The exact function of the R domain was detennined by studies of R domain deletion 
(CFT~), which showed that CFTR.::1R. was constitutively active and no longer 
required cAMP / ATP to conduct chloride, suggesting that the unphosphorylated R 
domain inhibits CFTR channel activity and thus phosphorylation is required to 
overcome this inhibition (Rich et ai, 1991). However, addition of an 
unphosphorylated R-domain to a CFTR variant in which the R-domain had been 
deleted (CFTR-.::1R.IS660A) did not inhibit CFTR activity and addition of a 
phosphorylated R domain actually stimulated activity (Winter & Welsh, 1997). 
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, Studies of CFTR channel gating, suggested that phosphorylation of the Rd' 
omam 
increases the rate of channel opening due to enhanced sensitivity to ATP (Winter & 
Welsh, 1997). Thus, phosphorylation of the R domain ~y cAMP-dependent protein 
kinase (PKA), resulting from an elevation in cAMP levels, allows ATP to open and 
close the channel (Winter & Welsh, 1997; Ostedgaard et aI, 2001) However pt' 
. , ro eln 
kinase C (PKC), cGMP-dependent kinase and tyrosine phosphorylation can also 
stimulate CFTR activity (Gadsby & Nairn, 1999; Sheppard & Welsh, 1999). In 
particular, CFTR phosphorylation by PKC, despite only producing weak channel 
activation, may potentiate or even be a prerequisite for CFTR activation by PKA 
(Chappe et aI, 2003). Once phosphorylated, CFTR channels open via the dimerisation 
of the NBDs produced by ATP binding (and hydrolysis), which in tum causes a 
conformational change in the MSDs allowing passive anion flow through the pore 
(Hwang & Sheppard, 2009). The balance of a complex array of protein kinases and 
phosphatases, such as protein phosphatase 2A (see chapter 3 for further discussion), 
then controls CFTR opening and closing by phosphorylation/dephosphorylation 
(Berger et aI, 1993). 
Since lung disease is the greatest cause of mortality among CF sufferers, the 
observation of particular importance to CF is that CFTR within the airways is highly 
expressed in serous cells of the SMG (CFTR antibodies localise to the apical 
membrane of SMG serous cells in situ; Englehardt et aI, 1992), which make up the 
majority of the surface area of the epithelium lining the glands as well as in the 
ciliated epithelium near gland orifices (Kreda et aI, 2005). 
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, 1.3 Airway submucosal gland secretion 
Since SMGs are small and most of their mass is embedded in the submucosal space, 
study of their secretions has proved problematic. One method pioneered by Quinton 
to measure SMG secretion, involves drying the airway surface using gas and then 
applying a layer of oil, so that when fluid emerges from SMG duct openings, it forms 
visible pools of liquid underneath the oil layer (Quinton, 1979). This liquid can then 
be collected using micropipettes for determination of volume and composition, or 
fluid volumes can be measured optically in situ from droplet dimensions (Joo et aI, 
2001). Another method used to isolate SMG secretions, was to abrasively remove the 
surface epitheJium of isolated pig distal bronchi, leaving the submucosal glands intact 
(Ballard et aI, 1999). 
Airway SMG secretions are primarily controlled by nervous innervation from the 
parasympathetic nervous system (Wine, 2007). Airway intrinsic neurons release 
neurotransmitters including vasoactive intestinal peptide (VIP) and substance P, 
which induce liquid secretion in the SMG through stimulation of VPAC2 and NKJ 
tachykinin receptors, respectively (Groneberg et aI, 2001; Phillips et aI, 2003). 
Stimulation of the vagus nerve causes· vigorous gland secretions in the feline trachea, 
which is mediated largely by the local release of acetylcholine (ACh; Ueki et aI, 
1980). This response can be mimicked by the direct application of ACh or other 
cholinergic agonists to the glands (Quinton, 1979), through the activation of M3 
muscarinic receptors, which increase [Ca2+]j (Ishihara et aI, 1992). Substance P is also 
thought to enhance SMG fluid secretion through increasing [Ca2+]j (Nagaki et aI, 
1994), whereas VPAC receptors are coupled to adenylyl cyclase and thus VIP 
mediates gland secretion by elevating [cAMP]j (Groneberg et aI, 2006). 
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, The active secretion of both HC03- and cr drives fluid secretion by the SMG's 
(Ballard & Inglis, 2004). In vitro measurements in excised porcine bronchi, secreted 
-15 Jll/cm2/h when treated with ACh in the absence of surface epithelial secretl· 
_ on, 
which could not be further enhanced in bronchi with an intact surface epithelium 
, 
suggesting that the source of the liquid was the SMG (Ballard et ai, 1999). Trout and 
colleagues investigated the role of CI- and HC03- in gland fluid secretion by treating 
porcine bronchi with the Na+-K+-2Cr cotransporter (NKCC) inhibitor bumetanide, or 
removal of cr from the Krebs solution bathing the excised bronchi, and the Na+-H+ 
exchanger (NHE) inhibitor dimethylamiloride (DMA; Trout et ai, 1998). The action 
of DMA is thought to result from the inhibition of H+ extrusion across the basolateral 
membrane, which reduces the capacity of the epithelial cells to generate cytoplasmic 
HC03- (Smith & Welsh, 1992). The cr content of the secreted fluid in Trout and 
colleagues' study (Trout et ai, 1998) was assessed by amperometric cr titration, and 
the HC03- content determined using electrometric titration (Maas, 1970). Trout et al 
(1998) demonstrated that -70% of the ACh-stimulated SMG fluid secretion was 
driven by NKCC-dependent cr secretion and the rest is supported by NHE-dependent 
HC03- secretion. Similar results were obtained in porcine bronchi exposed to 
substance P (Trout et ai, 2001). The magnitude of HC03- secretion that occurs in 
ACh-stimulated bronchi is sufficient to induce a measurable alkalinisation in the 
luminal bathing fluid (Inglis et ai, 2003). Under resting conditions, the distal bronchi 
cannulated in bath containing HC03 --buffered solution, secreted base equivalents, as 
pH electrode analysis showed an acidification of -0.065 pH units. The addition of 10 
JlM ACh evoked an increase in luminal pH at a rate of -0.003 pH units/min, which 
could be inhibited in HC03--free (HEPES-buffered) solutions containing the carbonic 
anhydrase inhibitor acetazolamide, consistent with HC03 - secretion. The partial 
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HC03--dependence of SMG fluid secretion was also observed in 
optical fluid 
secretion measurements in sheep SMGs, where carbachol-induced (h I' . 
c 0 InergIc 
agonist) secretion was reduced -67% by HC03 - replacement with HEPES (J 
- 00 et aI, 
2001a). Forskolin (directly activates adenylyl cyclase to produce cAMP) and VIP 
both induce porcine SMG fluid secretion (both at a rate -40% lower than carbachol), 
which is also mediated by a combination of cr and HC03 - secretion w'th h 
' 1 eac 
contributing around 50% of the liquid secretion (100 et aI, 2002b). However, unlike 
ACh or substance P, forskolin induces SMG fluid secretion through both a DMA-
sensitive pathway and a Na+-dependent ,DIDS (diisothiocyanostiIbene sulfonic acid)-
sensitive pathway, believed to represent HC03- uptake through a basolateral Na+-
HC03 - cotransporter (Ballard et ai, 2004). 
Most lines of evidence in studies of fluid secretion from human airway SMOs, 
suggest that secretion is dependent on apical CFTR. In addition to the expression of 
CFTR in SMG serous cells (which are believed to provide most of the liquid in gland 
secretions; Meyrick & Reid, 1970; Englehardt et ai, 1992), the CFTR blocker, 
CFTRinh- 172 (Ma et ai, 2002), inhibited pilocarpine- (cholinergic agonist) and 
forskolin- induced airway SMG secretion in pigs and humans without CF, but not in 
human bronchi with CF (Thiagarajah et ai, 2004). Interestingly, pH measurements of 
the fluid droplets secreted from porcine SMGs, detennined using the pH-sensitive 
fluorescent probe BCECF-dextran, showed that CFTRInh-172 had no effect on the pH 
of gland secretions under non-stimulated conditions (pH-6.9), but lowered the pH of 
pilocarpine-stimulated secretions from -7.1 to -6.7, consistent with the inhibition of 
CFTR-dependent HC03- secretion (Thiagarajah et ai, 2004). 
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Since other studies of human SMG secretion found that the VIP/forskolin-induced 
component of fluid secretion was absent in CF airways but the muscarinic component 
remained partially intact (100 et aI, 2002a), it was unclear whether CFTR is the sole 
apical transporter that mediates anion and liquid secretion in the airway submucosal 
glands. 
1.4 Calu-3 cells 
As serous cells are difficult to isolate and grow in culture, there was much excitement 
about Calu-3 cells, a cell line derived from a human lung adenocarcinoma, which 
have many properties of serous submucosal gland cells (Shen et aI, 1994; Haws et aI, 
1994). Such properties included the production of antimicrobials (such as lysozyme 
and lactoferrin; Dubin et aI, 2004), growth to confluence with high resistance (RT 
> 1 000 n.cm2) and the expression of high levels of functional cAMP- and ATP-
stimulated CFTR in their apical membranes (Haws et aI, 1994; Illek et aI, 1996). 
Unlike many immortalised cells, Calu-3 cells form sheets of cells that are joined by 
tight junctions (Wan et aI, 2000). These sheets form a fully functional polarised 
epithelium that can transport large quantities of ions and fluid. Since Calu-3 cells have 
a high level of natural CFTR expression, they make an ideal model for studying the 
role of CFTR in serous cell secretions (Haws et aI, 1994). However, caution must be 
employed when extrapolating the results of Calu-3 cell cultures to overall SMG 
function in vivo, since some important physiological aspects can be lost, (including 
nervous innervation) when cells are removed from their native environments and 
grown in media for prolonged periods. 
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Calu-3 cells are of special interest because they produce two kinds of anio . 
n secretion 
depending upon the mode of stimulation. When activated via agents th t I 
a e evate 
intracellular cAMP (such as VIP or forskolin), Calu-3 cells secrete a RCO - . h fl . 
_ 3 nc uld 
(Irokawa et ai, 2004). However, if activated by agents that elevate intracellular Ca2+ 
(such as acetylcholine stimulation of muscarinic receptors), Calu-3 cells secrete a cr-
rich fluid (Devor et ai, 1999), although it still contains a large component of RC0
3
-
(Lee et ai, 1998). More recently, it was shown that apically secreted RC03 -is Partially 
neutralized by proton secretion under some conditions (Krouse et ai, 2004). The 
source of the protons appears to be an 1"t-K+-ATPase, as it is ouabain-sensitive and 
requires.apical.K+ (Krouse et ai, 2004; it should be noted that the ouabain-sensitive 
apical H+-K+-ATPase present in Calu-3 cells is distinct from the R+-K+-ATPase found 
in the apical membrane of parietal cells, which can be inhibited by omeprazole, but is 
insensitive to ouabain). This may explain the unexpected similarity between the pR of 
CF and non-CF submucosal gland secretions, despite a lack of RC03 - secretion by CF 
serous cells (Jayarman et ai, 2001a). 
Calu-3 transport mechanisms have now been well studied and characterised, and are 
summarised in Figure 1.02. The dual nature of CFTR secretion as described above 
can be explained by a model proposed by Krouse and colleagues (Krouse et ai, 2004). 
Increasing intracellular Ca2+ stimulates basolateral Ca2+-activated K+ channels (I<ca), 
hyperpolarising the membrane. The proposed electrogenic Na+-HC03- cotransporter 
(NBC) can mediate entry or exit of HC03 - according to the membrane potential. 
Therefore hyperpolarising the basolateral membrane so that membrane potential is 
greater than the reversal potential of the NBC, causes HC03- exit rather than entry. As 
the NBC is the primary source of HC03- entry, [HC03-]i decreases, producing a cr-
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rich CFTR secretion. The Na+-K+-2Cr cotransporter (NKCC) provides cr entry into 
the cell, since the basal K+ conductance is able to maintain the apical voltage above 
the cr equilibrium potential. The basolateral Na+-K+-ATPase and apical H+-K+-
ATPase provide the driving force for CFTR-mediated anion secretion, by the -
hydrolysis of A TP (Ito et aI, 2000). The inwardly rectifying K+ channel (KIR) , 
expressed on the apical membrane of Calu-3 cells, optimizes the rate of secretion and 
is involved in K+ recycling for the apical H+-K+-ATPase (Wu et aI, 2004). However, 
elevating intracellular cAMP (using forskolin), causes a predominantly HC03 - -rich 
secretion (to exit the cell) via CFTR, due to the presence of active basolateral Na+-
HC03 -cotransport. 
A1 A2 M A5 
84 85 
Figure 1.02 - Calu-3 transport mechanisms. On the apical membrane- CFTR (AI&A2; shown in 
duplicate due to evidence that its CI- and HC03- conductances might be independently controlled), H+-
K+-ATPase (A3), inwardly rectifying K+ channel (K'R; A4) and aquaporin (A5). On the basolateral 
membrane- Na+-K+-2Cr cotransporter (NKCC; BI), Na+-HC03- co transporter (NBC; B2), Na+lH+ 
exchanger (NHE; B3), K+ channel (B4) and aquaporin (B5). All channels and exchangers shown are 
thought to be powered by basolateral Na+-K+-ATPase (indicated by NKP-). CO2 and H20 conversion 
by carbonic anhydrase (CA) is as an important source of cellular HC03 - . This Calu-3 transport model 
was reproduced from Krouse et ai, 2004. 
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Basolateral exit of HC03- may be mediated by CrIHC03- exchange. Previous RT-
PCR and immunofluorescence studies have shown the presence of an AE2 (SLC4A2) 
exchanger in Calu-3 cells (Loffing et ai, 2000). These findings are supported by 
intracellular pH (PHi) measurements examining the recovery of pHi following cell 
acidification with NR.CI, which revealed the presence of DNDS (4,4'-dinitrostilbene-
2,2'-disulfonate)-sensitive, CrIHC03- exchange (Inglis et ai, 2002; see chapter 4 for 
further discussion). 
CFTR is widely regarded as the sole mediator of apical cr and HC03 - secretion in 
Calu-3 cells and hliman airway epithelial' cells (Lee et ai, 1998; Krouse et aI, 2004). 
Illek and colleagues have shown that basolaterally permeabilised Calu-3 cells in the 
presence of a HC03 -gradient, conduct HC03 - through CFTR under cAMP-stimulated 
conditions (Illek et ai, 1997). In addition, pHi studies in human nasal epithelial (HNE) 
cells, using the pH sensitive dye BCECF, showed that normal, but not CF, HNE cell 
pHi may alkalinise/acidify in response to apical cr removal/re-addition, consistent 
with Cr-dependent HC03- transport through CFTR (Paradiso et ai, 2003; see chapter 
3 for further discussion). However, the discovery of SLC26 CrIHC03- exchange 
activity linked to the expression of CFTR in tracheal epithelial cells (Wheat et ai, 
2000), has led to some doubt over this hypothesis. 
1.5 SLC26 transporter family 
An essential function for most secretory epithelia is transepithelial cr and HC03-
transport. HC03- is a vital biological buffer that maintains the pH of the protective 
mucosal layers that line epithelia and plays an important role in the solubilisation of 
mucins and digestive enzymes in secreted fluids (Flemstrom & Isenberg, 2001; Taylor 
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& Abswani, 2002). Transepithelial cr transport, necessary for NaCl and fluid 
secretion, often involves cr uptake via potassium-coupled chloride-transporters, such 
as the NKCC (Hass, 1994), and to a lesser extent by DIDS-sensitive Cr/HC03-
exchange activity mediated by anion exchangers of the SLC4 family (Alper, 2009). -
The SLC4 family also includes a number of Na + -dependent HC03 - cotransporters 
(NBCs), which are critical to the uptake of HC03-. cr channels, such as CFTR, 
mediate cr secretion across the luminal membrane. The transporters involved in 
luminal HC03 - exit remained unclear until the discovery of SLC26A3 (Melvin et aI, 
1999) and the SLC26 family of anion transporters (Mount & Romero, 2004). In most 
secretory epithelia, the coordinated function of CFTR and one or more SLC26 crl 
HC03- exchangers mediate HC03- secretion (Dorwart et aI, 2008; Ohana et aI, 2009). 
The SLC26 genes encode a conserved family of anion transporter proteins. Ten 
SLC26 isoforms have been identified through cloning experiments (Table 1.01). 
SLC26Al (SAT-I) encodes a sol- transporter, shown to exchange sol- for oxalate 
(Bissig et aI, 1994). Positional cloning of disease genes identified other family 
members. 'Mutations in SLC26A2 (DTDST) lead to four different chondrodysplasias 
including diastrophic dysplasia, a cartilage disorder resulting in growth retardation 
(Hastbacka et aI, 1992). SLC26A3 (DRA) is associated with congenital chloride 
diarrhoea (Hoglund et aI, 1996). SLC26A4 (Pendrin) is associated with Pendred 
syndrome (a genetic disorder leading to hearing loss and hypothyroidism) and 
hereditary deafness (DFNB4; Everett et aI, 1997). More recent studies have reported 
that SLC26A5 (Prestin) is defective in non-syndromic hearing impairment (Liu et aI, 
2003). SLC26A6 (P AT -I) is associated with calcium oxalate urolithiasis, as 
SLC26A6 knockout mice develop a high plasma oxalate concentration, consistent 
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with impaired intestinal oxalate secretion due to the absence of SLC26A6 mediated 
Crloxalate exchange (Jiang et aI, 2006). These disease associations, as well as other 
characteristics of the SLC26 family, are summarised in Table 1.01. 
Human Gene Aliases Reported Tissue Disease 
Name substrates Distribution association(s) 
SLC26A1 SAT-1 50/- oxalate liver kidney 
SLC26A2 DTDST 50/-. cr widespread Chondrodysplasias 
SLC26A3 DRA.CLD 50/-. cr. intestine. sweat Congenital Chloride-
HC03-. OH-. gland. losing Diarrhoea 
oxalate pancreas. 
prostate 
SLC26A4 Pendrin cr. HC03-. r. inner ear. Pendred syndrome 
formate kidney. thyroid. 
airways Deafness (DFNB4) 
SLC26A5 Prestin - inner ear Deafness 
SLC26A6 CFEX. PAT-1 504"-. cr. widespread Urolithiasis 
HC03-. OH-. 
oxalate formate 
SLC26A7 PAT-2 50/-. cr. kidney. 
oxalate stomach 
SLC26AB TAT-1 50/-. cr. sperm. brain 
oxalate 
SLC26A9 PAT-4 50/-. cr. lung 
oxalate 
SLC26A10 none pseudogene 
SLC26A11 PAT-5 SO/- widespread 
Table 1.01 - The characteristics of the SLC26 family of anion exchangers. Table adapted from 
Mount & Romero. 2004. 
1.5.1 SLC26 CrlHC01- exchangers 
Functional characterisation of the SLC26 proteins has revealed distinctive patterns of 
anion specificity and transport modes. All SLC26 proteins, except SLC26A5 (prestin; 
a motor protein of cochlear outer hair cells), can function as anion exchangers, 
transporting both monovalent and divalent anions. The modes of transport mediated 
by SLC26 members include the exchange of chloride for bicarbonate, hydroxyl, 
sulfate, formate, iodide, or oxalate with variable specificity. Functional studies in 
Xenopus oocytes revealed that mouse SLC26A6 transports most of these substrates 
(Xie et ai, 2002), whereas human SLC26A4 transports only monovalent anions and 
not divalent anions (Scott et aI, 1999). 
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Physiological interest in the characterisation of the SLC26 family members was 
stimulated in particular by the observation that SLC26A4 (Pendrin) can function as a 
Crlformate exchanger in Xenopus oocytes, since Cr/formate exchange is thought to 
play an important role in the trans epithelial transport of NaCI by the renal proximal 
tubule (Scott & Kamiski, 2000). cr and formate radioisotope e6CI and [14C] formate) 
efflux measurements in Xenopus oocytes injected with human SLC26A4 
demonstrated that addition of chloride to the external bathing solution stimulated the 
efflux of e4C] formate and formate addition stimulated the efflux of 36CI in oocytes 
expressing Pendrin, consistent with Pendrin-mediated Crlformate exchange (Scott & 
Kamiski, 2000). However, subsequent immunolocalisation studies in the mammalian 
kidney (mouse, rat and human) failed to detect any evidence ofPendrin staining in the 
proximal tubules, but instead detected Pendrin on the apical surface of ~-intercalated 
cells of the cortical collecting duct (Royaux et ai, 200 I). The same study discovered 
that Pendrin instead plays a pivotal role in renal HC03 - secretion, since perfused 
cortical collecting duct tubules isolated from alkali-loaded Wild-type (WT) mice 
secreted HC03-, whereas tubules from alkali-loaded Pendrin knockout (KO) mice did 
, 
not. More recent studies have shown that Pendrin KO mice display significantly 
acidic urine (pH 5.2 compared to 6.0 in WT mice) along with elevated serum HC03-
concentration in vivo (Amlal et ai, 2010). Furthermore, pHi experiments (determined 
using the pH-sensitive fluorophore, BCECF) in ~-intercalated cells of the cortical 
collecting duct, showed a reduced alkalinisation in pHi in response to bath cr removal 
in Pendrin KO mice compared to WT mice, consistent with Pendrin mediating cr 
IHC03- exchange (Amlal et ai, 2010). 
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Many of the SLC26 members mediate CrIHC03- exchange in a limited number of 
tissues including the gastrointestinal tract and kidney, with distinct subcellular (apical 
or basolateral) localization (Soleimani et aI, 2006). These include: SLC26A3 in the 
pancreas (Ko et aI, 2002) and intestine (Melvin et aI, 1999); SLC26A4 in the thyroid 
and kidney (Soleimani et aI, 2001); SLC26A6 in the pancreas (Ko et aI, 2002) and 
intestine (Wang et aI, 2006); SLC26A 7 in the stomach (Petrovic et aI, 2003) and 
kidney (Petrovic et aI, 2004). 
More recent functional measurements' in Xenopus oocytes and HEK (human 
embryonic kidney) cells transfected with SLC26A 7 showed that SLC26A 7 functions 
as a cr channel, since the extent of the cr current was unaffected by H C03 -indicating 
that SLC26A 7 is impermeable to HC03- (Kim et aI, 2005). Also, as the presence of 
HC03 - increased the selectivity of SLC26A 7 for cr due to the regulation of the 
channel by [H+li, it was proposed that SLC26A 7 may function as a pHi sensor (Kim et 
aI, 2005). SLC26A9 was also demonstrated to mediate Cr/HC03- exchange activity 
when expoossed in transfected Xenopus oocytes (Chang et aI, 2009) and HEK cells 
(Xu et aI, 2005). However, like SLC26A 7, SLC26A9-mediated currents resemble a 
cr channel with minimal permeability to HC03 - (Dorwart et aI, 2007; see section 
3.11.1 for further discussion). SLC26A3 appears to function both as a coupled anion 
exchanger and as a channel depending on the ions being transported (Shcheynikov et 
aI, 2006). Evidence for SLC26A3 functioning as an anion channel was obtained when 
N03- and SCN- were used as substrates in oocytes and HEK cells expressing 
SLC26A3. Replacing cr with N03- (or SCN) in HEPES-buffered media produced a 
rapid increase in the outward current, measured at ~ +60 m V, due to influx of N03-, 
17 
indicating that SLC26A3 has an anion channel capability that can conduct N03- or 
SCN- under these conditions. 
cr/HC03- exchange mediated by SLC26A3 and SLC26A6, but not SLC26A4, can be 
inhibited by the anion transport inhibitor, DIDS, although the DIDS-sensitivity of 
SLC26A3 remains controversial. Intracellular cr and pH measurements in SLC26A3 
transfected HEK cells, using cr and pH sensitive dyes (MQAE and BCECF 
, 
respectively), showed that SLC26A3 mediated CrlHC03 - exchange could only be 
inhibited by -22% in the presence of I' mM DIDS and -45% with 4 mM DIDS 
(Lamprecht et aI, 2005). Similar experiments performed in SLC26A6 transfected 
Xenopus oocytes, demonstrated that SLC26A6 Cr-dependent changes in Oocyte pHi 
could be abolished by 5 J.lM DIDS (Shcheynikov et aI, 2006). cr uptake 
measurements in the HEK-Phoenix cell line, showed that SLC26A4 overexpression 
(by SLC26A4 transfection) lead to an increase in cr uptake, above the levels achieved 
in cells expressing endogenous levels of SLC26A4, which could not be significantly 
inhibited by 0.5 mM DIDS (Dossena et aI, 2006). It is noteworthy that H2-DIDS (a 
DIDS derivate that does not interfere with fluorescence) was shown to have no effect 
on anion transport through CFTR when applied externally (Haws et aI, 1992), but 
DIDS can inhibit CFTR when added to the intracellular side of the membrane 
(Linsdell & Hanrahan, 1996). 
The stoichiometry of CI-/HC03- exchange appears to differ between SLC26 
homologs, as determined by simultaneous measurements of HC03 - and cr fluxes in 
transfected Xenopus oocytes, such that SLC26A3 transports cr ~2 ions per HC03-
ion, whereas SLC26A6 transports HC03- ~2 ions per cr ion (Shcheynikov et aI, 
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2006). The proposed 1:2 stoichiometry of the SLC26A6 CrIHC03 - exchanger, was 
substantiated by the finding that luminal cr removal, in guinea pig pancreatic duct 
cells expressing SLC26A6 (Stewart et ai, 2009) or in SLC26A6 transfected Xenopus 
oocytes (Xie et ai, 2002), caused membrane hyperpolarisation. However, functional 
studies using human SLC26A6 polypeptide variants, found SLC26A6 to exhibit 
electroneutral anion exchange (Chemova et ai, 2005). The same study also discovered 
that mouse and human SLC26A6 proteins expressed in Xenopus oocytes, differ in 
their overall anion selectivity and transport mechanism. Therefore species differences 
must be taken into account when drawing comparisons between. SLC26 protein 
function in human and animal tissue. 
1.5.2 Regulation ofSLC26 CrIHC01- exchangers by CFTR 
Early patch-clamp studies investigating HC03 - transport across the luminal membrane 
of pancreatic duct cells, suggested that an apical cr conductance (CFTR) working in 
parallel with a CrIHC03- exchanger, provided the mechanism for electrogenic HC03-
secretion by these cells (Gray et ai, 1988; Novak et ai, 1988). Analysis of tracheal 
epithelial cells isolated from CF patients (deltaF508 mutation) revealed that a 
SLC26A3 CrIHC03 - exchanger was abundantly expressed in cells expressing 
functional CFTR, but not in cells that lacked CFTR or that expressed mutant CFTR 
(Wheat et ai, 2000). Subsequent results have shown a direct interaction between 
apically co-localised SLC26 exchangers and CFTR in other tissues (Ko et ai, 2002). 
For CFTR to regulate members of the SLC26 family, they need to exist in the same 
HC03 --transporting complex. Immunoprecipitation of pancreatic SLC26A3 caused 
CFTR to be co-immunoprecipitated from wild-type, but not in CF-deltaF508 mice, 
providing evidence for such a complex (Ko et ai, 2002). 
19 
All ten of the mammalian SLC26 proteins, predict a hydrophobic core, for which the 
details of membrane topology are as yet unknown. However, since the amino- and 
carboxyl-terminal domains of SLC26A3 and A6 are intracellular, it is expected that 
these proteins span the plasma membrane 10 to 14 times (Mount & Romero, 2004; 
Dorwart et ai, 2008). Some SLC26 proteins end with a class I PDZ interaction motif 
at their carboxyl terminus (Songyang et ai, 1997), with the exception of SLC26A1, 
A2, A4, A5 and All. PDZ (acronym representing the first three identified PDZ-
containing proteins: PSD95, DLG, ZO-l) domains are protein-protein interaction 
domains that play an essential role in the assembly of multiprotein complexes 
involved- in determining cell polarity, plasma membrane targeting and regulation of 
membrane proteins (Fanning & Anderson, 1999). PDZ domains mediate interactions 
between the carboxyl terminals of proteins that terminate in consensus PDZ binding 
sequences (Songyang et ai, 1997). The CFTR PDZ interaction domain (TRL) , has 
been shown to be required for binding to related PDZ domain proteins including 
Na+/H+ exchanger 3 (NHE3) regulatory factor (NHERF) and NHE3 kinase A 
regulatory, protein (E3KARP) in Calu-3 cells (Sun et ai, 2000). These interaction 
motifs may not be necessary for SLC26 transport function, as functional expression of 
SLC26A6 and three alternatively spliced variants of SLC26A6 with truncated 
carboxyl terminals in Xenopus oocytes, showed no difference between the cr and 
SO/- transport of the mutated and WT proteins (Lohi et ai, 2003). However, 
interestingly the same study demonstrated by in vitro binding assays, that the carboxyl 
terminus of SLC26A6, which contains a PDZ interaction motif identical to that of 
CFTR, interacts with both NHERF and E3KARP, and that truncation of the carboxyl 
terminus abrogated these interactions. 
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The carboxyl-tenninal cytoplasmic domain of all ten SLC26 proteins includes the 
STAS (Sulfate Transporter and Anti-Sigma) domain, uncovered due to the homology 
between the SLC26 gene family and bacterial anti-sigma factor antagonists (Aravind 
& Koonin, 2000). Structural analyses have indicated that CFTR and SLC26 
transporters interact through their R and STAS domains, respectively (Ko et ai, 2004). 
This interaction is enhanced by R domain phosphorylation by PKA, since 00-
immunoprecipitation of the STAS and R domains was higher from cells (HEK cells 
transfected with CFTR and SLC26A3) stimulated with forskolin (to activate PKA) 
than in cells treated with the PKA inhibitor H-89. The interaction between the SLC26 
exchanger and CFTR is also modulated by PDZ-scaffold proteins, such as EBP50, 
that tether the two transporters into a multimeric complex with other regulatory 
proteins (Ko et ai, 2004). These molecular interactions, in most cases, mutually 
stimulate the transport activity of both CFTR and the SLC26 exchanger, resulting in 
enhanced bicarbonate and fluid secretion from epithelial tissues. This structural 
coupling is summarised in Figure 1.03. 
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Figure 1.03 - Interactions between CFTR and SLC26 transporters. CFTR and SLC26 are 
envisaged to interact through binding of their respective Rand ST AS domains, a process that is 
enhanced by PKA-mediated phosphorylation of the CFTR R domain. PDZ-binding proteins, including 
EBP50 and E3KARP, help assemble all these proteins into a mUlti-component bicarbonate-transporting 
complex at the apical membrane of epithelial cells through interactions with the transporter's PDZ-
binding motifs. Reproduced from Gray, 2004. 
Pancreatic duct HC03 - secretion is proposed to be mediated by the co-ordinated 
transport of CFTR and apical SLC26 CrlHC03 - exchange. Both SLC26A3 and 
SLC26A6 have been identified in pancreatic duct cells by Northern hybridisation and 
immunohistochemical studies (Greeley et aI, 2001). SLC26A6 is likely to be the 
major CrIHC03 - exchanger involved in HC03 - secretion across the apical membrane 
of ductal cells, since the apical AE activity present in guinea pig pancreatic duct cells 
can be inhibited by relatively low concentrations of DIDS (assessed by Cr-dependent 
pHj measurements; Stewart et aI, 2009) and the co-localisation of CFTR and 
SLC26A6 in the apical membrane of rat pancreatic intralobular ducts (Shcheynikov et 
aI, 2006). Also, when CFP AC-l cells (human pancreatic cell line which lack 
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functional CFTR) were transfected with wild-type CFTR, SLC26A6 mRNA 
expression was enhanced and apical CrIHC03- exchange activity increased (Greeley 
et ai, 2001). Inhibition of CFTR by the addition of CFTR inhibitor, CFTRinh-172, 
enhanced cAMP-stimulated HC03- secretion from guinea pig intralobular pancreatic 
duct cells, as calculated from changes in luminal pH and volume (Stewart et ai, 2009). 
Deletion of SLC26A6 in mouse intralobular pancreatic duct cells revealed an 
enhanced spontaneous HC03- secretion by CFTR, due to the removal of tonic 
inhibition ofCFTR by SLC26A6 (Wang et ai, 2006). These data suggest that SLC26 
anion exchangers and CFTR reciprocally regulate one another, and compensate or 
compete with each other for HC03- secretion with Cr-rich fluid in the lumen (Song et 
ai, 2009). In SLC26A6 knockout mice, a five-fold upregulation in the expression of 
SLC26A3 to compensate and potentially replace the function of SLC26A6 in 
pancreatic ducts was observed (Ishiguro et ai, 2007). The proposed 2: 1 stoichiometry 
of the SLC26A3 CrIHC03- exchanger is believed to help generate the 140 mM HC03-
-rich fluid produced by the pancreatic duct, as an electronetural 1: 1 exchanger would 
be expecteQ to reverse under such conditions. 
In the villous epithelium of the duodenum, SLC26A6 mediated CrIHC03- exchange is 
facilitated by cr 'leak' through CFTR under basal conditions, thus maintaining a 
favourable outside/inside cr concentration gradient, as determined by the ~35% 
reduction in apical CrlHC03- exchange activity across the CF villous epithelium. A 
similar partial inhibition of apical CrIHC03- exchange was observed in WT duodenal 
epithelium following treatment with the CFTR-selective blocker glibenclamide 
(Simpson et ai, 2005). 
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As well as regulating CrIHC03 - exchange, CFTR has also been shown to markedly 
activate Cr/OH- exchange mediated by SLC26A3, A4 and A6 (Ko et ai, 2002). Such 
CFTR-regulated Cr-OH- I Cr-HC03- exchange in the airways, both in the submucosal 
and surface epithelial cells, may prove to be important in maintaining the pH of the 
ASL necessary for antimicrobial molecules and ultimately mucociliary clearance. The 
absence of such anion exchange could lead to a possible acidification of ASL, as has 
been reported in CF airways, which may further contribute to the characteristic weak 
lung defence (Coakley et ai, 2003). Clearance of bacteria could be deficient in low pH 
due to the reduction in ciliary beat frequency in the bronchial epithelium following the 
acidification of external pH (Clary-Meinesz et ai, 1998). In CF depleted PCL, a low 
pH could ''tighten'' adhesive interactions between reported membrane-bound mucins 
and mucins of the mucus layer of the ASL (Matsui et ai, 1998), by altering the 
exposure of hydrophobic regions of the mucin molecules (Bhaskar et ai, 1991), 
therefore reducing the effectiveness of the mucus against harmful inhaled particles. 
Also the fact that HC03 - secretion often accompanies mucus secretion suggests that 
HC03- re!Wlation is required for proper mucus production (see section 6.1; Holma & 
Hegg, 1989; Quinton, 2001; Garcia et ai, 2009). 
The roles of the SLC26 anion exchanger family are well documented in the kidney,. 
intestine and pancreas. This, along with evidence for a reciprocal interaction between 
SLC26 CrIHC03- transporters and CFTR, suggests that CFTR may mediate HC03-
transport via apical SLC26 transporters and therefore SLC26-mediated HC03-
transport may play an important role in airway fluid homeostasis and have 
implications in CF research. 
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1.6 Aims 
As described, most HC03 - secreting epithelia possess one or more SLC26 Cr/HC0
3
-
exchangers, which together with CFTR, mediate HC03 - transport across the luminal 
membrane. In the airways, the apical transporters involved in HC03 - secretion remain 
unclear. Hence, the purpose of this study was to investigate the potential role of 
SLC26 CrlHC03- exchangers in airway epithelia; specifically in serous cells of the 
submucosal gland as well as at the airway surface by employing the Calu-3 cell line 
and primary human bronchial epithelial (HBE) cells, respectively. 
The specific aims were: 
1) To assess the expression of SLC26 transporters at the RNA level by 
quantitative real time-PCR in Calu-3 cells and HBE cells in order to identify 
the SLC26 CrlHC03 -exchangers relevant for further study at the protein level. 
2) To investigate SLC26 Cr/HC0 3- exchange activity in Calu-3 cells and HBE 
cells by fluorimetry measurements of Cr-dependent changes in intracellular 
pH, (PHi), using the fluorescent dye biscarboxyethylcarboxyfluorescein 
(BCECF). 
3) To characterise CrlHC03 - exchange activity in Calu-3 cells by anion 
selectivity and pharmacological studies. 
4) To identify the contribution of individual SLC26 transporters using an RNA 
interference approach. 
5) To examine the localisation of SLC26 protein expression in Calu-3 cells by 
immunocytochemical analysis. 
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6) To assess the role of CFTR in Calu-3 cell HC03- transport, and its potential 
regulation of CrIHC03- exchange activity, using CFTR inhibitors and CFTR 
knockdown Calu-3 cells. 
7) To establish the physiological role of CrIHC03- exchange in serous cell 
HC03 - and fluid secretion, by measuring the pH and volume of Calu-3 cell 
fluid secretion under differing buffer conditions and in the presence of 
pharmacological agents. 
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2. Methods 
2.1 Cell culture 
Routine tissue culture techniques were perfonned in a class II vertical laminar flow 
hood (Jouan Ltd, UK). All culture media, media supplements and consumables were 
obtained sterile or sterilised using a high pressure and temperature autoclave. Cell 
lines were routinely passaged once per week and frozen stocks were maintained in 
liquid nitrogen. In all cases culture media and solutions were pre-warmed in a water 
bath at 37°C prior to use. 
2.1.1 Calu-3 cells 
The human adenocarcinoma-derived cell-line, Calu-3 (passage 20-50; Shen et ai, 
1994), were grown in T 75 Costar cell culture flasks, at an initial seeding density of 3 
million cells per flask. Cells were grown in a culture medium containing 30 mls of 
minimal essential medium eagle (MEME) supplemented with 10% foetal calf serum, 
2 mM L-glutamine, 100 Umrl penicillin, 100 /lgmrl streptomycin and 5 mls 100x 
non-essential amino acids per 500 ml of medium (Sigma). The cells were incubated in 
humidified air containing 5% C02 at 37°C. 
CFTR knockdown (KD) Calu-3 cells, provided by Prof. Alan Cuthbert (Cambridge 
University), produced by small inhibitory RNA persistent down regulation of CFTR 
using a retroviral vector (MacVinish et ai, 2007), were cultured in Calu-3 media (as 
above) supplemented with geneticin (400 /lglml; G418; Sigma). SLC26A4, SLC26A9 
and cyclophilin B knockdown Calu-3 cells were grown in media supplemented with 
puromycin (10 /lglml; Sigma; see section 2.2). 
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Generally cells reached confluency after 7 days, as detennined by light microscopy. 
To subculture, media was removed and cells were washed 3 times with sterile 
phosphate buffered saline (PBS; Sigma). Cell flasks were then incubated in 5 ml of 
trypsin solution (0.05% trypsin and 0.02% ethylenediaminetetraacetic acid, EDT A, in 
Earle's balanced salt solution; Sigma) for 5-15 minutes in a humidified incubator at 
37°C. Following incubation 15 ml of pre-warmed culture medium was added to the 
flask and the suspension was agitated gently. The resulting cell suspension was 
centrifuged at 800g for 5 min. The supernatant was discarded and the cell pellet was 
re-suspended in 10 ml of media. 
Cells were then seeded at 250,000 cells cm-2 onto clear Costar Transwell® or 
Snapwell® inserts (0.45 /lm pore size, 1.12 cm2 surface area), for microfluorimetery 
and Ussing chamber studies, respectively. Transwells and Snapwells were supplied 
with 0.5 ml of media to the apical surface and 1.5 ml basolaterally. Cells grown under 
air-liquid interface (ALI) conditions, spent 5 days submerged before the media from 
the apical "Surface was removed from the Transwell/Snapwell insert. Calu-3 cells 
generally formed a confluent monolayer after 5 days growth on Transwell inserts, 
with an organised cytoskeleton (Figure 2.01). Experiments were carried out 7-14 days 
post-seeding. 
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Figure 2.01- Confluent Calu-3 cell monolayer cytoskeleton staining by phalloidin. Phalloidin 
TRITC staining of the actin cytoskeleton of a confluent Calu-3 cell monolayer grown on a Transwell 
insert under submerged conditions for 7 days post-seeding. Scale bar represents 47.62 !lM. 
The integrity (confluence) of the cell monolayer and hence the viability of the cells 
was routinely assessed by measuring transepithelial resistance (RT) using an epithelial 
voltohmmeter (EVOM; World Precision Instruments, UK) attached to 'chopstick' 
electrodes. Calu-3 cells grown on Transwell inserts normally reached a stable 
resistance of ~800 n.cm2 after 5-7 days and resistance remained stable for up to a 
further 7 days (Figure 2.02). 
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Figure 2.02 - WT Calu-3 cell monolayer resistances. Mean wild-type Calu-3 cell monolayer 
resistances (n.~m2) after 1, 3, 7 and 10 days post-seeding on Transwell inserts, grown under submerged 
conditions. The resistance of a blank Transwell insert (without cells) was subtracted from RT 
measurements. mean ± S.E.M. n=24. 
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For [Ca2+]i measurements, Calu-3 cells were seeded onto 22 mm x 40 mm glass, 
coverslips and grown for 5-7 days submerged in 1 ml of media until confluent. 
2.1.2 FR T cells 
Fischer rat thyroid (FRT) cells stably transfected with Pendrin or CFTR (Pedemonte 
et ai, 2007; Pedemonte et ai, 2010), were a gift from Dr Luis Galietta (Istituto 
Giannina Gaslini, Genova, Italy). In brief, human Pendrin was cloned by extracting 
RNA from human bronchial epithelial cells, which was retrotranscribed into eDNA, 
from which the full-length Pendrin-coding sequence could be amplified. FRT cells, 
already expressing the yellow fluorescent protein (YFP)-HI48Q/I152L, were 
transfected with a plasmid vector carrying the Pendrin-coding sequence and 
neomycin-resistance gene, using lipofectamine. FRT cells were also transfected with a 
plasmid vector containing wild-type·CFTR. 
Non-transfected (control), Pendrin-transfected and CFTR-transfected FRT cells were 
grown in T 75 Costar cell culture flasks, at an initial seeding density of 2 million cells 
per flask. Cells were grown in a culture medium containing 30 ml of Coon's modified 
Ham's F-12 media supplemented with 10% foetal calf serum, 2 mM L-glutamine, 100 
Umri penicillin, 100 J,tgmri streptomycin and 5 ml 100x non-essential amino acids 
per 500 ml of medium (Sigma). CFTR-transfected FRT cell media was supplemented 
with 0.75 mg/ml geneticin (G418; Sigma) and 0.6 mg/ml zeocin (Sigma). Pendrin-
transfected FRT cell media was supplemented with 1 mg/ml geneticin (G418; Sigma) 
and 0.5 mg/ml hygromycin (Sigma). The cells were incubated in humidified air 
containing 5% C02 at 37 °C and cultured using the same methods as Calu-3 cells. 
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2.1.3 Primary human bronchial epithelial cells 
Human bronchial epithelial cells (HBE cells; Clonetics) were isolated by an 
enzymatic method, cultured and harvested for cryopreservation. These cryopreserved 
cells were then defrosted and grown in 50 ml of bronchial epithelial cell basal media 
(BEBM) containing BEGM singlequots (Clonetics) in a T-162 flask (Fisher) until 
confluent. P I (passage 1) cells were trypsinised with 10 ml trypsin EDT A at 37°C for 
5 min. Cells were reseeded at 5 x lOs cells to T -162 flasks in 50 ml differentiation 
media containing 50% BEBM: 50% dulbecco's modified eagles medium (DMEM; 
4.5g mrl glucose), BEGM singlequots (without triiodothreonine, retinoic acid and 
GA 1000), gentamicin (1: 1000) and all trans retinoic acid (5x 10-8 M; all Clonetics). 
HBE cells were seeded at 8.25x104 cells/well on Costar Transwell inserts (0.45 J..lm 
pore size, 1.12 cm2 surface area) and fed with differentiation media (as above), 0.5 ml 
apically and 1.5 ml basolaterally, every 2 days. For SLC26 expression studies, HBE 
cells were grown on transwells under 3 different protocols: 7 days submerged 
(submerged protocol); 7 days submerged and 7 days at ALI (D7 protocol); 7 days 
submerged and 14 days at ALI (D14 protocol). For pHi experiments, HBE cells were 
grown using the D14 protocol. 
2.2 shRNA knockdown of SLC26A4 and SLC26A9 in Calu-3 cells 
SLC26A4, SLC26A9 and cyclophilin B (control) knockdown Calu-3 cells were 
provided by Dr Emma Hickman (Novartis, Horsham, UK). Short hairpin RNA 
(shRNA) knockdown of the relevant gene expression was achieved by applying 
Sigma MISSION lentiviral transduction particles to Calu-3 cells according to the 
manufacturers instructions, using a multiplicity of infection ratio of 1 and knockdown 
cells were selected using 10 J..lg/ml puromycin (Sigma; Table 2.01). 
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Product No. ~hRNA Target Sequence rrarget Gene 
TRCNOOOOO44283 ~CGGGCGATTGTGATGATCGCCATTCTCGAGAATGGCGA SLC26A4 
~CATCACAATCGCTTTTTG 
TRCNOOOOO44284 pCGGCCAGCAGCAATGGAACTGTATCTCGAGATACAGTT 
tCATTGCTGCTGGTTTTTG 
TRCNOOOOO44285 ~CGGCCAACCTGAAAGGGATGTTTACTCGAGTAAACATCC 
~TTTCAGGTTGGTTTTTG 
TRCNOOOOO44287 ~CGGCCCTATCCTGACATACTTTATCTCGAGATAAAGTAT 
k;TCAGGATAGGGTTTTTG 
TRCNOOOOO44049 PCGGCCAGAAAGTATTACTAGCCAACTCGAGTTGGCTAGT ~LC26A9. 
~TACTTTCTGGTTTTTG 
TRCNOOOOO44050 pCGGCCCAGGTGTACAATGACATTACTCGAGTAATGTCAT 
~GTACACCTGGGTTTTTG 
TRCNOOOOO44051 CCGGGTGGGAGAGAAACTTCGCAATCTCGAGATTGCGAA 
k;TTTCTCTCCCACTTTTTG 
TRCNOOOOO44052 pCGGGATCCTGATTTCGGTGCTCAACTCGAGTTGAGCAC 
CGAAATCAGGATCTTTTTG 
TRCNOOOOO49248 PCGGCCATCGTGTAATCAAGGACTTCTCGAGAAGTCCTTG ~yclophilin B 
ATTACACGATGGTTTTTG 
TRCNOOOOO49249 pCGGCTTCGGAAAGACTGTTCCAAACTCGAGTTTGGAACA 
k;TCTTTCCGAAGTTTTTG 
TRCNOOOOO49250 CCGGCCGGGTGATCTTTGGTCTCTTCTCGAGAAGAGACC 
~GATCACCCGGTTTTTG 
TRCNOOOOO49251 CCGGGTTCTTCATCACGACAGTCAACTCGAGTTGACTGTC 
GTGATGAAGAACTTTTTG 
TRCNOOOOO49252 CCGGGCCTTAGCTACAGGAGAGAAACTCGAGTTTCTCTC 
CTGTAGCTAAGGCTTTTTG 
.. Table 2.01 - SLC26A4, SLC26A9 and cyclophllin B gene shRNA product information. 
2.3 Measurement of pHi 
~ 
Cells were loaded with 10 J.1M of the pH-sensitive fluorescent dye, 2',7'-bis-(2-
carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM), in Hepes-
buffered salt solution (composition given below) for 45-60 minutes at 37°C (Hegyi et 
aI, 2004). This time period was chosen as it resulted in little pHi buffering by BCECF~ 
AM, but achieved sufficient loading to adequately measure changes in pHi for up to 
90 minutes, as monitored by the signal to noise ratio of the fluorescence traces. 
Transwells were placed in a perfusion chamber and mounted onto an inverted 
microscope (Nikon) stage. Cells were brought into focus using a x60 magnification 
fluorescence lens (Nikon) and perfused with a HC03--buffered Krebs solution, gassed 
with a 95% 02, 5% C02 mixture at 37°C, to maintain solution pH at 7.4. The 
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temperature of the solution was heated to 37°C by running the perfusion inlet tubes, 
through tubing circulating hot water connected to a water bath. HEPES-buffered 
solutions were not gassed. Transwell apical and basolateral bath volumes were 0.5 
and 1 ml and were perfused at a rate of 3 and 6 ml min-!, respectively. pR was 
measured using a Life Sciences Microfluorimeter System (Life Sciences Resources, 
UK)_ To measure pIli, patches of 15-20 cells were excited alternately at 490 nm and 
440 nm wavelengths with a xenon-quartz lamp at a frequency of 2 Hz using a 
Rainbow filter wheel (Life Sciences Resources, UK) and the fluorescent light emitted 
by the cells was detected at 535 nm every 512 milliseconds using a photomultiplier 
tube. The filter wheel was synchronised with the computer data collection software 
such that photomultiplier tube counts were recorded using photon counters at 
specified times when light excitation was maximal. 
The ratio (R) between the counts at 490 nm (proton-bound BCECF; pHi-dependent 
count) and 440 nm (proton-free BCECF; pHi-independent count) was recorded using 
PhoCal software and used to calculate pHi. R values were calibrated to pHi using the 
K+-H+ exchanger ionophore, nigericin (10~M), in high K+ solutions of various pH 
values from 5.6-8.6 (see section 2.10). Nigericin equilibrates pHi with pHe, so that pHi 
is determined by the high K+ solution's pH and therefore the R value that results will 
be equal to the pH of the solution (Marilyn, 1992). An example of a nigericin 
calibration is shown in Figure 2.03. 
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Figure 2.03 - Mean fluorescence ratio-pHi calibration standard curve for WT Calu-3 cells. 
Fluorescence ratio (490/440) was measured using high K+ nigericin solutions of known pHi values 
(5.6-8.6) in WT Calu-3 cells. Red line indicates line of best-fit, correlating mean fluorescence data 
(indicated by black circles; all data points from 3 experiments) with pHi values. n=3. 
2.3.1 Analysis of pHi data 
Mean changes in pHi were estimated by calculating the average pHi over 60 second 
periods (120 data points). Mean pHi values were calculated immediately before 
(labelled A in Figure 2.04) and after (labelled B) a new solution was applied, to 
establish a basal pHi. This value was then subtracted from the mean pHi obtained once 
a new steady state had been established (labelled C), to determine the mean change i~ 
pHi. The initial rate of pHi change (.:1pH/.:1t) was calculated by linear regression fitted 
to a minimum of 40 data points, upon re-acidification (labelled D). Linear regression 
data were only used with an? (regression coefficient) value >0.5. 
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Figure 2.04 - Analysis of pB; data. Standard zero-Cr response, illustrating the effects of standard and 
Crfree HC03--buffered solutions on pH; in Calu-3 cells. Blue areas indicate data used to calculate mean 
pH; change and the red line indicates the plot of linear regression used to determine the rate of pH; 
change (re-acidification). 
2.3.2 Determination ofCalu-3 cell buffering capacity 
In order to convert changes in pHi into rates of base equivalent flux, cellular buffering 
capacity had to be taken into account. The total intracellular acid/base buffering 
capacity (Ptotal) is the sum of the C02-HC03--dependent buffering capacity (PHC03-) 
and the intrinsic C02-independent buffering capacity (Pi). Wild-type and CFTR KD 
Calu-3 cell Pi was estimated using the ammonium pulse technique (Roos & Boron, 
1981). Cells were exposed to varying concentrations of NH4CI (0, 2.5, 5, 10, 20, 30 
mMlL) in the absence of Na+ and HC03- from the bath solution to block Na+- and 
HC0 3--dependent pH regulatory mechanisms (see solutions section 2.10). Exposure 
of cells to a solution of NH3-NH4 + leads to the rapid entry of membrane-permanent 
NH3 into the cell, causing an alkalinisation in pHi due to the consumption of H+ as 
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intracellular NH3 is converted to NH/. ~i was then calculated by the Henderson-
, 
Hasselbalch equation (Figures 2.05 & 2.06). The total buffering capacity was 
is the intracellular concentration of HC03). The rate of change in pHi was converted 
to the transmembrane efflux of bicarbonate (-J(B» using the equation: -J(B)= rate of 
pHi change x ~total. 
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Figure 2.05 - Wild-type Calu-3 cell buffering capacity at various pHi values. The intrinsic 
buffering capacity (Pi), buffering capacity of the HC03-IC02 system (PHC03-) and total buffering 
capacity (Plotai) of WT Calu-3 cells grown on transwell inserts under submerged conditions for 7 days 
post-seeding. n=4. Lines indicate line of best-fit, correlating mean fluorescence data (all data points 
from 4 experiments). 
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Figure 2.06 - CFTR KD Calu-3 cell buffering capacity at various pHi values. The intrinsic 
buffering capacity (~i)' buffering capacity of the HC03-/C02 system (~HC03-) and total buffering 
capacity (~totai) of CFTR Knockdown Calu-3 cells grown on transwell inserts under submerged 
conditions for 7 days post-seeding. n=3. See Figure 2.05 for further details (please note that the absicca 
differs bet\feen Figure 2.05 and 2.06). 
A similar relationship between pH and buffering capacity was observed in WT, CFTR 
KD and Pendrin KD Calu-3 cells. 
2.4 Measurement of rCa2Ji 
[Ca2+]i was measured in confluent Calu-3 cell monolayers grown on coverslips, using 
the Ca2+-sensitive dye, fura-2, in a methodology similar to that previously described 
in neuroblastoma cells (Brown et aI, 2005). Cells were washed in HEPES-buffered 
solution, and loaded with fura-2 by incubating coverslips in a solution of 3 flM Fura-2 
acetoxymethyl ester (AM; Molecular Probes) in HEPES buffered solution for 45 min 
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at room temperature. Single coverslips were mounted into a coverslip holder 
(PerkinElmer, UK), which was inserted into a thermostatically-controlled and 
magnetically stirred fluorimeter cuvette maintained at 37°C. Fura-2 fluorescence was 
monitored using a PerkinElmer LS-50B fluorimeter, with excitation and emission 
wavelengths of 340 nm and 510 nm respectively. Once a steady baseline fura-2 
fluorescence count was established, thapsigargin (200 nM) was added to the HEPES-
buffered solution in the cuvette. [Ca2+]i was calculated using PerkinElmer WinLab 
software, which uses the Grynkiewicz equation ([Ca2+]i= Kd (F-FminIFmax-F) and 
assumes a dissociation constant (Kd) of 224 nM at 37°C (Grynkiewicz et ai, 1985). 
Fmax (maximum fura-2 fluorescence) was determined by the addition of 50 /lM 
ionomycin and the addition of 1 mM MnCh to obtain FMn (fluorescence after 
quenching offura-2), was used to calculate Fmin (minimum fura-2 fluorescence) using 
the equation: Fmin= 1/3(Fmax - FMn) + FMn. In situ calibrations were performed at the 
end of each experiment to account for variations in Calu-3 cell confluence and Fura-2 
loading. 
2.5 Short-circuit current measurements 
Short-circuit current (Isc) measurements were performed on Calu-3 cells cultured on 
Snapwell inserts, mounted in Ussing-type chambers on a gas and heating manifold 
(Costar). Cells were submerged in HC03--buffered Krebs solution, perfused with a 
95% 02, 5% C02 gas mixture and heated at 37°C, to maintain solution pH at 7.4. 
Chambers were connected to an automatic voltage-clamp apparatus (World Precision 
Instruments) via KCl/agar salt-bridges and reversible electrodes (Ag/AgCI for current 
passage, calomel for voltage sensing). Two chambers were used simultaneously to 
allow direct comparison between submerged and ALI grown Calu-3 cells. After 5 
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minutes of equilibrium in Krebs solution, the offset potential was corrected for using 
the offset circuit setting on the voltage clamp. In open-circuit mode, the transepithelial 
voltage was checked (usually around -10 mV for Calu-3 cells), to ensure that 
electrodes were properly connected and to test for air-bubbles. Then the voltage clamp 
was switched to short-circuit mode and Isc values were recorded. Agonists and 
inhibitors were added to the static Krebs solution of the chambers by pipette. 
2.6 Fluid and mucin secretion assays 
2.6.1 Fluid secretion volume measurements 
Confluent Calu-3 cell monolayers, grown for 7-10 days on Costar transwell supports 
under submerged conditions, were washed three times with PBS (lml to apical and 
basolateral compartments) to remove any mucus secretions from the apical surface of 
the monolayer. PBS was carefully aspirated from the apical and basolateral 
compartments to ensure no residual fluid remained on either side of the transwell. The 
~ 
rate of fluid secretion was determined by applying 200 III and 1 ml of Krebs solution 
to the apical and basolateral surfaces of the cells, respectively, as well as the desired 
agonist or inhibitor. Cells were placed in a humidified C02 incubator at 37°C and the 
volume of the apical fluid was measured using an appropriate Gilson pipette, after 
24/48172 hours. For HC03--free experiments, Calu-3 transwells bathed in HEPES-
buffered solution were placed in a humidified incubator maintained at 37°C without 
C02 gassing. Krebs solutions were used instead of media for fluid secretion studies, as 
this allowed alterations to be made to the composition of the external fluid bathing the 
cells (such as cr rem,oval), in the same way as the pHi experiments. After the required 
incubation time the total fluid volume was measured by removing the first 180 III of 
apical fluid, with the reminder removed 1 III at a time, to ensure accuracy. 
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Evaporation was taken into account by measuring the reduction in the apical volume 
of fluid on transwells coated with silicone gel to stop fluid leakage across the 
membrane, which equated to 2.0 ± 0.4 Jll/cm2124 h (n=12). All fluid secretion values 
have been corrected for evaporation. 
2.6.2 pH measurements of secreted fluid 
For pH measurements, the first 180 JlI of apical fluid was removed and the pH of this 
solution measured using a micro pH electrode (Hamilton, Switzerland) attached to a 
pH meter (pH meter 240, Coming). pH was measured immediately upon removal of 
the transwell from the incubator, one transwell at a time, to minimise changes in pH 
when the HC03--buffered solutions were exposed to air. Measurement of the rate of 
change in pH of the HC03--buffered solutions following removal from the CO2 gassed 
incubator, determined that solution pH alkalinised by 0.04 pH units min-I, which 
should be taken into consideration when approximating the margin of error of these 
measurements. The remaining fluid volume was then measured and later analysed for 
mucin content. 
2.6.3 PAS assay 
The mucin content of the apical fluid was measured using a periodic acid-Shiffs 
(PAS) assay (Mantle & Allen, 1978). PAS is a non-specific staining method used to 
detect glycoproteins, such as mucins, through the oxidisation of glucose by periodic 
acid. This creates aldehydes that react with the Schiff reagent to form a purple stain 
that can be detected by spectrophotometry. Aliquots of Calu-3 cell fluid secretions 
were thoroughly mixed and 100 JlI sample used for each PAS analysis. The 100 JlI 
secretion sample was made up to 1 ml with deionised water. For the standard curve, 
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purified digested porcine mucin was used (Img/ml in deionised water; mUCIn 
obtained from Prof. Jeff Pearson, Newcastle University) and diluted into 50,20, 10,5, 
2 and 1 Ilg/ml samples using deionised water. As a negative control, a 1: 10 dilution of 
HC03--buffered Krebs solution was used. The fluid secretion, mucin standard curve 
and negative control samples were individually combined with 100 III of periodic acid 
mixture (made from 10 ml of 7% acetic acid plus 20111 of 50% periodic acid) in 5 ml 
glass test tubes and placed in a water bath for 1 hour at 37 °C, covered with foil to 
avoid evaporation. Schiffs solution was made by combining 6 ml of Schiffs reagent 
with 0.1 g sodium metabisulfite in a lOml test tube, which was also placed in the 37 
°C water bath for 1 hour. 100 III of Schiffs solution was then applied to each sample 
(including mucin standard curve and negative control samples) and left to develop for 
30 minutes at room temperature. The relative PAS staining in each sample was read 
using a spectrophotometer (UNICAM 8625'> at an absorbance wavelength of 555 nm. 
The negative control Krebs solution was used to set the spectrophotometer reading to 
zero. The absorbance readings of the Calu-3 fluid secretion samples were then 
converted to glycoprotein (mucin) concentrations using the standard curve (Figure 
2.07). 
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Figure 2.07 - Mucin concentration standard curve. Spectrophotometer 555 om absorbance readings 
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indicates line of best-fit, correlating mean absorbance readings (indicated by black circles) with mucin 
concentration. 
2.7 Quantitative RT-PCR analysis of SLC26 gene expression 
Total RNA was isolated and cDNA prepared as described below. Quantitative RT-
PCR (Taqman) analysis was used to ascertain levels of test gene and endogenous 
control mRNA present in the Calu-3 and HBE cell samples at various time points. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a housekeeping 
gene control and was quantified using pre-optimised Taqman primer probe mixes 
(Applied Biosystems). SLC26 gene expression was assayed using previously 
optimized primer probe sets (Applied Biosystems, Assays-on-Demand) described in 
Table 2.02 below. Amplicons were designed to span intron-exon boundaries to 
preclude possible amplification of genomic DNA sequences. 
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Assay ID lContext Sequence ~ene Symbol IT arget Exons 
Hs00222784 m 1 TCCCTCAGGTCGGCCACGGGACCTG ~LC26A1 1 
Hs00164423 m1 GGAGTTTATCAGGTAGCGATGGGCT ~LC26A2 1 
Hs00230798_m1 ATGAATCCTGGATTTCAGCCCCCTA ~LC26A3 ~ 
Hs00166504 m 1 GGAGGAAAGACACAGGTTGCTGGCA ~LC26A4 10 
Hs01398264 m1 ~LC26A5 f4 
Hs01398267 m1 ~LC26A5 7 
Hs00370470 m 1 TGGCAGAGTACTCAGAGGCCAAGGA ~LC26A6 14 
Hs00369311 m1 TTCCACAAGGAATTCCCTCACCTAG ~LC26A7 17 
Hs00369519 m1 TCCAGTGCCGCTGCTCATGGCACAG SLC26A8 ~ 
Hs00369432 m 1 TTTGCTCACCCACTGCTTGTAAATG SLC26A9 1 
Hs00369451 m1 ~LC26A9 ~O 
Hs00543412 m 1 GAGCTGCTGGCCATCGGTCTCACCA ~LC26A11 3 
Table 2.02 - SLC26 gene assay primer sequences. SLC26A5 and SLC26A9 pruner sequences were 
unavailable. 
Total RNA was isolated from HBE cells using the Qiagen RNeasy mini-prep kit 
according to the manufacturer's instructions. RNA was quantified and checked for 
purity and integrity using the Bioanalyser 2100 (Agilent Technologies) and RNA total 
nano chips and reagent kits (Agilent Technologies). cDNA synthesis performed with 
the Oene~p RT-PCR kit (Applied Biosystems cat no.N808-0143) as advised by the 
manufacturer and at a concentration of 20 ng/ml total RNA. A standard was generated 
from pooled cDNA generated in the same way from commercially manufactured total 
RNA derived from a variety of human tissues (liver, spleen, kidney, lung, testis, 
pancreas, brain, and foetal brain - Total RNAs purchased individually from 
Clontech). 
Reactions were performed in 25 III reaction volumes. 'Assay-on-demand' (FAM-
labelled) and Endogenous control (VIC-labelled) Primer/MOB Probe mixes (both 
from Applied Biosystems) were used at a 1 :20 dilution as recommended. Reactions 
also contained 12.5 III of2x Taqman Universal PCR mastermix (Applied Biosystems) 
and a final volume of 5 III cDNA at the appropriate dilution. Sterile water was added 
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to 25 III and also used as a negative control for cDNA. The standard curve wa,s 
prepared from serial dilutions of mixed human cDNA to generate total starting RNA 
curve of 100 ng down to 6.25 ng. The unknown samples were loaded at 50 ng starting 
RNA per well and all standards and samples were tested in triplicate. Reactions were 
performed in 96-well optical plates and were analysed on an ABI PRISM 7700 
sequence detector (Applied Biosystems) with the following programme: 50°C for 2 
min and 95 °C for 10 min followed by 45 cycles of 95°C for 15 s and 60°C 1 min. 
Data were quantified by the relative method from the standard curve (ABI PRISM 
7700 Sequence Detection System. User Bulletin No.2, PE Applied Biosystems, 1997) 
and RNA expressed as percentage compared to standard curve with normalisation 
against the individual endogenous controls. 
2.8 Immunocytochemistry 
Calu-3 cells grown for 7-14 days post-seeding on transwell inserts, were fixed and 
permeabilised using methanol. This involved washing the transwells with PBS prior 
to, and following, incubation with cold 100% methanol (-20°C) for 15 minutes on 
ice. Following fixation the membrane of the transwell inserts were removed using a 
scalpel and placed in a 24-well plate. 
Non-specific binding sites were blocked by incubating with 3 % horse serum (diluted 
in PBS) for 1 hour at room temperature on an orbital shaker. The primary antibody, 
mouse anti-Pendrin polyclonal antibody (Abnova) at 1 :200 or mouse anti-CFTR 
antibody (R & D systems) at 1 :200, diluted in 3 % horse serum, was then added and 
incubated overnight at 4 °C following 1 hour incubation at room temperature on an 
orbital shaker. Cells were then washed with PBS followed by further blocking with 3 
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% goat serum in PBS for 1 hour at room temperature on an orbital shaker. Finally, a 1 
hour incubation at room temperature on an orbital shaker with goat anti-mouse Alexa 
Fluor 488 (green; Molecular Probes, Invitrogen) at 1: 1 00 in 3 % goat serum was 
carried out for secondary detection. Cells were then rinsed in PBS. Control 
experiments omitted the primary antibody. 
In some cases cells were co-stained for the tight junctional protein zona occludens 1 
(ZO-l), by applying a rabbit anti-ZO-1 antibody at 1 :500, and the secondary antibody, 
goat anti-rabbit Alexa Fluor 568 (red; Molecular Probes, Invitrogen) in parallel with 
other primary and secondary antibodies. 
The actin cytoskeleton of cells was stained usmg Alexa Fluor 633 Phalloidin 
(Molecular Probes, Invitrogen) at a concentration of 1 :500. 
Following incubation with relevant secondary antibodies, membranes were washed 
three times in PBS and mounted on a glass microscope slide, sandwiched between a 
minimal quantity of Vector shield (Molecular Probes, Invitrogen) and overlaid with a 
coverslip. Cells were imaged using confocal laser scanning microscopy (CLSM) 
using a Leica TCS-NT system (Leica UK Ltd.) with appropriate excitation and 
emission filter sets for dual fluorophore detection and Z or XY-series images collected, 
using xl 00 oil immersion lens. Z-section images were captured at -1 Ilm intervals. 
For each experiment, positive signals were verified by comparison with no-primary 
antibody controls. Leica software, under identical conditions of imaging, illumination 
intensity and photo-multiplier settings for each cell type, was used to capture images. 
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2.9 Western blot analysis 
The relative level of CFTR protein expression in CFTR KD, Cyclophilin B KD 
(control KD) and Pendrin KD Calu-3 cells, compared to WT Calu-3 cells, was 
determined by Western blot analysis. 
Calu-3 cells on transwell inserts were washed once with ice cold PBS followed by 5 
min incubation on ice with modified radio immunoprecipitation assay (RIP A) buffer 
containing: 50 mM Tris buffer pH 7.5, 1 % Nonidet P-40 (Sigma), 0.25% sodium 
deoxycholate (Sigma), 150 mM sodium chloride (Fisher), 1 mM sodium fluoride 
(Sigma), 5 mM B-glycerolphosphate (Sigma), 1 complete protease inhibitor cocktail 
tablet + EDTA (Roche), 0.5 mM phenylmethylsulphonylfluoride (PMSF) (Sigma), 
ImM sodium orthovanadate (Sigma), and made up to 50 ml with water. PMSF and 
sodium orthovanadate were added to aliquots of modified RIP A buffer just prior to 
use. After incubation with modified RIP A buffer, cells were scraped off transwell 
• 
inserts using a cell scraper. The cell lysate was then centrifuged at 21,000 g and 4 °C 
for 10 min to remove cell debris and DNA. 
Total cell protein concentration was quantified using using a bicinchoninic acid 
(BCA) assay. A BCA Protein Assay Kit (PiercelUptima) was used according to the 
manufacturer's instructions. Measurement of the absorbance of a range of bovine 
serum albumin (BSA) standards (0.025-2 /Jg; Sigma) at 562 nm and the subsequent 
construction of a standard curve allowed the protein concentration of unknown 
samples to be estimated. Samples were analysed using a SpectraMax 250 microplate 
reader and SOFTmax Pro analysis software (Molecular Devices). 
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Polyacrylamide gels for electrophoresis were prepared from liquid polyacrylamide 
before being poured between glass plates that were clamped together with a 1 mm 
divide. Separating gel consisted of: 375 mM Tris pH 8.8, 10% Acrylamide/Bis 19:1 
solution, 0.1 % SDS. Stacking gel consisted of: 125 mM Tris pH 6.8, 4% 
Acrylamide/Bis 19: 1 solution, 0.1 % SDS. Stacking gel was laid on top of the 
separating gel and had a comb inlaid to form wells. Protein samples were prepared to 
contain equal amounts of total protein and SDS sample buffer (50 mM Tris HCI pH 
6.8, 2% SDS, 6% glycerol, 0.02% bromophenol blue, and 1 % ~-mercaptoethanol) 
before being loaded into the gel wells with a lane reserved for a coloured protein 
standard (used to estimate the molecular weight of the resulting protein bands). 
Gels were immersed in SDS-PAGE running buffer (25 mM Tris Base, 192 mM 
glycine, 3.5 mM SDS in water) and electrophoresis ran over 1-2 hours at 100 V 
increasing to 180 V when the loading dye had entered the separating gel. When the 
~ 
protein samples had run far enough through the gel (assessed using the prestained 
protein standards) the protein was transferred to a nitrocellulose membrane. The gel 
was placed in a sandwich between blotting paper against the nitrocellulose membr~e 
and immersed in transfer buffer (25 mM Tris Base, 192 mM glycine, 0.35 mM SDS, 
and 20% methanol in water). Transfer occurred over 1 hour at 100 V incubated at 4 
DC. The protein-bound membrane was then removed from the sandwich and blocked 
by incubation in Tris-buffered saline (TBS; Tris 12.6 mM, NaCI 137 mM adjusted to 
pH 7.6 with HCI) containing non-fat milk powder (4%) and Tween-20 (0.1 %), with 
mild agitation overnight at 4 DC. This reduces the incidence of non-specific binding 
directly to the membrane and thus high background signal. The membrane was then 
incubated with mouse anti-CFTR antibody prepared in the TBS-milk-Tween solution 
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at a 1 :500 dilution, for 2 hours at room temperature, inside a tube with constant 
rolling. After primary antibody incubation the membrane was washed three times with 
TBS-O.l % Tween solution before incubation with anti-mouse polyclonal IgG 
conjugated to horse radish peroxidase (HRP; Abeam) at a 1:1000 dilution (in TBS-
milk-Tween solution), for 2 hours at room temperature inside a tube with constant 
rolling, after which time, the membrane was washed again in TBS-O.l % Tween. 
To Visualise immunostained proteins, membranes were stained for 5 min with a 
chemiluminescence solution (ECL Plus Western Blotting Detection Reagent, 6E 
Healthcare) prepared just before use according to the manufacturer's instructions. The 
membranes were then imaged using a Fujifilm FLA-3000 fluorescent image analyser. 
The antibodies were stripped from the nitrocellulose in order to re-stain the membrane 
with a GAPDH antibody to double-check the relative concentration of protein in the 
samples. Nitrocellulose was immersed in stripping buffer (200 mM glycine (Fisher), 
3.5 SDS (Fisher), 1 % Tween 20 in H20 with pH adjusted to 2.2) for two 10 min 
incubations, before two 5 min washes in TBS-O.l % Tween solution, with mild 
agitation, at room temperature. Membranes were then re-blocked ready for addition 
of the anti-GAPDH monoclonal antibody (used at dilution of 1: 10000; Cell Signaling 
Technology, UK). 
Western blot images were scanned into a computer and analysed using AlphaEaseFC 
5.0 Software (Alpha Innotech). The integrated density value (lDV) of each band was 
measured. The IDV is the sum of the values of the average pixel intensity in the 
48 
selection, which is equivalent to the product of the area and mean background pixel 
intensities. The IDV was corrected for intensity of the background. The selection area 
remained constant for each set of bands analysed. Graphs and statistical analyses of 
band IDVs nonnalised to GAPDH were done using GraphPad Prism software. 
2.10 Solutions and reagents 
The standard Krebs ringer HC03'-buffered (KRB) bath solution contained (in mM): 
115 NaCI, 5 KCI, 25 NaHC03, 1 MgCh, 1 CaCh and 10 D-glucose. In the high K+ 
KRB solution, the KCI concentration was increased to 115 mM and NaCl reduced to 5 
mM to maintain osmolarity. In the Cr-free KRB solution, cr was substituted for 
gluconate, with 6 mM Ca-gluconate replacing I mM CaCh to compensate for the 
Ca2+ buffering capacity of gluconate and 5 mM KCI was replaced with 2.5 mM 
K2S04. The Na+-free KRB solution consisted of {in mM): 115 NMDG-CI (from a 1M 
stock solution- pH to 7.0 at 37°C using HCI), 5 KCI, 1 MgCh, 1 CaCh, 25 choline 
HC03' and 10 D-glucose, with 10 JlM atropine added just before use to prevent 
possible activation of muscarinic receptors by choline. 
The HC03'-free, HEPES (4-{2-Hydroxyethyl)piperazine-l-ethanesulfonic acid) -
buffered solution consisted of (in mM): 130 NaCI, 5 KCI, 1 MgCh, 1 CaCh, 10 Na-
HEPES and 10 D-glucose. The Cr-free HEPES-buffered solution contained (in mM): 
130 Na-gluconate, 2.5 K2S04, 1 Mg-gluconate, 6 Ca-gluconate, 10 HEPES (free acid) 
and 10 D-glucose. All HEPES-buffered solutions were set to pH 7.4 by the addition of 
either HCI or NaOH and HC03' solutions adjusted to pH 7.4 by bubbling with 5% 
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High K+ calibration solutions contained (in mM): 5 NaCI, 130 KCI, 1 MgCh, 1 CaCh, 
10 Na-HEPES, 10 D-glucose and 10 J..lM nigericin. High K+ solutions were made to a 
range of pH values (5.6-8.6) using HCl. For pH 8.6, a TRIS-buffer was used in place 
of HE PES. For pH 6.2 and 5.6, MES-buffer was used. 
The ammonium pulse solutions (used to calculate buffering capacity) consisted of (in 
mM): 115 NMDG-CI, 4.5 KCI, 1 MgCh, 2 CaCh, 10 HEPES (free acid), 30 NH4CI, 5 
BaCh and 10 D-glucose (PH to 7.4 at 37 °c using CsOH). The concentration of 
NH4CI was lowered to 20, 10, 5, 2.5 and 0 mM, by replacement with equimolar 
NMDG-CI (125, 135, 140, 142.5 and 145 mM respectively). 
All stock solutions of agonists and inhibitors used for pHi and fluid secretion 
experiments were made in dimethyl sulfoxide (DMSO), except nigericin, fostriecin 
(both made in 100% ethanol), 8CPT-2Me-cAMP, VIP, carbachol and adenosine (all 
dissolved in deionised water). 
All general chemicals were purchased from Sigma-Aldrich (Sigma-Aldrich Company 
Ltd., UK), except forskolin (Tocris), BAPTA-AM (Fulka), 8CPT-2Me-cAMP 
(Tocris) and okadaic acid (Calbiochem). 
2.11 Statistical analysis 
Statistical analysis was performed using either paired Student's t test or one-way 
ANOVA with Bonferroni's post hoc test, depending on the number of groups being 
analysed. P values of <0.05 were considered statistically significant. Results are 
presented as mean ± S.E.M, where n indicates the number of experiments. All 
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statistical analysis was undertaken usmg GrapbPad Prism software (GrapbPad 
Software, U.S.A.). 
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3. Apical Cr/HC01- exchane:e activity in Calu-3 cells 
3.1 Introduction 
In most HC03- secreting epithelia, apical HC03- transport is mediated via CFTR and 
cr/HC03- exchange. In airway serous submucosal gland cells, from which the Calu-3 
cell line is derived, CFTR is widely regarded as the sole mediator of apical cr and 
HC03- secretion (Illek et ai, 1997; Lee et ai, 1998; Krouse et aI, 2004). However, the 
discovery of SLC26 CrIHC03- exchange activity linked to the expression of CFTR in 
tracheal epithelial cells, has led to some doubt over this hypothesis (Wheat et ai, 
2000). 
The presence of Cr/HC03- anion exchange (AE) was assessed in Calu-3 cells by the 
removal and re-addition of cr independently from the apical and basolateral 
perfusates. Crremoval should reverse an active CrlHC03- exchanger, with cr exiting 
the cell down its concentration gradient, driving HC03- influx and thus raising 
.. 
intracellular pH (pHj), as has been previously shown in pancreatic duct cells (Zhao et 
ai, 1994; Lee et ai, 1999; Rakonczay et ai, 2008). Following the subsequent re-
addition of cr, a Cr/HC03- exchanger would be expected to transport in the forward 
mode (Cr IN: HC03- OUT) and thus re-acidify pHj. 
3.2 cAMP-dependent stimulation 
Initial experiments focussed upon the potential presence of apical and basolateral cr 
IHC03- exchange activity under non-stimulated and cAMP-stimulated conditions, by 
directly activating adenylyl cyclase using forskolin (Figure 3.01). Forskolin has been 
previously shown to stimulate an almost pure HC03- secretion from voltage-clamped 
Calu-3 cells grown on permeable supports (Devor et ai, 1999). Under non-stimulated 
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conditions apical cr removal had no effect on pHi. However removal of basolateral 
cr produced an alkalinisation in pHi of 0.43 ± 0.01 pH units (mean ± s.e.m.; P<0.001 
paired t-test; n=35; Figure 3.02), which subsequently re-acidified back to baseline 
pHi following cr re-addition to the basolateral perfusate at a rate of 0.52 ± 0.03 pH 
units min-I (-J(B)= 49.08 ± 6.96 mM B min-I; n=35). 
The addition of forskolin (5 J.lM added to apical solution) in the presence of bilateral 
cr (Figure 3.01), produced an acidification of 0.13 ± 0.01 pH units (n=35) at a rate of 
0.08 ± 0.01 pH units min-I (-J(B)= 2.26 ± 0.32 mM B min-I). Forskolin-stimulation 
produced a 'switch' in AE activity, activating an apical anion exchanger and 
inhibiting basolateral AE. Apical cr removal caused an alkalinisation of 0.64 ± 0.03 
pH units (P<0.001, n=35) after forskolin stimulation (Figure 3.02). In contrast to the 
alkalinisation seen on removal of basolateral cr, this alkalinisation was somewhat 
biphasic, with an initial fast rate of change, followed by a much slower gradual 
.. 
increase in pHi until a plateau in pHi was reached. The rate of this apical AE activity 
was 0.77 ± 0.08 pH units min- I (P<0.001, n=35) measured following apical cr re-
addition (-J(B)= 67.26 ± 13.34 mM B min-I). No change in pHi was observed 
following the removal ofbasolateral cr under forskolin-stimulated conditions. 
Neither activation of the apical AE nor basolateral AE inhibition was seen upon 
application of dideoxyforskolin, an inactive analogue of forskolin, confirming that 
changes in [cAMP]i are responsible for the forskolin-induced 'switch' in AE activity 
(P>0.05 compared to non-stimulated apical & basolateral cr dependent changes in 
pHi; n=3). The addition of dideoxyforskolin had no significant effect on pHi. 
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Figure 3.01- pHi experimental trace of forskolin-induced 'switch' in AE activity in Calu-3 cells. 
The effects of forskolin (5JlM) on changes in pRi following the independent removal of apical or 
basolateral chloride in Calu-3 cells. Apical ocr denotes the removal of apical chloride and Baso ocr 
the removal of chloride basolaterally. 
A B 
Figure 3.02- Forskolin-induced ' switch ' in AE activity in Calu-3 cells. Mean alkalinisation (PRJ 
produced by chloride removal (A) and the rate of re-acidification upon chloride re-addition in C'!lu-3 
cells (B), under non-stimulated and forskolin-stimulated (FSK; 5 JlM) conditions. n=35. Paired 
observations. A: *P<O.OOI compared to apical OCr. tP<O.OOl compared to baso ocr. B: *P<O.OOI 
compared to apical OCr. tP<O.OOl compared to baso OCr. 
Both the alkalinisation m pHi produced upon basolateral cr removal in non-
stimulated Calu-3 cells and the alkalinisation in pHi following the removal of apical 
cr under forskolin-stimulated conditions, are consistent with CrlHC03- exchange 
activities. However, the apical zero cr induced alkalinisation may also represent cr-
dependent HC03 - influx through CFTR, which will be discussed later, but for 
54 
simplicity the apical cr -dependent changes in pHi will be referred t ._ 
o as apIcal AE 
activity. The basolateral anion exchange seen under non-stimulated . . . 
condItIons IS 
consistent with the AE2 CrlHC03- exchanger shown in previous Calu 3 II 
- ce transport 
models (discussed in full in chapter 4). However, at the time of wn·t· . 
lng, no studIes 
have shown the presence of an apical CI-IH C03 - exchanger in these cell s. 
HC03 - secretion across the apical membrane was investigated using the l·nh.b.t 
1 lor stop 
method (Hegyi et ai, 2003). Exposing Calu-3 cells to basolateraI4,4'-diisothiocyano_ 
1,2-diphenylethane-2,2'-disulfonate (H2-DIDS; 500J.tM) and 5-(N-Ethyl-N-
isopropyl)-amiloride (EIPA; 3J.tM) produced a marked decrease in pHi (Figure 3.03). 
This acidification in pHi was due to H2-DIDS inhibition of HC03- transport across the 
basolateral membrane via the Na+-HC03- cotransporter (NBC) and CrIHC0
3
-
exchangers and EIPA inhibition ofH+ transport via the Na+lH+ exchanger (NHE), and 
thus reflects the rate of HC03- secretion across the apical membrane through cr 
IHC03"'" exchangers and/or CFTR as previously described (Szalmay et ai, 2001). 
These inhibitor stop experiments showed that the rate of apical HC03- secretion was 
enhanced by forskolin-stimulation (P<0.05; n=4; Figure 3.04), which complements 
the stimulation of apical AE by forskolin. This forskolin-mediated increase in the rate 
of acidification in pHi could be abolished (P<O.OI; n=4) by the addition of CFTR pore 
blocker GlyH-10l (Muanprasat et ai, 2004; for a general review of the mechanisms of 
CFTR inhibition see Li & Sheppard, 2009). Interestingly, EIP A addition alone had no 
significant effect on pHi in either non-stimulated or forskoHn-stimulated Calu-3 cells, 
suggesting the basolateral NHE does not contribute to pHi changes under these 
conditions (P>0.05; n=4). The base efflux under non-stimulated and forskolin-
stimulated conditions in Calu-3 cells, was approximately a quarter of the base efflux 
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previously observed in non-stimulated and secretin-stimulated (also elevates cAMP) 
pancreatic duct cells respectively, which are known to secrete a HC03--rich fluid of 
~140 mM [HC03-] (Hegyi et aI, 2003). 
7. 
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Figure 3.03- pHi experimental trace of forskolin-stimulated HC03' secretion in Calu-3 cells. 
Intracellular acidification after basolateral application of H2-DIDS (500 ,....M) and amiloride (3 ,....M) 
under non-stimulated conditions and forskolin-stimulated (5 ,....M) conditions in the presence and 
absence ofCFTR inhibitor GlyH-IOl. 
A B 
Figure 3.04- Forskolin-stimulated HC03- secretion in Calu-3 .cells. The rate of intracellular 
acidification (PHi min"; A) and base efflux (mM B min" ; B), following the basolateral application of 
H2-DIDS and amiloride (inhibitor stop method) under non-stimulated conditions and forskolin-
stimulated conditions (+FSK), in the presence and absence ofCFTR 'inhibitor GlyH-IOl. n=4. Paired 
observations. A: *P<O.OI compared to control inhibitor stop tP<O.OI compared to inhibitor 
stop+FSK+GlyH-IOl. B: *P<0.05 compared to control inhibitor stop tP<O.OI compared to inhibitor 
stop+FSK +GlyH-1 0 I . 
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The cAMP dependence of the apical AE was further investigated using physiological 
cAMP agonists vasoactive intestinal peptide (VIP) and adenosine (ADO). _ VIP 
released by non-cholinergic neurons innervating airway submucosal glands stimulates 
a HC03- rich fluid secretion by elevating cAMP and activating CFTR (Wine & Joo, 
2004). VIP has been shown to regulate CFTR via basolateral VPAC1 receptor 
activation of both PKA and PKC-dependent pathways, as well as increasing CFTR 
expression in Calu-3 cells (Derand et ai, 2004; Chappe et ai, 2008). Samples from 
Calu-3 cell secretions showed that they release ATP, which is converted by 
ectonucleotidases to form ADO (Huang et ai, 2001). ATP signalling in Calu-3 cells is 
thought to be via ADO, rather than A TP itself, since Calu-3 cells do not express P2Y 
receptors (Communi et ai, 1999). A2A and A2B adenosine receptor mRNA have been 
shown to be expressed in Calu-3 cells, with short-circuit measurements indicating the 
presence of A2B receptors on both membranes and A2A receptors on the basolateral 
membrane (Szkotak et ai, 2003). These membrane surface receptors are coupled to 
adenylyl cyclase and thus raise intracellular cAMP. A2B adenosine receptors, in 
particular, have been linked to cr and HC03- secretion from airway cells due to their 
coupling with CFTR through stimulation of protein kinase A (PKA)(Clancy et ai, 
1999). 
Basolateral VIP and bilateral ADO addition elicited similar changes in pHi In 
response to the removal of apical chloride, compared to forskolin (P>0.05; n=4; 
Figure 3.05). 
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Figure 3.05- cAMP agonists VIP & adenosine stimulate apical AE activity in Calu-3 cells. The 
effect of apical forskolin (FSK; 5f,lM), basolateral vasoactive intestinal peptide (VIP; 150nM) and 
bilateral adenosine (ADO; lOf,lM) on the mean alkalinisation in pHi following the removal of apical cr 
in Calu-3 cells. n=4. Agonists ran in parallel in separate experiments. *P<O.OOI compared to apical 
OCr. 
Interestingly, the extent of apical AE activation was dependent on which membrane 
ADO was applied to (Figure 3.06). The mean change in pHi produced in response to 
apical cr removal after exposure to basolateral ADO was significantly smaller 
(P<0.05; n=3) compared to bilateral ADO addition. In contrast, apical ADO addition 
produced a similar stimulation of the apical AE compared to bilateral ADO, 
highlighting the importance of local changes in cAMP on apical AE activity. This is 
consistent with the finding that the addition of apical ADO stimulates cr secretion in 
Calu-3 cells, with little change in intracellular cAMP levels, suggesting localised 
activation ofCFTR by apical adenosine receptors (Huang et aI, 2001). 
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Figure 3.06- AdenoSine-stimu;ated apical AE activity in Calu-3 cells. The effect of bilateral, apical 
only and basolateral only adenosine (ADO; 10 f.LM) addition on the mean alkalinisation (pH j) produced 
by apical chloride removal (A) and the rate of re-acidification upon apical chloride re-addition in Calu-
3 cells (B). n=3. Each condition ran in parallel in separate experiments. A: *P<O.05 compared to 
bilateral ADO. 
An alternative way of looking at forskolin stimulation of the apical AE was to apply 
forskolin after the removal of apical cr (Figure 3.07). Under these conditions 
forskolin (S IlM) addition did not produce a gradual alkalinisation in pHi (response 1). 
In the absence of apical cr, forskolin addition produced a rapid alkalinisation in pHi 
after 37.S ± 4.0 s (n=4) , at a rate and magnitude (ApHi change) similar to that 
produced upon removal of apical cr with prior incubation with forskolin (S IlM; 
response 2; P>O.OS; n=4). 
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Figure 3.07- Forskolin induces an alkalinisation in pHi in the absence of apical Cr. A comparison 
between the effects of the addition of forskolin (5 J.lM) during apical zero cr and the removal of apical 
cr following prior incubation with forskolin on pHj in Calu-3 cells. 
To further investigate the mechanisms involved in the stimulation of apical AE 
activity by cAMP, the effects of the protein kinase A (PKA) inhibitor H-89 (50 IlM) 
on AE activity was examined in Calu-3 cells (PKA ICso ~48 nM; Chijiwa et aI, 1990). 
Figure 3.08 shows that the forskolin-stimulated apical AE was inhibited by 64.9 ± 
8.9% (mean change in pHi; P<0.001; n=8) in Calu-3 cells treated with H-89, 
compared to untreated 'control' cells. 
A B 
t:: 
E 
-£ -£ 
Co 
.e: 
.: t:: 
.. 0 
CI ~ t:: .. 
.&:. :g U 
~ o. 
e 
'0 
.. 
.,+- fJ>" 1V 
.,+-.~ 0: fJ>" <,..'< 
.,*' <,..'< .,~~ ",v 
.<c ",v 
.'< ~ ~ 
.! ~ ~ 
Figure 3.08- Inhibition of apical AE by PKA inhibitor H-89. The effect of PKA inhibitor H-89 
(50J.lM) on the mean alkalinisation (pHj) produced by apical chloride removal (A) and the rate of re-
acidification upon apical chloride re-addition in forskolin-stimulated Calu-3 cells (B). n=8. Calu-3 cells 
pre-treated with 50 J.lM H-89 for 60mins and H-89 present in bilateral solutions throughout the 
experiments. H-89 treated and untreated Calu-3 cell experiments ran in parallel. A: ·P<O.OOI compared 
to apical OCr+FSK. B: ·P<O.OOI compared to apical ocr+FSK. 
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A similar affect was seen in Calu-3 cells pre-treated with the general protein kinase 
inhibitor staurosporine (PKC ICso -2.7 nM; PKA ICso -S.4 nM; Tamaoki et aI, 1990), 
which reduced the mean change in pHi upon apical cr removal by SI.6 ± 10.9%-and 
the rate of anion exchange by 61.0 ± 16.0% (P<O.OS; n=4; Figure 3.09). 
A B 
Figure 3.09- Inhibition of apical AE by protein kinase inhibitor staurosporine. The effect of 
protein kinase inhibitor staurosporine (cells pre-treated with I ~M staurosporine for 60 mins) on the 
mean alkalinisation (PRJ produced by apical chloride removal (A) and the rate of re-acidification upon 
apical chloride re-addition in forskolin-stimulated Calu-3 cells (B). n=4. Staurosporine treated and 
untreated Calu-3 cell experiments were run in parallel. A: *P<0.05 compared to apical OCr+FSK. B: 
*P<0.05 compared to apical OCr+FSK. 
The fact that not all apical AE activity was abolished by either H-89 or staurosporine 
suggests other kinases or other cAMP targets are involved in the stimulation of the 
apical AE in Calu-3 cells. Other potential downstream targets of cAMP, which may 
be involved in stimulation of apical AE activity, were tested including 
phosphatidylinositol (PI) 3-kinase (inhibited using L Y294002) and the guanine-
nucleotide exchange protein directly activated by cAMP (Epac; stimulated using 
agonist 8CPT-2Me-cAMP). PI-3 kinases are members of the PI kinase family of 
enzymes that convert PI to PI phosphates, which in turn can be cleaved to form 
inositol 1,4,S-trisphosphate (IP3). IP3 is an important secondary messenger as it 
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2+ b . C 2+ I 
elevates [Ca]i y promotmg a re ease from intracellular sto h th 
res suc as e 
endoplasmic reticulum. Studies of cr currents using the path-clamp technique 
demonstrate that PI3-kinase is involved in bile secretion from biliary epithelial ~ells 
(Feranchak et aI, 1999). cAMP activates PI3-kinase activity, which in turn stimulates 
cr secretion and thus bile acid secretion via IP3 production (Kagawa et aI, 2002). 
Thus, PI-3 kinase (and IP3) represent a crossover of cAMP and Ca2+ signalling 
pathways (see section 3.3). In CF epithelial cells, expression of M508-CFTR can be 
rescued by dexamethasone, through a PI3-kinase dependent pathway (Caohuy et aI, 
2009). 
The PI3-kinase inhibitor L Y294002 had no significant effect (P>0.05) on apical AE 
activity under either basal or forskolin stimulated conditions (Figure 3.10). 
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Figure 3.10- PI3-kinase inhibitor LY294402 does not affect Calu-3 apical AE activity. The effects 
of PI3-kinase inhibitor (L Y294402; cells pre-treated with 20 J.LM LY for 60 mins and LY present in 
perfusate throughout the experiments) on the mean alkalinisation (PHJ produced by apical chloride 
removal (A) and the rate of re-acidification upon apical chloride re-addition in unstimulated and 
forskolin-stimulated Calu-3 cells (B). n=4. L Y treated and untreated Calu-3 cell experiments ran in 
parallel. 
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Epac (1&2) are guanine-nuc1eotide-exchange factors for the Ras-like small GTPase 
Rapl and are directly activated by cAMP (de Rooij et aI, 1998). Short-circuit current 
studies demonstrated that Epac1 mediates the PKA-independent stimulation of 
intestinal cr secretion by forskolin (Hoque et aI, 2010). The effects of the Epac 
agonist 8CPT-2Me-cAMP could be abolished by the Ca2+ chelator BAPTA-AM, 
suggesting that, like PI3-kinase in biliary epithelial cells, Epac activates cr secretion 
by elevating [Ca2+k 8CPT-2Me-cAMP has also been shown to stimulate Ca2+ release 
from intracellular Ca2+ stores in pancreatic ~-cells (Kang et aI, 2003). 
The addition of the membrane permeable Epac agonist 8CPT-2Me-cAMP to the 
apical perfusate was also unable to stimulate apical AE activity. Furthermore, apical 
AE in Epac-stimulated cells was still responsive to forskolin. These results suggest 
that cAMP stimulation of the apical exchanger is predominately through a PKA-
dependent pathway and the residual activity in the presence of PKA inhibitors is not 
due to Epac (Figure 3.11). 
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Figure 3.11- Epac activation does not stimulate apical AE activity in Calu-3 ceUs. The effect of 
Epac agonist 8CPT-2Me-cAMP (50 f.LM) on the mean alkalinisation (PHi) produced by apical chloride 
removal (A) and the rate of re-acidification upon apical chloride re-addition in Calu-3 cells (B). n=3. 
Paired observations from same experiments. 
63 
Genistein (4,5,7-trihydroxyisoflavone), is a tyrosine kinase inhibitor (Akiyama et ai, 
1987), but it has been shown to potentiate cAMP-stimulated CFTR activity (Illek et 
ai, 1996; Hwang et ai, 1999). The actions of genistein are thought to involve 
enhanced phosphorylation of CFTR, via the inhibition of protein phosphatases 
(Reenstra et ai, 1996) or by direct binding of genistein to CFTR to alter channel 
gating (French et ai, 1997; Hwang et ai, 1999) and even inducing increased CFTR 
expression (Schmidt et ai, 2008). However, elevated concentrations of genistein (100 
IlM) can inhibit CFTR, by altering channel gating or blocking the channel pore 
(Lansdell et ai, 2000). In Calu-3 cells genistein addition alone stimulated chloride 
efflux and enhanced cAMP-stimulated HC03" and cr currents across the apical 
membrane (Illek et ai, 1997). In light of these results I investigated whether genistein 
might be involved in activating or potentiating apical AE activity. 
Genistein did not stimulate apical AE alone, but enhanced the mean change in pHi 
upon apical cr removal in the presence of the cAMP agonist forskolin, from 0.62 ± 
0.02 to 0.82 ± 0.04 pHi units (P<O.OOI; n=4; Figure 3.12). However, the rate of apical 
• AE activity following the re-addition of apical cr was not affected by genistein 
(P>0.05; n=4). 
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Figure 3.12- Potentiation of apical AE activity by genistein in forskolin-stimulated Calu-3 cells. 
The effects of genistein (30 flM) on the mean alkalinisation (PHJ produced by apical chloride removal 
(A) and the rate of re-acidification upon apical chloride re-addition in unstimulated and forskolin-
stimulated (5 flM) Calu-3 cells (B). n=4. Paired observations. A: *P<O.OOI compared to apical ocr 
+FSK. 
3.3 Effects of Ca2+ on apical Cr/HCO~- exchange activity 
Calu-3 cells are known to secrete HC03- upon stimulation by both cAMP and Ca2+ 
agonists (Krouse et aI, 2004). Ca2+ is a known to regulate a variety of transporters 
including anion exchangers (Green et aI, 1990). Elevation of [Ca2+]i is known to 
stimulate CFTR-dependent Cr/HC03- exchange in pancreatic duct cells, as revealed 
by [Ca2+]i and pHi measurements in ATP treated CAPAN-1 cells (Namkung et aI, 
2003). Also since there was potential for cross-talk between cAMP and Ca2+ 
signalling pathways (such as via IP3), it was important to test the effects of increases 
in intracellular Ca2+ on apical AE activity in Calu-3 cells. Thapsigargin, which raises 
[Ca2+]i by inhibiting Ca2+ uptake into the endoplasmic reticulum through the Ca2+ 
ATPase (Thastrup et aI, 1990), did not stimulate apical AE activity (Figure 3.13). 
Similarly no apical CrtHC03- exchange could be seen following carbachol addition 
(Figure 3.14). 
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Figure 3.13- Elevation of [Ca2+)( by thapsigargin fails to stimulate apical AE activity. The effect of 
thapsigargin (200 nM) on changes in pHi following the removal of apical or basolateral cr in Calu-3 
cells. Apical ocr denotes the removal of cr from the apical solution and Baso ocr the removal of cr 
from the basolateral solution. 
Figure 3.14- Elevation of [Ca2+)( fails to stimulate apical AE activity. The effects of Ca2+ agonists 
thapsigargin (200 nM) and carbachol (10 JlM) on the mean aIkalinisation in pHi following the removal 
of apical cr in Calu-3 cells. n=4. Each agonist was applied in separate experiments, that were run in 
parallel. 
Ca2+ signalling via protein kinase C (PKC) also appears to have little involvement 
with apical AE activity, since the PKC agonist, 1,2-dioctanoyl-sn-glycerol (DOG), 
failed to either stimulate apical AE under basal conditions or alter apical activity 
under forskolin-stimulated conditions (Figure 3.15). 
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Figure 3.15- Protein kinase C activation does not affect apical AE activity in Calu-3 cells. The 
effects ofPKC agonist DOG (cells pre-treated with 5 f.lM DOG for 60 mins) on the mean alkalinisation 
in pHi following the removal of apical cr in Calu-3 cells. n=4. DOG pre-treated and untreated Calu-3 
cell experiments ran in parallel. 
To ensure that intracellular Ca2+ was being increased under these conditions, [Ca2+]i 
levels were measured using the Ca2+ sensitive dye FURA-2 (see methods). These 
experiments showed that [Ca2+]i increased from 166 ± 35 nM to 581 ± 108 nM 
(P<0.01; n=6) upon the addition of 200 nM thapsigargin. The effect of thapsigargin 
on [Ca2+]i could be completely blocked by pre-loading the Calu-3 cells with the Ca2+ 
chelator BAPTA-AM (Figure 3.16). 
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Figure 3.16- Thapsigargin elevates [Ca2+)i in Calu-3 cells. Raw trace of fura-2 Ca2+ experiment (A) 
and the effect of thapsigargin (200 nM) on changes in [Ca2+]i in untreated and BAPTA-AM (50 f.lM) 
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pre-loaded Calu-3 cells (B). n=6. BAPTA pre-treated and untreated cell experiments . 
ran m parallel. 
·P<O.Ol compared to basal. tP<O.05 compared to +BAPTA and +Thaps+BAPTA. 
These results suggest that cAMP is the primary mediator of the activation of apical 
AE activity, as [Ca2+]i agonists fail to stimulate apical AE. 
3.4 Profile of apical CrIHC01- exchanger 
3.4.1 Anion selectivity 
All SLC26 proteins, except SLC26A5, can function as anion exchangers, transporting 
both monovalent and divalent anions. The modes of transport mediated by SLC26 
members include the exchange of chloride for bicarbonate, hydroxyl, sulfate, fonnate, 
iodide, thiocyanate or oxalate with variable specificity. 
The anion selectivity of the apical AE was then examined by measuring the rate of re-
acidification after cr withdrawal from the apical solution, using a range of 
monovalent (iodide, bromide, nitrate, fonnate and thiocyanate) and divalent (sulphate 
and oxalate) anions (Figure 3.17). The recovery of pHi following the re-addition of 
apical cr could only be mimicked by the equimolar addition of monovalent anions, 
but with variable rates of recovery (Figure 3.18). The exchanger has a greater affinity 
for iodide and bromide compared with chloride, thiocyanate, nitrate and fonnate 
(formate 0.6: nitrate 0.8: thiocyanate 0.8: chloride 1: bromide 1: iodide 1.3). One-way 
ANOVA showed a significant difference (P<O.OI; n=5) between the rate of 
acidification upon addition of iodide and the other anions, except bromide. 
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Figure 3.17- pHI experimental trace of the anion selectivity of apical AE in Calu-3 cells. The 
recovery of pHi by the introduction of monovalent (iodide bromide ru·trate C t d thi ) , , , lorma e an ocyanate 
and divalent (sulphate and oxalate) anions in zero cr conditions Equl·mol b ·· f · C 
. ar su stltutlon 0 aruons lor 
Cr(124mM). 
Figure 3.18- Anion selectivity of apical CrIHC03- exchange activity in Calu-3 cells. The rate of 
recovery of pHi by the introduction of monovalent anions (iodide, bromide, nitrate, formate and 
thiocyanate) in apical zero cr conditions. n=5. Paired observations. · P<O.Ol compared to chloride. 
tP<O.OOl compared to formate, nitrate and SCN. ·P<O.Ol compared to formate. 
Because fonnate is a weak acid, this anion could affect pHi directly. Exposing the 
cells to a solution containing 115mM NaFonnate did not cause a significant change in 
pHi under either non-stimulated (0.004 ± 0.007 pH units; P>0.05; n=3) or forskolin-
stimulated conditions (-0.001 ± 0.10 pH units; P>0.05; n=3). Therefore, it can be 
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lOnna e 10 owmg 
removal of apical chloride is due to fonnate supporting apical AE t"t th th 
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by acting as a weak acid. 
3.4.2 HC03--dependence 
The HC03 - and OH- dependence of the apical anion exchange activity was tested by 
removing HC03- from the perfusate bathing the cells and replacing with a HEPES-
buffered solution. As Figure 3.19 shows, in bilateral HC03--free HEPES conditions 
, 
cr removal produced a slow alkalinisation in pHi of 0.27 ± 0.05 pH units, suggesting 
that there maybe some OH- transport by the exchanger. However re-addition of 
external cr only produced a small re-acidification of 0.04 ± 0.03 pH units, which was 
consistently seen in all HEPES experiments. These data demonstrated that apical AE 
activity favours HC03- over OH-, suggesting that Cr-dependent HC03- transport was 
responsible for the observed changes in pHi. 
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Figure 3.19- Apical AE activity under HC03--free conditions. Raw trace ofREPES experiment (A) 
and the effects of apical chloride removal (-Cn and subsequent chloride re-addition (+Cn on pRi under 
bilateral RC03- free conditions, in forskolin-stimulated (5 )lM) Calu-3 cells (B). n=4. Paired 
observations. 
To investigate a potential interaction between carbonic anhydrase (CA) and the apical 
AE Calu-3 cells were exposed to the potent CA inhibitor acetazolamide (100 IlM; , 
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Figure 3.20). Acetazolamide addition had no sigru· fi t ffi 
can e ect on pHi In cells 
perfused with HEPES-buffered solutions (P>0.05· n=4) Alth gh. 
, . ou In the presence of 
external HC0 3-, acetazolamide decreased the rate of apic I AE .. 
a actlvity by 33.7- ± 
5.7% (P<O.OI; n=4). 
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Figure 3.20- Carbonic anhydrase inhibition reduces the rate of apical AE activity. The effect of 
carbonic anhydase inhibitor acetazolamide (ATZ; 100 IlM), in the presence and absence of external 
HC03-, on the mean alkalinisation (pH j) produced by apical chloride removal (A) and the rate of re-
acidification upon apical chloride re-addition in forskolin-stimulated Calu-3 cells (B). n=4. 
KRBIHC03- and KRBIHC03-+ATZ represent paired observations from same experiment. HEPES and 
HEPES+ATZ represent paired observations from same experiment. KRBIHC03- and HEPES 
experiments ran in parallel. B: *P<O.Ol compared to KRBIHC03-. 
3.4.3 Cr-dependence 
By altering the cr concentration of the apical bathing solution, it was possible to 
assess the c r concentration gradient required for reversal of the anion exchanger. 
Normal [Cn was 124 rnM in the standard KRB/HC03- solution and [Cn was 
isoosmotically replaced with NaGluconate (Figure 3.21). Apical AE activity was 
supported in a concentration-dependent manner from complete cr removal to 70 mM 
cr. The removal of 24 rnM cr (100 mM cr solution) did not produce a significant 
change in pHi (P>0.05; n=4). Ifwe assume a normal intracellular cr concentration of 
30 mM, then with an extracellular [Cn of 0 or 10 mM an apical CrlHC03 - exchanger 
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would be expected to reverse and absorb HC03 -. However, in the presence of 70 mM 
[Cn in the external bathing solution a 1:1 Cr/HC03- exchanger would be unlikely to 
reverse. In forskolin-stimulated Calu-3 cells pHi is 7.30 ± 0.04, which equates to-an 
[HC03 -]i of 19 mM (using the Henderson-Hasselbach equation). Therefore there is 
only a small concentration gradient for HC03 - influx via a 1: 1 CrIHC03 - exchanger 
(25 mM out: 19.1 mM in). Whereas there is much larger concentration gradient for cr 
influx (70 mM out: 30 mM in), assuming a normal [Cr]i of 30 mM as has been 
previously suggested (Devor et ai, 1999), which would favour HC03- secretion (with 
an extracellular [Cn > 33 mM) through an electroneutrall:l CrIHC03- exchanger. 
In the absence of extracellular cr, HC03 - could also potentially enter the cell via 
CFTR, as cr efflux through CFTR would be expected to depolarise the apical 
membrane potential, causing HC03 - influx driven by the electrical gradient (see 
section 3.9). Again assuming a [Cni of 30 mM, HC03- could potentially be driven 
through CFTR by a cr gradient, with an extracellular [Cn < 39 mM, as determined 
by the Nernst equation . 
Therefore the alkalinisation in pHi following a decrease in extracellular [Cn from 124 
mM to 0/10/30 mM may represent Cr-dependent HC03- transport by both an apical 
CrlHC03 - exchanger and CFTR. However, neither reversal of a 1: 1 CrlHC03-
exchanger, nor HC03 - influx through CFTR can explain the increase in pHi observed 
in the presence of 70 mM extracellular [Cr]. However, as HC03- transport via a cr 
IHC03- exchanger is dependent on the cr gradient in both forward and reverse 
modes, a decrease in extracellular [Cn from 124 mM to 70 mM would decrease the 
driving force for HC03- secretion and therefore may produce an alkalinisation in pHi. 
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Also, lowering external [Cn would depolarise the apical membrane potential and this 
would reduce HC03 - efflux via CFTR, so this could also possibly explain the increase 
in pHi at 70 rnM extracellular [Cll Another explanation is that [Cni is greater than 
expected, which in the case ofHC03-infiux through CFTR would require a [Cni> 53 
rnM to counter an extracellular [Cn of 70 mM. Or that HC03- transport under these 
conditions is mediated by a CrIHC03- exchanger with a stoichiometry of 1:2 or 1 :3. 
Also, by calculating [HC03 -]i at each of the pHi values achieved from lowering 
extracellular [Cn, it is possible to determine the equilibrium potential (using the 
Nernst equation) for both HC03- and cr under each condition (VHC03- and VCI-; 
assuming a [Cni of 30 rnM). Under each extracellular [Cn tested, VHC03- and VCI-
varied greatly from one another (e.g. at 70 rnM extracellular [Cn, [HC03 -]i reaches 31 
mM, which equates to VHC03- of +6 mY; compared to VCI- of -23 mY, assuming a 
[Cni of 30 mM), suggesting that these changes in pHi cannot be simply explained by 
the relative concentration gradients of these two anions alone and that membrane 
potential is likely to be an important factor in these responses. 
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Figure 3.21- cr gradient required for apical AE reversal. The mean changes in pHi after altering 
extracellular apical chloride concentration from 0 mM to 100 mM (A) and the subsequent rate of re-
acidification upon restoration of 124 mM external chloride (B) in forskolin stimulated Calu-3 cells. 
n=4. Paired observations. A: *P<O.OOI compared to all concentrations. B: *P<0.05 compared to 70 
mM. tP<O.OOI compared to 100 mM .• P<0.05 compared to 100 mM. 
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The Na+-K+-2Cr co-transporter (NKCC) present on the basolat I 
era membrane of 
Calu-3 cells is involved in providing cr for secretion via CFTR (Kr 
OUse et ai, 2004). 
By inhibiting the NKCC, [CrJi would be expected to fall reducing th CI- ._ 
, e gradIent 
necessary for apical AE reversal in the absence of external cr and th c. 
erelore may 
reduce HC03 -intake through an apical CrIHC03 - exchanger in the reve d 
rse mo e. 
Inhibiting cr uptake through the basolateral NKCC, by using the NKCC inhibitor 
bumetanide (20 IlM), the alkalinisation in pHi upon apical cr removal was 
diminished by 66.6 ± 15.5% (P<O.OI; n=4), highlighting the importance of 
intracellular cr to support AE activity (Figure 3.22). However, no difference was 
observed in the rate of apical AE activity following cr re-addition, despite a probable 
increase in the external-to-internal cr gradient (P>0.05; n=4). It should be noted that 
bumetanide has also been shown to partially inhibit CFTR cr conductance in human 
sweat ducts (Reddy & Quinton, 1999), therefore the inhibition of apical AE by 
bumetanide may not be solely due to the inhibition of the basolateral NKCC. 
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Figure 3.22- Bu~etanide inhibition of basolateral NKCC reduces apical AE in Calu-3 cells. The 
effect of basolateral bumetanide (20 f.1M) on the mean alkalinisation (PHi) produced by apical chloride 
removal (A) and the rate of re-acidification upon apical chloride re-addition in forskolin-stimulated 
Calu-3 cells (B). n=4. Paired observations. A: *P<O.OI compared to apical OCr+FSK. 
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3.4.4 Na+-dependence 
To examine the Na+ dependence of the apical AE, extracellular NaCl was replaced 
with NMDGCI in the apical solution. Removal of external Na+ enhanced the 
alkalinisation in pHi caused by the removal of apical chloride under forskolin-
stimulated conditions from 0.49 ± 0.07 to 0.63 ± 0.03 pH units (P<0.05; n=4), 
suggesting that while apical AE can still be supported without extracellular Na+, its 
activity maybe modulated indirectly by transporters that are Na+-dependent (Figure 
3.23). 
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Figure 3.23- Na+-dependence of apical AE activity in Calu-3 cells. The effect of bilateral Na+ 
removal on the mean alkalinisation (PHi) produced by apical chloride removal (A) and the rate of re-
acidification upon apical chloride re-addition in forskolin-stimulated Calu-3 cells (B). n=4. Na + and 
Na+-free conditions applied in separate experiments ran in parallel. A: *P<O.05 compared to apical ocr 
+FSK. 
3.4.5 Electrogenicity 
To investigate whether the apical anion exchanger is electrogenic, Calu-3 cells were 
exposed to a bilateral high external K+ concentration (115 mM) and the K+ channel 
agonist, l-ethyl-2-benzimidazolinone (1-EBIO; 1 mM), .in order to clamp the resting 
membrane potential to OmV. In Calu-3 cells, l-EBIO activates Ca2+-activated K+ 
channels, which in tum hyperpolarise the cells (Tamada et aI, 2001). A high [K+] 
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solution was applied to prevent changes in membrane potential during the experiment 
by K+ channels. Bilateral high K+ and EBIO, did not significantly affect apical AE 
activity when applied individually, but together reduced the mean alkalinisation 
induced by chloride removal as well as the rate of re-acidification upon chloride re-
addition by 26.7 ± 9.7% and 23.7 ± 2.3%, respectively (P<0.05; n=4; Figure 3.24A). 
Interestingly, when high K+ was applied only to the basolateral membrane, the mean 
alkalinisation was enhanced by 39.9 ± 2.3% (P<O.OOl), but the rate ofre-acidification 
was decreased by 48.1 ± 7.4% compared to normal [K+] (P<0.05; Figure 3.24B). 
However, since the addition of the high K+ solution basolaterally itself caused pHi to 
alkalinise (mean alkalinisation in pHi of 0.48 ± 0.01 pH units at a rate of 0.15 ± 0.02 
pHi units min-I), the difference in buffering capacity at this more alkali pHi would 
affect the rate of apical AE in the presence ofbasolateral high K+. Conversion to base 
efflux showed that there was no significant difference in base flux under normal K+ 
concentration (-J(B)= 108.8 ± 10.5 mM B min-I) compared to high K+ basolaterally (-
J(B)= 103.7 ± 11.55 mM B min-I; P>0.05; n=3; data not shown). Also the presence of 
apical AE activity at this more alkali pHi rules out the possibility that the AE is 
" stimulated by the acidification produced following the addition of forskolin, rather 
than by the rise in cAMP. 
From these experiments the electrogenicity of the apical AE activity is uncertain. 
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Figure 3.24- The effect of changes in membrane potential by high K+ and l-EBIO on apical AE 
activity. The effect of bilateral high K+ (115 mM), basolateral only high K+ and K+ channel opener 
EBIO (1 mM) on the mean alkalinisation (PHi) produced by apical chloride removal (A) and the rate of 
re-acidification upon apical chloride re-addition in forskolin-stimulated (5 flM) Calu-3 cells (B). pHi 
responses in the presence of high K+ and 1-EBIO compared to control apical OCr+FSK responses. n=4. 
Each condition in separate experiments ran in parallel. A: *P<O.05 compared to apical OCr+FSK. 
tP<O.OOl compared to all conditions. B: *P<O.05 compared to apical OCr+FSK. tP<O.05 compared to 
apical OCl"+FSK and +bilateral high K+. 
3.4.6 H2.-DIDS sensitivity 
H2-DIDS is known to inhibit a wide variety of anion transporters including many of 
the SLC26 members (Mount & Romero, 2004). Apical H2-DIDS (500 IlM) addition 
did not significantly affect either the mean alkalinisation of pHi upon chloride 
removal or the rate of acidification following cr re-addition (P>O.05; Figure 3.25). 
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Figure 3.25- Apical AE activity is insensitive to HrDIDS. The effect of apical H2-DIDS (500 flM) 
on the mean alkalinisation (PHi) produced by apical chloride removal (A) and the rate of re-
acidification upon apical chloride re-addition in forskolin-stimulated Calu-3 cells (B). n=4. Paired 
observations. 
3.4.7 Bilateral cr removal 
So far the properties of the apical AE had only been studied by removing cr from the 
apical (luminal) membrane. In order to investigate whether the removal of basolateral 
cr might impact on the measurement of pHi caused by apical cr removal, cr was 
removed bilaterally. Figure 3.26 shows that the alkalinisation produced by removal of 
apical cr was reversed by an equal acidification upon basolateral cr removal. 
However, the re-addition of apical cr then produced a further acidification, 
suggesting that the removal of basolateral cr did not inhibit apical AE, but produced 
an acidification under these conditions through another pathway (Figure 3.26). At 
this new acidic pHi, apical AE activity was still present (active) and was not 
significantly different in either rate or amplitude to the control (P>O.05; n=4; data not 
shown). 
78 
Apical ocr -------
7.8 Baso ocr --------
KRB/HC03' +FSK 
Time(s) 
Figure 3.26- Basolateral cr removal masks apical AE activity (expt.1). The effect ofbasolateral cr 
removal on apical CrIHC03- exchange activity in forskolin-stimulated (5 ,....M) Calu-3 cells. 
Prior exposure to basolateral zero cr also abolished the substantial alkalinisation 
induced by apical cr removal, although an initial transient response to apical cr 
removal was seen (Figure 3.27). Upon re-addition of basolateral cr, the apical cr 
gradient caused an alkalinisation of pHi, suggesting that the apical AE was still active. 
AplcaIOCr'-----
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Figure 3.27- Basolateral cr removal masks apical AE activity (expt.2). The effect ofbasolateral c r 
removal on apical Cr IHC03- exchange activity in forskolin-stimulated (5 ,....M) Calu-3 cells. 
In order to attempt to block the effects of basolateral cr removal on pHi, H2-DIDS 
(500 /lM) was _applied to the basolateral membrane (Figure 3.28). In the presence of 
H2-DIDS the apparent inhibition of the apical AE by basolateral cr removal was 
eliminated (Figure 3.29A). However, the rate of apical AE activity was still 
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significantly decreased in the presence of basolateral H2-DIDS (P<O.Ol; n=3; Figure 
3.29B). 
ApicaIOCr----
Time(s) 
Figure 3.28- pHi experimental trace of basolateral cr removal masking apical AE activity 
through a H2-DIDS sensitive mechanism. The effect of basolateral HrDIDS on changes in pHi 
induced by bilateral cr removal in forskolin-stimulated Calu-3 cells. 
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Figure 3.29- Basolateral cr removal masks apical AE activity through a H2-DIDS sensitive 
mechanism. The effects of basolateral H2-DIDS on mean changes in pHi following the removal of 
apical or bilateral cr (A) and on the rate of re-acidification upon re-addition of apical cr in Calu-3 
cells (B). n=3. Paired observations. A: *P<O.05 compared to apical OCHFSK. tP<O.OI compared to 
bilateral OCHFSK+H2DIDS. B: *P<O.Ol compared to apical OCHFSK. 
80 
3.5 Regulation of apical CrlHC03- exchange by CFTR 
A key part of the project was to investigate if CFTR expression and/or CFTR 
activation by cAMP agonists is involved in the regulation of apical CrlHC03-
exchange activity in Calu-3 cells, as is seen in many other tissues including pancreatic 
duct cells (Ko et ai, 2004). The role of CFTR in the pHi response to apical cr 
removal was evaluated using the CFTR channel inhibitor, CFTRinh-172 (Ma et ai, 
2002). The alkalinisation produced by removal of apical cr following forskolin 
stimulation (0.56 ± 0.09 pH units; n=4) and adenosine stimulation (0.48 ± 0.10 pH 
units; n=4), were both significantly inhibited (P<O.OOI and P<O.OI respectively) by 10 
IlM CFTRinh-172 (Figure 3.30). 
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Figure 3.30- Apical AE activity is abolished by CFTRinh-l72. The effect of apical CFTRinb-l72 (10 
~M) on the mean alkalinisation in pHi following the removal of apical cr in forskolin (FSK; 5 ~M) and 
adenosine (ADO; 1 0 ~M) stimulated Calu-3 cells. n=4. Apical OCHFSK and +FSK +CFTRinb-l72 
represent paired observations from same experiment. Apical ocr+ ADO and + ADO+CFTRinh-l72 also 
represent paired observations from same experiment. FSK and ADO experiments ran in parallel. 
*P<O.OOI compared to apical OCHFSK. tP<O.Ol compared to apical OCHADO. 
Another CFTR inhibitor, the pore blocker GlyH-10l, was also tested (Muanprasat et 
ai, 2004). The addition of GlyH-10l (10 IlM) produced an alkalinisation of 0.23 ± 
0.02 pH units (n=4), opposing the equivalent acidification produced by the prior 
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addition of forskolin. Interestingly, prior addition of either CFTR inhibitor abolished 
the acidification in pHi normally produced by forskolin addition. In the presence of 
GlyH-lOl, apical AE was abolished, suggesting that apical AE activity was dependent 
on the anion transport by CFTR (Figure 3.31). 
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Figure 3.31- Apical AE activity is abolished by CFTR pore blocker GlyH-10l. Representative 
recording of GlyH-IOI experiment (A) and the effect of apical GlyH-IOI (10 ~M) on mean changes in 
pHi following the removal of apical cr in forskolin-stimulated (5 ~M) Calu-3 cells (B). n=4. Paired 
observations. *P<O.OI compared to apical OCHFSK. 
A different approach was then applied to inhibit CFTR, by adding apical GlyH-101 in 
zero cr conditions to determine if it was still possible to re-acidify the cells by the re-
addition ofCr (Figure 3.32). Uriexpectedly, application of GlyH-101 during an apical 
zero cr induced alkalinisation produced a rapid re-acidification in pHi, at a rate 
similar to that of the re-addition of cr (Figure 3.33). However pHi did not return to 
pre GlyH-lOl values. 
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Figure 3.32- pHI experimental trace of CFTR pore blocker GlyH-lOl re-acidifying Calu-3 pHi 
following an apical zero cr induced alkalinisation. The effect of apical GlyH-10l (10 J.1M) on 
changes in pHi when applied during apical zero cr conditions, compared to the re-addition of apical cr 
in forskolin-stimulated (5 J.1M) Calu-3 cells. 
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Figure 3.33- CFTR pore blocker GlyH-lOl re-acidifies Calu-3 pHi following an apical zero cr 
induced alkalinisation. Comparison of the mean acidification (A) and rate of acidification in pHi (B), 
produced by the re-addition of Cr or by the addition of GlyH-IOI (10 J.1M), following the removal of 
apical cr in forskolin-stimulated (5 J.1M) Calu-3 cells. n=4. Paired observations. 
These experiments were then repeated using basolateral H2-DIDS to investigate if a 
basolateral transporter could be involved in the rapid re-acidification caused by GlyH-
101. In the presence of basolateral H2-DIDS, the mean acidification upon apical cr 
removal was enhanced (P<O.OOI; n=4), while the rate of AE activity decreased 
(P<O.OOI), as was also seen in the bilateral ocr experiments (Figures 3.29 & 3.34). 
The addition ofH2-DIDS basolaterally was sufficient to inhibit 77.4 ± 11.3% (n=4) of 
the re-acidification produced by applying GlyH-l 01 under zero cr conditions and a 
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full recovery in pHi could only be achieved by re-applying cr to the apical perfusate 
(Figure 3.35A). However, the rate of re-acidification achieved by the re-addition of 
apical cr in the presence of both apical GlyH-lOl and basolateral H2-DIDS (0.28 ± 
0.04 pH units min-I; n=4) was significantly slower compared to the addition of apical 
cr in the absence or presence of basolateral H2-DIDS alone (P<O.OOI and P<0.05 
respectively; n=4; Figure 3.35B). 
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Figure 3.34- pHI experimental trace of basolateral Hz-DIDS blocking the GlyH-lOl-induced 
acidification under apical zero cr conditions. The effect ofbasolateral H2-DIDS (500 IlM) on GlyH-
10 1 (10 IlM) induced changes in pHi when applied during apical zero cr conditions in forskolin-
stimulated (5 IlM) Calu-3 cells. 
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Figure 3.35- Basolateral Hz-DIDS blocks the GlyH-lOl-induced acidification under apical zero 
cr conditions. The effect of basolateral Hz-DIDS (500 IlM) on the mean acidification (A) and rate of 
re-acidification in pHi (B) induced by either the re-addition of apical chloride (+Cr) or addition of 
apical GlyH-101 (10 IlM), during apical zero cr conditions in forskolin-stimulated (5 IlM) Calu-3 
cells. n=4. Paired observations. A: *P<O.OOI compared to +Cr. tP<O.OOl compared to all conditions. 
B: *P<O.OOI compared to +Cr. tP<O.Ol compared to +GlyH-101(+H2-DIDS). ·P<0.05 compared to 
+cr(+GlyH-l0 1+H2-DIDS). 
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A possible explanation for the effect of GlyH-lOl is that inhibition of anion 
permeation through CFTR may cause a repolarisation of membrane potential. The 
repolarisation caused by GlyH-101 maybe large enough to cause the reversal of the 
basolateral NBC, producing an efflux ofHC03-. To test this hypothesis the [K+] of the 
basolateral solution was increased in order to depolarise the basolateral membrane and 
thus counter any change in membrane potential caused by the blockage of CFTR 
(Cuthbert & MacVinish, 2003). However, under these conditions the application of 
GlyH-lOl in the absence of apical cr still caused a re-acidification suggesting that the 
acidification due to GlyH-101 is not caused by a change in membrane potential and 
reversal of the NBC (Figure 3.36). 
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Figure 3.36- The GlyH-lOl-induced acidification under apical zero cr conditions is insensitive to 
basolateral high K+. The effect ofbasolateral high K+ on GlyH-IOI-induced (10 IlM) acidification in 
pHi when applied during apical zero cr conditions in forskolin-stimulated (5 IlM) Calu-3 cells. n=3. 
Paired observations. P>0.05 between all conditions. 
In addition to basolateral H2DIDS blocking the GlyH-101-induced acidification under 
apical zero cr conditions, prior application of basolateral H2DIDS also overcame the 
inhibition of the apical AE by GlyH-lOl (Figure 3.37). 
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Figure 3.37- pHi experimental trace of CFTR inhibitor GlyH-lOl abolishing apical AE activity 
through a basolateral HrDIDS-sensitive mechanism. The effect of basolateral HrDIDS (500 J.l.M) 
on changes in pHi following the removal of apical cr in the presence of apical CFTR inhibitor GlyH-
101 (10 J.l.M), in forskolin-stimulated (5 J.l.M) Calu-3 cells. 
In the presence of basolateral H2-DIDS, GlyH-101 had no' significant effect on the 
alkalinisation produced by apical cr removal (Figure 3.38A), however the rate of AE 
was reduced from 0.37 ± 0.03 to 0.19 ± 0.01 pHi units min-I (P<O.Ol; n=4; Figure 
3.38B). This reduction in the rate of re-acidification may represent the CFTR 
component of the Cr-dependent HC03- transport, which is required for maximal' AE 
activity'. The inhibition of CFTR may also be reflected by the slower monophasic 
alkalinisation in response to apical Crremoval in the presence ofbasolateral H2-DIDS 
and apical GlyH-1 01, compared to the biphasic alkalinisation in the absence of GlyH-
101 (see Figure 3.37). 
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Figure 3.38- CFTR inhibitor GlyH-lOl abolishes apical AE activity through a basolateral Hr 
DIDS-sensitive mechanism. The effect ofbasolateral H2-DIDS (100 flM), in the absence and presence 
of CFTR inhibitor GlyH-lOl (10 flM), on the mean alkalinisation (PHJ produced by apical chloride 
removal (A) and the rate of re-acidification upon apical chloride re-addition (B), in forskolin-stimulated 
(5 flM) Calu-3 cells. n=4. Paired observations. B: *P<O.OI compared to apical OCr+FSK+baso 
H2DIDS. 
3.5.1 CFTR Knockdown cells 
To further investigate the role of CFTR in regulating CrlHC03- AE activity, 
experiments were conducted on CFTR Knockdown (KD) Calu-3 cells, which have a 
CFTR content of <5% and show 25% of the cAMP-dependent Cl -secretion of that of 
wild-type (WT) Calu-3 cells (MacVinish et aI, 2007). The reduced expression of 
CFTR in Calu-3 KD cells was confirmed by immunocytochemical analysis (Figure 
3.39). 
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Figure 3.39- Reduced CFTR expression in CFTR KD Calu-3 cells. Immunofluorescent staining of 
CFTR using a mouse anti-CFTR antibody (green) in WT Calu-3 cells (A), no primary negative control 
(B), and in CFTR KD Calu-3 cells (C). All images are XY sections. Scale bar represents 10 flm. n=3. 
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Initial mean pHi values were not significantly different between WT (7.43 ± 0.03; 
n=50) and CFTR KD (7.39 ± 0.05; n=32; P>0.05) Calu-3 cells. Forskolin stimulation 
showed that CFTR KD cells also display a switch from basolateral fo apical AE 
activity in response to increases in cAMP (Figures 3.40 & 3.41). Although the 
presence of forskolin was not sufficient to completely inhibit the basolateral AE (see 
basolateral AE chapter). 
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Figure 3.40- pHi experimental trace of the forskolin-induced changes in AE activity in CFTR KD 
Calu-3 ceUs. The effect of forskolin (FSK; 5 flM) on changes in pHj following the removal of apical 
and basolateral chloride in CFTR Knockdown (KD) Calu-3 cells. 
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Figure 3.41- Forskolin-induced changes in AE activity in CFTR KD Calu-3 ceUs. Mean 
alkalinisation (pHj) produced by chloride removal (A) and the rate of re-acidification upon chloride re-
addition in CFTR KD Calu-3 cells (B), under non-stimulated and forskolin-stimulated (FSK; 5 flM) 
conditions. n=4. Paired observations. A: *P<O.OO I compared to apical ocr. B: *P<O.OOI compared to 
apical OCr. 
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CFTR KD Calu-3 cells produced a similar alkalinisation (0.56 ± 0.04 pH units) in 
response to apical cr removal in the presence offorskolin, as WT Calu-3 cells (0.51 ± 
0.01 pH units; P>0.05; n=4; Figure 3.42A). However the reduced expression of 
CFTR in the KD Calu-3 cells appears to be reflected in the significantly reduced rates 
of re-acidification compared to WT cells (Figure 3.42B). The rate of the apical cr 
IHC03- exchange was reduced in CFTR KD cells by -48% (P<O.Ol) from 0.75 ± 0.09 
pH units min-I (-J(B)= 97.6 ± 13.3 mM B min-I) in WT cells to 0.39 ± 0.02 pH units 
min-I (-J(B)= 65.9± 9.8 mM B min-I) in KD cells (Figure 3.43). 
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Figure 3.42- The rate of apical AE activity is reduced in CFTR KD Calu-3 cells. Comparison of 
the mean changes in pHi following removal of apical chloride (A) and the rate of re-acidification upon 
chloride re-addition (B), between Wild-type (WT) and CFTR Knockdown (KD) Calu-3 cells. n=4. WT 
and CFTR KD cell experiments carried out in parallel. B: *P<O.Ol compared to WT. 
Figure 3.43- The rate of apical Cr-dependent base efflux is reduced in CFTR KD Calu-3 cells. 
Comparison of t4.e rate of base efflux (mM B min-I) produced by the re-addition of cr, following the 
removal of apical cr in forskolin stimulated WT and CFTR KD Calu-3 cells. n=4. WT and CFTR KD 
cell experiments carried out in parallel. *P<O.05 compared to WT. 
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Similar to WT cells, the alkalinisation in pHi following apical cr removal in CFTR 
KD Calu-3 cells was insensitive to the anion exchange inhibitor H2-D1DS (0.46 ± 0.07 
pH units; P>0.05; n=4) and was almost abolished (inhibited by 91.3 ± 1-.8%) by pre-
exposure to CFTR inhibitor GlyH-101 (P<0.05; n=4; Figure 3.44). 
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Figure 3.44- The pharmacological profile of apical AE activity in CFTR KD Calu-3 cells. The 
effects of apical HTDIDS (500 flM) and apical GlyH-lOl (10 flM) addition on the percentage mean 
alkalinisation in pHj following the removal of apical chloride (A) and the percentage rate of re-
acidification upon chloride re-addition (B) in forskolin-stimulated (5 flM) CFTR KD Calu-3 cells. pHj 
responses in the presence ofHTDIDS and GlyH-IOI compared to control apical OCr+FSK responses. 
n=4. H2-DIDS and 6IyH-IOI experiments carried out in parallel. A: *P<O.OOI compared to apical ocr 
+FSK and +H2-DIDS. B: *P<O.OOI compared to apical OCr+FSK and +H2-DIDS. 
Apical AE activity was only supported by monovalent anions in CFTR KD cells and 
showed a similar selectivity profile to WT Calu-3 cells (see Figure 3.18); the 
exchanger had a significantly greater affinity for iodide compared with chloride and 
formate (P<O.OOI ; Figure 3.45). Comparing the CriX selectivity ratios of WT 
(formate 0.6: chloride 1: iodide 1.3) and CFTR KD Calu-3 cells (chloride 1: formate 
1.2: iodide 2.1), suggests that iodide is transported with greater affinity in CFTR KD 
cells in relation to chloride. 
90 
";" 
* c: 
·s 
;t-
~ 
c: 
0 
i 
CJ 
0;:: 
'6 
·u 
CO 
~ o. 
'0 
~ Q: 
Figure 3.45- Apical CrlBC03- exchange anion selectivity in CFTR KD Calu-3 cells. The rate of 
recovery of pHi by the introduction of chloride, formate and iodide in zero cr conditions. n=4. Paired 
observations. *P<O.OOI compared to chloride and formate. 
These results show that the apical AE present in CFTR KD cells has a similar profile 
to the apical AE found in WT cells, suggesting that CFTR KD Calu-3 cells may 
exhibit the same apical CrIHC03- exchange activity, despite reduced expression of 
CFTR. 
3.6 Regulation of apical Cr/HCO~- exchange by protein phosphatase activity 
Several epithelial transporters are regulated by protein phosphatase (PP) activity, 
including the basolateral NKCC and apical CFTR present in Calu-3 cells (Liedtke et 
ai, 2005; Thelin et ai, 2005). Bumetanide-sensitive 86Rb uptake studies showed a 
four-fold increase in NKCC activity following addition of the PPlIPP2A inhibitor 
okadaic acid and immunoblot analysis detected both PP2A and PPI i!1 Calu-3 cells 
lysates (Liedtke et ai, 2005). Patch-clamp experiments on NIH 3T3 fibroblasts stably 
expressing CFTR revealed that PKA-activated cr currents were decreased by PP2A 
addition (the effects of which could be blocked by PP2A inhibitor calyculin A), but 
not PP1 or PP2B, suggesting PP2A-mediated dephosphorylation of CFTR is involved 
in channel rundown (Berger et ai, 1993). However, studies in excised patches of 
Chinese hamster ovary and human airway epithelial cells showed that rundown of 
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CFTR was iQ.sensitive to the PP2A inhibitor okadaic acid (Becq et ai, 1994). Further 
patch-clamp studies in excised baby hamster kidney cells over-expressing CFTR 
suggested a role for PP2A, PP2C and alkaline phosphatase- in CFTR 
dephosphorylation, as the addition of each phosphatase could reduced CFTR channel 
activity by >90% (Luo et aI, 1998). Thus, CFTR regulation by phosphatases appears 
to be cell-type specific (Gadsby et ai, 1999). In intestinal and airway epithelia, PP2A 
and PP2C have been shown to inactivate CFTR (Travis et ai, 1997; Thelin et ai, 
2005). In Calu-3 cells, mass spectrometry revealed that PP2A regulatory subunits can 
physically associate with the carboxyl terminus of CFTR (Thelin et ai, 2005). As 
protein phosphatases can be activated by increases in cAMP, through a PKA-
independent pathway (Feschenko et ai, 2002), they represent a potential mechanism 
for regulating HC03- transport processes on both the apical and basolateral 
membranes. 
To investigate whether protein phosphatases can regulate AE activity, wild-type Calu-
3 cells were pre-treated with the PPl/PP2A inhibitor okadaic acid (100 nM) for 60 
minutes during BCECF-AM loading. Calu-3 cells pre-treated with okadaic acid had a 
more acidic initial pHi compared to untreated cells (7.03 ± 0.06; P<O.OI; n=15). 
Surprisingly, okadaic acid exposure produced a switch in AE activity, completely 
inhibiting the basolateral AE and activating an apical AE activity under basal 
conditions (Figure 3.46). The alkalinisation in pHi following apical cr removal in 
okadaic acid treated cells was further enhanced by forskolin (5 J.lM) addition (from 
0.22 ± 0.01 to 0.45 ± 0.02 pH units; P<O.OOI; n=5; Figure 3.47A). While the rate of 
apical AE activity in forskolin-stimulated cells was comparable between untreated 
and okadaic acid-treated cells (Figure 3.47B), the mean alkalinisation in pHi upon 
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apical cr removal in okadaic acid-treated Calu-3 cells was not as large (P<O.05; n=5). 
Forskolin addition produced a similar acidification in pHi, in both magnitude and rate, 
in okadaic acid treated cells compared to untreated Calu-3 cells (P>O.05; n=5). 
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Figure 3.46- pHi experimental trace of protein phosphatase inhibitor okadaic acid activating 
apical AE activity in Calu-3 cells. The effects of protein phosphatase inhibitor okadaic acid (OA; 100 
nM) on changes in pHi following the removal of chloride in unstimulated and forskolin-stimulated (5 
~M) WT Calu-3 cells. 
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Figure 3.47- Protein phosphatase inhibitor okadaic acid activates apical AE activity in Calu-3 
cells. The effects of okadaic acid (OA; 100 nM) on the mean change in pHi following the removal of 
chloride (A) and the mean rate of re-acidification in pHi upon the re-addition of chloride (B) in 
unstimulated and forskolin-stimulated (5 ~M) WT Calu-3 cells. n=5. OA treated and untreated Calu-3 
cell experiments were run in parallel. A: *P<O.OOI compared to apical ocr. tP<0.05 compared to 
+FSK. +P<O.OOI compared to +OA. B: no significant difference between OA treated and untreated 
cells. 
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Increasing the concentration of okadaic acid from 100 nM to 500 nM did not further 
enhance okadaic acid stimulation of apical AE activity under basal conditions, but 
lowering the okadaic acid concentration to 10 nM abolished apical AE stimulation 
(Figure 3.48). The dose-response of okadaic acid on apical AE activity appears to 
reflect the inhibition of PPI rather than PP2A, according to the specificity of okadaic 
acid for the two protein phosphatases (PP2A ICso - 0.5 nM; PPI ICso - 50 nM). 
Stimulation of apical AE activity by 100 nM okadaic acid is unlikely to be due to an 
acidification in pHi, as a similar acidic initial pHi was observed in cells treated with 
10 nM okadaic acid (7.09 ± 0.25; P>0.05; n=3). 
* 
:f 
Co 
.= 
41 
C) 
c:: 
.. 
.s:::. 
u 
c:: 
:ll 
:E 
Figure 3.48- The concentration-dependent activation of apical AE activity by protein 
phosphatase inhibitor okadaic acid. Dose-response effect of okadaic acid (0,10,100,500 nM) on 
mean changes in pHi following the removal of apical chloride in unstimulated WT Calu-3 cells. n=4. 
OA treatments were carried out in separate experiments that were run in parallel. *P<O.OOI compared 
to no OA and 10 nM OA. 
To test whether PP2A was involved in the stimulation of the apical AE by okadaic 
acid, the effect of another PP inhibitor, fostriecin, was examined. Fostriecin is a 
potent inhibitor of PP2A (ICso - 1.5 nM) and only inhibits PP 1 at high concentrations 
(ICso - 130 IlM). At 100 nM, a concentration that should only inhibit PP2A, fostriecin 
was unable to stimulate apical AE activity, in marked contrast to 100 nM okadaic 
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acid. However, fostriecin pre-treatment did decrease the activity of the forskolin-
stimulated apical AE (both mean alkalinisation and rate of re-acidification; Figure 
3.49). 
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Figure 3.49- PP2A inhibition by fostriecin fails to activate apical AE activity in Calu-3 cells. The 
effects of fostriecin (100 oM) on the mean change in pHi following the removal of chloride (A) and the 
mean rate of re-acidification in pHi upon the re-addition of chloride (B) in unstimulated and forskolin-
stimulated WT Calu-3 cells. n=4. Fostriecin treated and untreated Calu-3 cell experiments were run in 
parallel. A: *P<O.O l compared to apical OCHFSK. B: *P<O.OOI compared to apical OCr+FSK. 
These results therefore suggest that PP 1 inhibition by okadaic acid is responsible for 
the stimulation of apical AE activity under basal conditions. However, PP2A appears 
to be involved in regulating apical AE in the presence of forskolin. 
The profile of the basal apical AE exchange activity in okadaic acid treated WT Calu-
3 cells was similar to the forskolin-stimulated AE activity seen in untreated cells: H2-
DIDS insensitive, Na+-independent (Figure 3.50) and only transports monovalent 
anions (Figure 3.51). 
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Figure 3.50- PPI inhibition by okadaic acid reveals an Hz-DIDS-insensitive and Na+-independent 
apical AE activity. The effects of apical H2-DIDS (500 11M) and apical Na+ removal (replaced with 
NMDG) on the mean alkalinisation in pHi following the removal of apical chloride in okadaic acid 
treated (l00 nM) Calu-3 cells. n=3. H2-DIDS and GlyH-lOl experiments carried out in parallel. 
Figure 3.51- Anion selectivity of apical CrtHC03- exchange in okadaic acid treated Calu-3 cells. 
The rate of recovery of pHi by the introduction of monovalent (iodide, formate and chloride) and 
divalent (oxalate and sulphate) anions in zero cr conditions, in okadaic acid (l00 nM) treated WT 
Calu-3 cells. n=4. Paired observations. 
Interestingly GlyH-I0l (10 J-LM) studies showed that the basal apical AE activity 
observed in the presence of okadaic acid was not blocked by GlyH-101 suggesting 
that it is independent of CFTR. In contrast, the enhancement of apical AE activity by 
forskolin was prevented by GlyH-101, showing that this was likely' due to CFTR 
activation (Figures 3.52 & 3.53). 
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Figure 3.52- pHi experimental trace of CFTR-independent apical AE activity in okadaic acid 
treated Calu-3 cells. The effects of apical CFTR inhibitor GlyH-101 (10 J.lM) on changes in pHi 
following the removal of chloride in unstimulated and forskolin-stimulated (5 J.lM) WT Calu-3 cells 
treated with okadaic acid (OA; 100 nM). 
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Figure 3.53- CFTR-independent apical AE activity in okadaic acid-treated Calu-3 cells. The 
effects of apical CFTR inhibitor GlyH-1 0 1 on the mean alkalinisation in pHi following the removal of 
apical chloride (A) and the mean rate of re-acidification in pHi upon re-addition of apical chloride (B), 
in unstimulated and forskolin-stimulated WT Calu-3 cells treated with okadaic acid (100 nM). n=4. 
Paired observations. 
The CFTR-dependence of the okadaic acid stimulated apical AE activity was also 
investigated in CFTR KD Calu-3 cells. Okadaic acid-treated CFTR KD cells also 
exhibited apical AE under basal conditions, which could be enhanced by forskolin 
addition (Figure 3.54A). However, unlike WT ~alu-3 cells (see Figure 3.47), the rate 
of AE activity in forskolin-stimulated CFTR KD cells was significantly decreased in 
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the presence of okadaic acid, supporting the hypothesis that this enhancement by 
forskolin is through a CFTR-dependent mechanism (Figure 3.54B). 
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Figure 3.54- Okadaic acid-induced apical AE activity is enhanced by forskolin through a CFTR-
dependent mechanism. The effects of okadaic acid (l00 oM) on the mean change in pHj following the 
removal of apical chloride (A) and the mean rate of re-acidification in pHj upon the re-addition of 
apical chloride (B) in unstimulated and forskolin-stimulated CFTR KD Calu-3 cells. n=5. OA treated 
and untreated CFTR KD Calu-3 cell experiments were run in parallel. A: *P<O.O 1 compared to apical 
OCr. tP<O.Ol compared to +OA. B: *P<O.OOI compared to apical OCHFSK. 
3.7 SLC26A4 
Results so far, show that Calu-3 cells exhibit cAMP-dependent apical CrlHC03' 
exchange activity. This apical AE is insensitive to H2-DIDS, Na+-independent and 
exchanges HC03' with a range of monovalent anions (r=Br'>Cr=Formate=N03' 
=SCN,), but is not supported by divalent anions. 
The apical AE found in Calu-3 cells is believed to be a member of the SLC26 family. 
Several SLC26 proteins can function as CrlHC03' exchangers in a variety of tissues 
and cell types including: A3 in the pancreas (Ko et aI, 2002) and intestine (Melvin et 
aI, 1999); A4 in the thyroid and kidney (Soleimani et aI, 2001); A6 in the pancreas 
(Ko et aI, 2002) and intestine (Wang et aI, 2002); A7 in the stomach (Petrovic et aI, 
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2003) and kidney (Petrovic et ai, 2004); A9 in transfectedXenopus oocytes (Chang et 
ai, 2009) and HEK cells (Xu et ai, 2005). However, SLC26A 7 and SLC26A9 can also 
function as cr channels (Kim et ai, 2005; Dorwart et ai, 2007). Of these five 
candidates, only Pendrin (SLC26A4) is unable to transport divalent anions including 
SO/- and oxalate (Scott & Kamiski, 2000; Mount & Romero, 2004). As well as 
studies demonstrating that Pendrin functions as a CrlHC03 - exchanger, experiments 
in Xenopus oocytes transfected with human SLC26A4 showed that Pendrin also 
mediates crlr exchange (Scott et ai, 1999). Similar Xenopus experiments even 
suggested that Pendrin may function as a coupled 1:1 electroneutral Crlr, rlHC03-
and crl HC03- exchanger, which preferentially transports r (Shcheynikov et aI, 
2008). The same study found that apically expressed Pendrin mediates r secretion 
from mouse parotid duct cells, which could be enhanced by forskolin and was absent 
in SLC26A4 knockout mice. Therefore the profile of the apical anion exchanger is 
most consistent with Pendrin (SLC26A4), due to its selectivity for monovalent anions, 
affinity for iodide and insensitivity to H2-D1DS. 
To investigate which of the 10 known SLC26 isoforms may be acting as an apical cr 
IHC03- exchanger, quantitative Real-Time PCR (RT-PCR) experiments were carried 
out to identify which SLC26 isoforms are present in Calu-3 cells and to quantify the 
relative expression of each isoform compared to one another. Cells were grown to 
confluence on transwell supports to be consistent with the conditions used for pHi 
experiments. 
Quantitative RT-PCR (Taqman) analysis showed that many SLC26 transporters are 
expressed in Calu-3 cells, several of which have been shown to act as Cr/HC03-
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exchangers (SLC26A4, A6, A 7 and A9). SLC26A2 and A6 were highly expressed, 
relative to the lower expression of A4, A5, A7, A9 and All. SLC26AI and A3 were 
very weakly expressed and A8 was not present in Calu-3 cells (Figure 3.55). 
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Figure 3.55- SLC26 mRNA expression in WT Calu-3 cells. Quantative RT-PCR (Taqman) analysis 
of SLC26 expression in WT Calu-3 cells grown on transwell supports, relative to standard curve and 
normalised to GAPDH (%). n=3. 
Pendrin expressIOn III WT Calu-3 cells was continued by immunofluorescent 
staining, using a mouse polyclonal anti-Pendrin antibody (ABNOVA) and showed a 
punctuate pattern of staining across the monolayer (Figure 3.56). Co-staining with an 
antibody for the tight junction protein zona occludins I (ZO-I), revealed that Pendrin 
appeared to be localised to the apical membrane of Calu-3 cells. Western blot analysis 
ofPendrin expression was unsuccessful with the ABNOVA antibody. 
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Figure 3.56- Apical Pendrin expression in WT Calu-3 ceUs. Immunofluorescent co-staining of WT 
Calu-3 cells using a mouse polyclonal Pendrin antibody (green) and rabbit ZO-l andbody (red), XY 
section (A) and XZ section (B), and no primary negative control (C). Scale bars represent IOllm. Scale 
same for A & C. n=3 . 
To study the potential role of Pendrin in Calu-3 cells, Pendrin KD Calu-3 cells were 
developed using an shRNA approach (see Methods section 2.2). Several knockdown 
cell lines were produced, with Pendrin (mRNA) expression varying from 32.1 ± 4.4% 
(No.83 KD) to 8.5 ± 0.7% (No.84) of that in control Calu-3 cells (Figure 3.57). The 
no.84 KD cell line was selected for pHi experiments due to similar transepithelial 
resistance and growth patterns to that of the WT cells. Cyc10philin B KD Calu-3 cells 
were also produced alongside the Pendrin KD cells, using the same shRNA method, 
to act as a control. 
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Figure 3.57- Pendrin mRNA expression in knockdown Calu-3 cells. Quantative RT-PCR (Taqman) 
-
analysis of the percentage Pendrin expression in Pendrin KD Calu-3 cells (83,84,85,87) normalised to 
GAPDH, compared to that of control cyclophilin B KD Calu-3 cells. n=3 . 
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The 91.5% knockdown of Pendrin expression in the Pendrin KD (no.84) cells was 
apparent from the lack of Pendrin staining, compared to WT and control KD Calu-3 
cells (Figure 3.58). 
Figure 3.58- Reduced Pendrin expression in Pendrin KD Calu-3 cells. Immunofluorescent staining 
of Wild-type (WT), CFTR knockdown (CFTR KD), Pendrin knockdown no.84 (A4 KD) and 
cyclophilin B knockdown (control KD) Calu-3 cells using a mouse polyclonal Pendrin antibody (green, 
above) and rabbit ZO-1 antibody (red, below). WT no 10 represents immunofluorescence from WT 
Calu-3 cells with only the secondary antibodies applied. Note: cells stained with either antibody are 
separate XY sections taken from the same confluent monolayer of each cell type. Scale bars represent 
IOllm. n=3. 
CFTR expression was not significantly affected by Pendrin knockdown, as confirmed 
by Western Blot analysis (Figures 3.59 & 3.60). 
CFTR KD control KD A4KD WTCALU-3 
CFTR (~180 kDa) 
GAPDH (~40 kDa) 
Figure 3.59- Western blot CFTR expression in wild-type and knockdown Calu-3 cells. CFTR and 
GAPDH Western Blot staining of CFTR KD, Cyclophilin B KD (CON KD), Pendrin KD no.84 (A4 
KD) and WT Calu-3 cells. CFTRIGAPDH band intensity ratios: CFTR KD= 0.45 ; control KD= 2.98 ; 
A4 KD= 2.34; WT CALU-3= 2. 18. n=3. 
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Figure 3.60- Western blot analysis of CFTR expression in wild-type and knockdown Calu-3 ceUs. 
Percentage CFTR expression ofCFTR KD, cyclophilin B KD (control KD) and Pendrin KD (A4 KD) 
Calu-3 cells compared to WT Calu-3 cells, derived from CFTRJGAPDH band intensity ratios. n=3. 
Pendrin (A4) KD Calu-3 cells still showed a forskolin-stimulated apical AE, but the 
rate of activity was reduced by 47.6 ± 2.4% in the A4 KD cells compared to control 
cyclophilin B KD cells (P<O.OOl; n=5; Figure 3.61), results which are similar to 
apical AE present in CFTR KD Calu-3 cells (see Figure 3.41). 
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Figure 3.61- The rate of apical AE activity is reduced in Pendrin KD Calu-3 cells. Comparison of 
the mean changes in pH; following removal of chloride (A) and the rate of re-acidification in pH; upon 
the re-addition of chloride (B), between control cyclophilin B KD and Pendrin KD (A4 KD) Calu-3 
cells. n=5. WT and A4 KD cell experiments carried out in parallel. B: *P<O.OOI compared to WT 
apicaIOCHFSK. 
The profile of the apical AE activity in Pendrin KD Calu-3 cells was also studied. The 
apical AE was H2-DIDS insensitive, completely inhibited by CFTR inhibitor GlyH-
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101 (Figure 3.62) and only transports monovalent anions (Figure 3.63), suggesting 
that the apical AE in Pendrin KD cells is similar to that in WT Calu-3 cells. 
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Figure 3.62- The pharmacological profile of apical AE activity in Pendrin KD Calu-3 cells. The 
effects of apical H2-DIDS (500 ).lM) and apical GlyH-lOl (10 ).lM) addition on the percentage mean 
alkalinisation in pHi following the removal of apical chloride (A) and the percentage rate of re-
acidification upon chloride re-addition (B) in forskolin-stimulated (10 ).lM) Pendrin KD Calu-3 cells. 
pHi responses in the presence of Hr DIDS and GlyH-lOl compared to control apical OCHFSK 
responses. n=4. HrDIDS and GlyH-lOl experiments carried out in parallel. A: *P<O.OOI compared to 
apical OCHFSK and +H2DIDS. B: *P<O.OOI compared to apical OCr+FSK and +H2DIDS. 
However, one important feature of the apical AE activity in Pendrin KD Calu-3 cells, 
was that there was no significant difference between the rate of recovery of pHi by 
chloride, formate or iodide (P>0.05; n=4). A4 KD Calu-3 cell cr;x selectivity ratio: 
chloride 1: formate 1.1 : iodide 1.3. 
Figure 3.63- Anion selectivity of apical CrIHC03' exchange in forskolin-stimulated Pendrin KD 
Calu-3 cells. The rate of recovery of pHi by the introduction of monovalent (iodide, formate and 
chloride) and divalent (oxalate and sulphate) anions in zero cr conditions. n=4. Paired observations. 
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3.8 SLC26A9 
As previously shown in Figure 3.55, SLC26A9 is one of several members of the 
SLC26 family expressed in Calu-3 cells. SLC26A9 has been shown to act as a 
'CFTR-like' chloride channel and is regulated by CFTR when expressed in HEK cells 
(Bertrand et at, 2009). Since the activity of the apical AE present in Calu-3 cells is 
CFTR dependent, then it may also interact with other apical anion conductances such 
as SLC26A9. Therefore an A9 KD Calu-3 cell line was developed using a similar 
shRNA approach used to create the A4 KD cells (see methods section 2.2). The no.5l 
KD cell line was selected for pHi experiments due to its ~48% reduced expression of 
SLC26A9 compared to control cyc10philin B KD Calu-3 cells (Figure 3.64). 
Figure 3.64- SLC26A9 mRNA expression in knockdown Calu-3 cells. Quantative RT-PCR 
(Taqman) analysis of the percentage SLC26A9 expression in SLC26A9 KD Calu-3 cells (49,50,51 ,52) 
normalised to GAPDH, compared to that of control cyclophilin B KD Calu-3 cells. n=6. 
The A9 KD (no.51) Calu-3 cells showed similar AE activity profile to both the 
Pendrin and CFTR KD Calu-3 cells, with a reduced rate of apical AE activity under 
forskolin stimulated conditions (51.8 ± 10.4%; P<O.OI; n=6; Figure 3.65B). Unlike 
the other KD cells, A9 KD Calu-3 cells also exhibited a 17.4 ± 6.6% reduction in the 
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overall mean alkalinisation induced by apical zero cr exposure (P<0.05; n=6; Figure 
3.65A). 
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Figure 3.65- The rate of apical AE activity is reduced in SLC26A9 KD Calu-3 cells. Comparison of 
the mean changes in pHi following removal of chloride (A) and the rate of re-acidification in pHi upon 
chloride re-addition (B), between cyclophilin B KD and SLC26A9 KD (A9 KD) Calu-3 cells. n=6. WT 
and A9 KD cell experiments carried out in parallel. A: *P<O.05 compared to WT apical OCHFSK. B: 
*P<O.Ol compared to WT apical OCr+FSK. 
3.9 The effects of proinflammatory cytokines on apical CrlHCO,2- exchange 
In cystic fibrosis (CF), reduced airway surface liquid (ASL) production and 
thickening of the mucus within the ASL prevents mucociliary clearance, providing 
favourable conditions for bacterial formation. Airway disease in CF is characterised 
by chronic infection resulting in an inflammatory response dominated by the mass 
recruitment of neutrophils in the airways, which produce inflammatory cytokines in 
aid of eradicating the infectious pathogens (Courtney et ai, 2004). Excessive amounts 
of proinflammatory cytokines have been observed in the airways of CF sufferers 
(Khan et ai, 1995). 
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Interleukin (IL)-I~ treatment has been demonstrated to increase CFTR mRNA 
expression in Calu-3 cells and could therefore alter apical AE activity (Brouillard et 
ai, 2001). Cytokines IL-4 and IL-13 both decrease the barrier function ofCalu-3 cells, 
as revealed by electrophysiological analysis and reduced expression of tight junction 
protein ZO-1 (Ahdieh et ai, 2001). IL-4 was also shown to induce up-regulation of 
Pendrin mediated thiocyanate-chloride exchange in human bronchial epithelial cells 
(Pedemonte et ai, 2007). IL-4 exposure also increased chloride and fluid secretion 
from T84 cells (Ziind et ai, 1996), whereas IL-13 treatment enhanced CFTR 
expression and abolished aquaporin 5 expression in human nasal epithelial cells 
during differentiation (Skowron-zwarg et ai, 2007). But of particular importance and 
relevance to apical AE activity was the finding that IL-17 A induced CFTR-dependent 
HC03- secretion in human bronchial epithelial cells (Kreindler et ai, 2009). Ussing 
chamber studies showed that IL-17A treatment enhanced forskolin-stimulated HC03-
dependent Isc, which alkalinised the pH of the mucosal fluid bathing the bronchial 
epithelial cells. 
, 
Proinflammatory cytokines IL-l~, IL-4, IL-13 and IL-l 7 A were applied to the media 
of Calu-3 cells for 48 hours prior to qRT-PCR mRNA analysis and pHi experiments. 
qRT-PCR analysis of potential SLC26 CrlHC03- exchangers expressed in Calu-3 
cells showed SLC26A4 (Pendrin) mRNA expression was not significantly altered by 
any interleukin treatment (P>0.05; n=3; Figure 3.66), whereas IL-4 and IL-13 
enhanced both SLC26A6 (P<O.OI; n=3; Figure 3.67) and A9 (P<O.OOI; n=3; Figure 
3.68) mRNA expression. 
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Figure 3.66- SLC26A4 mRNA expression in cytokine treated Calu-3 cells. Quantative RT-PCR 
(Taqman) analysis of SLC26A4 expression in cytokine-treated Calu-3 cells relative to standard curve 
and normalised to GAPDH (%). Calu-3 cells pre-treated with cytokine IL-IP (20ng/ml), IL-4 
(lOng/mI), IL-13 (IOng/ml) and IL-17A (SOng/ml). n=3. 
Figure 3.67- SLC26A6 mRNA expression ill cytokine treated Calu-3 cells. Quantative RT-PCR 
(Taqman) analysis of SLC26A6 expression in cytokine-treated Calu-3 cells relative to standard curve 
and normalised to GAPDH (%). Calu-3 cells pre-treated with cytokine IL-lP (20ng/ml), IL-4 
(lOng/ml), IL-13 (lOng/ml) and IL-17 A (SOng/ml). n=3. *P<O.Ol compared to untreated control Calu-3 
cells. 
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Figure 3.68- SLC26A9 mRNA expression in cytokine treated Calu-3 cells. Quantative RT-PCR 
(Taqman) analysis of SLC26A9 expression in cytokine-treated Calu-3 cells relative to standard curve 
and normalised to GAPDH (%). Calu-3 cells pre-treated with cytokine IL-lP (20ng/ml), IL-4 
(IOng/ml), IL-13 (IOng/ml) and IL-17 A (SOng/mI). n=3. *P<O.OOI compared to untreated control Calu-
3 cells. 
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Cytokine treatment failed to activate apical AE activity under non-stimulated 
conditions. Following forskolin-stimulation apical AE activity was present in each 
cytokine treated cell monolayer, although neither the mean change in pHi upon apical 
cr removal nor the rate of re-acidification after cr re-addition was significantly 
different to paired untreated Calu-3 cells (P>O.05; Table 3.01). 
Cytokine Mean change in pHi P value Rate of re-acidification P value n 
(PH units) vsWT (PHi min-I) vsWT 
IL-IP 0.47 ± 0.11 ns 0.35 ± 0.05 ns 6 
IL-4 0.28 ± 0.04 ns 0.31 ± 0.05 ns 6 
IL-13 0.20± 0.05 ns 0.14 ± 0.03 ns 5 
IL-17A 0.50± 0.07 ns 0.34± 0.05 ns 7 
Table 3.01- Interleukin-lp, -4, -13 and -17A pre-treatment has no effect on apical AE activity in 
Calu-3 cells. The effect of cytokine IL-l ~ (20ng/ml), IL-4 (1 Ong/ml), IL-13 (1 Ong/ml) and IL-17 A 
(50ng/ml) pre-treatment (present in cell media for 48hours) on the mean changes in pHi following 
removal of chloride and the rate of re-acidification in pHi upon the re-addition of chloride in Calu-3 
cells. ns: P value >0.05 compared to untreated Calu-3 cells. 
3:10 Cr-dependent pHi changes in FRT cells: Pendrin vs CFfR 
As CFTR conducts HC03-, it is possible that under zero cr conditions, CFTR would 
open to allow cr to leave the cell down its concentration gradient and HC03 - may 
enter the cell and produce an alkalinisation in pHi. The ability of Pendrin and CFTR 
alone to transport HC03- in exchange for cr was tested in stably transfected FRT 
cells (see Methods section 2.1.2). Control, non-transfected FRT cells produced an 
alkalinisation of 0.24 ± 0.01 pH units in response to basolateral cr removal, which 
was not enhanced by forskolin stimulation (0.32 ± 0.05 pH units; P>0.05). This 
constitutively active basolateral AE activity was not significantly altered by either 
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Pendrin or CFTR transfection. Importantly, the control FRT cells showed no 
significant response to apical cr removal, under basal or forskolin stimulated 
conditions. 
Pendrin (A4) transfected FRT cells produced an alkalinisation in pHi of 0.16 ± 0.06 
pH units following apical cr removal under non-stimulated conditions (Figures 3.69 
& 3.71). Re-addition of apical Crproduced a re-acidification at a rate of 0.10 ± 0.02 
pH units min-I. Forskolin addition did not produce a significant change in pHi 
(P>0.05; n=6) and neither the mean alkalinisation nor the rate of re-acidification, due 
to cr removal and cr re-addition respectively, were significantly increased in A4 
FRT cells (P>0.05; n=6). 
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Figure 3.69- Apical AE activity in Pendrin transfected FRT cells. The effects of forskolin (5 f.lM) 
on changes in pHi following the removal of apical chloride in Pendrin transfected FRT cells. 
CFTR transfected FRT cells had a more neutral initial pHi (7.26 ± 0.05) compared to 
A4 FRT cells (7.64 ± 0.08; n=13; P<O.OOl). CFTR transfected cells also produced an 
alkalinisation in response to apical cr removal under basal conditions, however this 
change in pHi was enhanced following forskolin addition (0.10 ± 0.01 to 0.28 ± 0.03 
pH units; P<0.05; n=6; Figures 3.70 & 3.71). Likewise the rate of re-acidification 
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increased from 0.05 ± 0.01 to 0.14 ± 0.03 pH units min-1 upon forskolin stimulation 
(P<0.05; n=6). 
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Figure 3.70- Forskolin enhances apical cr removal induced pHi changes in CFTR transfected 
FRT cells. The effects of forskolin (5 11M) on changes in pHi following the removal of apical chloride 
in CFTR transfected FRT cells. 
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'Figure 3.71- Apical cr removal and re-addition induced changes in pHI in Pendrin and CFTR 
transfected FRT cells. Comparison of the mean changes in pHi following removal of chloride (A) and 
the rate of re-acidification in pHi following the re-addition of chloride (B), in control, Pendrin 
transfected (A4) and CFTR transfected (CFTR) FRT cells, in the presence and absence of forskolin. 
n=6. A4 and CFTR transfected FRT cell experiments ran in parallel. A: *P<O.05 compared to apical 
ocr (CFTR). B: *P<O.05 compared to apical ocr (CFTR). 
Apical AE activity in Pendrin transfected FRT cells was unaffected by the CFTR 
inhibitor GlyH-101 (Figure 3.72). 
111 
A B 
c: 
o i 0.1 
o 
;: 
is 
'u 
'l' 
~ 
'0 
Gl 
~ 
Figure 3.72- Pendrin transfected FRT cells exhibit CFTR-independent apical AE activity. The 
effects of apical CFTR inhibitor GlyH-lOl (10 f.lM) on the mean alkalinisation (PHi) produced by 
apical chloride removal (A) and the rate of re-acidification upon apical chloride re-addition (B), in 
unstimulated and forskolin-stimulated (5 f.lM) Pendrin transfected FRT cells. n=3. Paired observations. 
Changes in pHi due to apical cr removal in CFTR transfected FR T cells were almost 
completely abolished by pre-treatment with GlyH-101 (P<O.OOl; n=3; Figure 3.73). 
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Figure 3.73- Apical zero cr induced changes in pHi in forskolin-stimulated CFTR transfected 
FRT cells is inhibited by GlyH-lOl. The effects of apical CFTR inhibitor GlyH-lOl (10 f.lM) on the 
mean alkalinisation (PH0 produced by apical chloride removal (A) and the rate of re-acidification upon 
apical chloride re-addition (B), in unstimulated and forskolin-stimulated (5 f.lM) CFTR transfected FRT 
cells. n=3. Paired observations. A: *P<O.OOI compared to apical ocr and +FSK+GlyH-lOl. B: 
*P<0.05 compared to apical OCr. tP<O.Ol compared to +FSK+GlyH-lOl. 
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The changes in pHi due to apical cr removal and re-addition were unaffected by the 
addition of apical H2-DIDS in both Pendrin (Figure 3.74) and CFTR transfected FRT 
cells (Figure 3.75). 
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Figure 3.74- HrDIDS insensitive apical AE activity in forskolin-stimulated Pendrin transfected 
FRT cells. The effect of apical HrDIDS (500 J.lM) on the mean alkalinisation (PHi) produced by apical 
chloride removal (A) and the rate of re-acidification upon apical chloride re-addition (B), in forskolin-
stimulated (5 J.lM) Pendrin transfected FRT cells. n=3. Paired observations. 
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Figure 3.75- Hz-DIDS insensitive apical zero cr induced changes in pHI in forskolin-stimulated 
CFTR transfected FRT cells. The effect of apical HrDIDS (500 J.lM) on the mean alkalinisation 
(PHi) produced by apical chloride removal (A) and the rate of re-acidification upon apical chloride re-
addition (B), in forskolin-stimulated (5 J.lM) CFTR transfected FRT cells. n=3. Paired observations. 
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An important difference between apical Cr-dependent changes in pHi in Pendrin and 
CFTR transfected FRT cells was their anion selectivity profiles. Both cell types were 
only able to transport monovalent anions (AE activity was not supported by divalent 
anions oxalate or sulphate), but A4 transfected cells had a greater affinity for iodide 
compared with chloride and formate (Figure 3.76), whereas CFTR transfected cells 
transported each with equal specificity (Figure 3.77). 
Iodide addition in Pendrin FRT cells under apical zero cr conditions, produced a 
significantly faster rate and overall re-acidification in pHi compared to other 
monovalent anions (P<0.05). Comparing the CriX selectivity ratios of Pendrin FRT 
(chloride 1: formate 1.1: iodide 3.2) and CFTR FRT cells (chloride 1: iodide 1.1: 
formate 1.3) with that ofWT Calu-3 cells (formate 0.6: chloride 1: iodide 1.3), would 
suggest that neither CFTR nor Pendrin are solely responsible for the apical anion 
selectivity seen in Calu-3 cells. However, the greater affinity of Pendrin for iodide 
would explain the iodide selectivity ofWT Calu-3 cells. 
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Figure 3.76- Anion selectivity of re-acidification in pHI following apical cr removal in Pendrin 
transfected FRT cells. The mean acidification (A) and rate of recovery (B) of pHi by the introduction 
of monovalent (iodide, formate and chloride) and divalent (oxalate and sulphate) anions in zero cr 
conditions. n=4. Paired observations. A: *P<O.05 compared to chloride. tP<O.OI compared to formate. 
B: *P<O.05 compared to chloride and formate. 
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Figure 3.77- Anion selectivity of re-acidification in pHi following apical cr removal in CFTR 
transfected FRT cells. The mean acidification (A) and rate of recovery (B) of pHi by the introduction 
of monovalent (iodide, formate and chloride) and divalent (oxalate and sulphate) anions in zero cr 
conditions. n=4. Paired observations. 
3.11 Discussion 
The cAMP-activated apical AE activity present in Calu-3 cells is Na+-independent, 
H2-DIDS-insensitive and can transport a range of monovalent anions in exchange for 
HC03- with the selectivity profile Iodide=Br->Cr=Formate =N03-=SCN-. The profile 
of this exchanger is most consistent with Pendrin. However, as seen in CFTR 
transfected FRT cells, apical cr removal could also induce HC03- influx through 
CFTR. This coupled with the finding that the addition of the CFTR inhibitors GlyH-
101 or CFTRinh-172 abolishes apical AE activity in Calu-3 cells, strongly suggests 
CFTR rather than an apical CrlHC03- exchanger is responsible for mediating HC03-
exit across the apical membrane of Calu-3 cells, as has been previously postulated 
(Illek et ai, 1997; Lee et ai, 1998). 
3.11.1 Apical AE activity in Calu-3 cells: SLC26 CrlHC03-exchanger or CFTR? 
The alkalinisation seen in cAMP-stimulated Calu-3 cells following apical cr removal 
and the subsequent re-acidification in pHi upon cr re-addition can be interpreted as 
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being due to HC03 - flux through CFTR and/or due to CrIHC03 - exchange activity. 
Overall my results are consistent with a combination of both CFTR and an apical cr 
1HC03- exchange being involved, which I propose together form the mechanism 
driving HC03- transport across the apical membrane ofCalu-3 cells. The argument in 
support of the involvement ofa CrlHC03- exchanger in apical HC03- transport can be 
divided into 4 main findings: 
1. Affinity of apical AE activity for iodide is inconsistent with CFTR anion selectivity. 
The iodide selectivity of the apical AE present in Calu-3 cells is consistent with the 
high affinity of Pendrin for iodide as seen in the Pendrin transfected FRT cells. My 
results in WT Calu-3 cells suggest that the apical AE has the selectivity profile: 
Iodide=Br>Cr=Formate=N03-=SCN-. Apical AE activity in Pendrin transfected FRT 
cells had an anion selectivity of Iodide>Cr=Formate, whereas CFTR transfected cells 
transported each of these monovalent anions at equal rates. Previous CFTR Isc anion 
substitution measurements performed in a-toxin permeabilised Calu-3 cells 
aetermined the cAMP-stimulated CFTR anion selectivity to be: Br>CI>N03->SCN-
>Iodide>Formate>HC03- (Illek et ai, 1997). The same study found that CFTR did not 
conduct divalent anions such as SO/- and was blocked by both formate and iodide. 
Also in studies using excised inside-out membrane patches from CFTR transfected 
CHO cells, iodide (150 mM) blocked CFTR (Tabcharani et ai, 1992). The 
permeability of iodide compared to chloride through CFTR has led to conflicting 
results, although this maybe due to differences in iodide permeability according to 
whether measurements were made from the cytoplasmic or luminal side of the CFTR 
channel (Linsdell et ai, 1997). Although iodide block of CFTR would suggest that the 
116 
anion selectivity of the apical AE activity in Calu-3 cells and its high affinity for 
iodide are not consistent with the selectivity profile of CFTR, by blocking CFTR, 
iodide addition during an apical cr removal induced alkalinisation may result in a re-
acidification similar to that seen upon the addition CFTR pore blocker GlyH-10l. 
Therefore potential future work into the profile and selectivity of the Calu-3 apical AE 
activity should include the addition ofbasolateral H2-DIDS during anion substitution 
studies in order to determine whether the exchanger transports iodide, or the re-
acidification in pHi is due to iodide blocking CFTR resulting in activation of a H2-
DIDS-sensitive basolateral HC03- transporter. However, my experiments in CFTR 
transfected FRT cells would suggest that CFTR has a similar permeability for iodide 
compared to chloride under these experimental conditions and is therefore unlikely to 
be blocked by iodide. 
SLC26A9, a cr channel preferentially expressed in lung tissue (Lohi et ai, 2002) and 
which my mRNA studies have shown to be expressed in Calu-3 cells, is known to be 
highly selective for iodide when expressed in Xenopus oocytes (selectivity sequence-
Iodide> Br-> N03>Cr; Dorwart et ai, 2007; Loriol et ai, 2008). Like CFTR, iodide is 
known to block cr conductance through SLC26A9 (Dorwart et ai, 2007). However, 
simultaneous measurement of membrane potential, pHi and [CrJi have revealed that 
OH- and HC03 - flux through SLC26A9 in transfected oocytes is very small (A9-
mediated HC03- flux -0.33 mM min-I; Dorwart et ai, 2007), with little or no change 
in pHi observed following cr removal (Dorwart et ai, 2007; Loriol et ai, 2008). cr 
current measurements in HEK cells showed that SLC26A9 is constitutively active and 
its activity is not enhanced by forskolin (Bertrand et ai, 2009). Also, SLC26A9 cr 
currents can be partially inhibited by 0.1 mM DIDS (by -36%; Dorwart et ai, 2007). 
117 
These results would suggest that SLC26A9 is unlikely to be responsible for the 
changes in pHi observed in Calu-3 cells. A recent study in the bronchial cell line, 
CFBE4l0, expressing CFTR and transduced with SLC26A9, found that SLC26A9 
expression resulted in an increase in CFTR-dependent, forskolin-stimulated currents 
(Avella et ai, 2010). SLC26A9 expression enhanced CFTR expression and co-
immunoprecipitation experiments showed that SLC26A9 physically interacts with 
CFTR in the apical membrane of these cells. Therefore, as SLC26A9 expression 
maybe required for maximal CFTR activity and/or expression, the reduced rate of 
apical AE activity seen in forskolin-stimulated SLC26A9 knockdown Calu-3 cells 
could perhaps be due to a decrease in cr conductance through CFTR, rather than 
SLC26A9. 
The iodide selectivity of the apical AE activity may also suggest the presence of an 
outwardly rectifying chloride channel (ORCC) in Calu-3 cells, as has been previously 
reported in patch-clamp experiments (Haws et aI, 1994). ORCCs have a greater 
permeability for iodide relative to chloride and can be regulated by CFTR (Gabriel et 
"ai, 1993). However, ORCCs are unlikely to be responsible for the apical 'AE' activity 
seen in Calu-3 cells as ORCCs can be inhibited by H2-D1DS (Schwiebert et ai, 1995) 
and are more likely to be found on the basolateral membrane, as more recent patch 
clamp studies of Calu-3 cells demonstrated that ORCCs are only occasionally seen in 
the apical membrane of confluent monolayers, but are found with more abundance in 
non-polarised individual cells (Xia et ai, 1997). 
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As neither CFTR, SLC26A9 nor ORCCs can explain the high affinity of the apical 
AE for iodide, I believe that Pendrin is the most likely candidate to mediate cr-
dependent H C03 - transport. 
2. Apparent inhibition of apical AE activity by CFTR pore blocker GlyH-IOI due to 
the masking effect of a H2-DIDS sensitive basolateral transporter. 
pHi experiments showed that while forskolin-stimulated apical AE activity was 
abolished by inhibiting CFTR (with either CFTRinh-172 or GlyH-101), it was restored 
by the addition of basolateral H2-DIDS. This result would suggest that the inhibition 
of apical CFTR actually reveals a H2-DIDS-sensitive basolateral transport process 
which masks the effects of apical AE reversal on pHi. The identity of this basolateral 
transporter and the mechanism by which CFTR inhibition leads to its activation are 
currently unknown, but its sensitivity to H2-DIDS would suggest that the transporter 
responsible maybe the NBC (in reverse mode), a basolateral CrIHC03- exchanger or 
even a basolateral anion channel. Both pNBCl and NBC4 mRNA expression have 
• been detected in Calu-3 cells, both of which are electrogenic and have different 
stoichiometries (either 1:2 or 1 :3) according to the cell type in which they are 
expressed (Kreindler et ai, 2006). My data certainly suggests that the basolateral NBC 
is active under forskolin-stimulated conditions, as the addition ofbasolateral H2-DIDS 
reduces the rate of apical AE activity, presumably due to blocking HC03 - uptake 
through the NBC. Intracellular pH studies carried out in normal and CF pancreatic 
duct cells (CAPAN-l, CFPAC-l) highlighted the role of CFTR cr transport in the 
cAMP-dependent potentiation of NBC activity, which was not present in CF cells 
(Schumaker et ai, 1999). Therefore inhibiting CFTR in Calu-3 cells may result in an 
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alteration of NBC activity. However, reversal of the NBC seems unlikely as Calu-3 
Ussing chamber studies demonstrated that in the presence of l-EBIO, which would be 
predicted to cause cellular hyperpolarisation by stimulating K+ channels, the NBC 
was not reversed as HC03- secretion continued (Krouse et ai, 2004). The same study 
also predicted that for an NBC with a 1:2 (Na+:HC03-) stoichiometry, as postulated by 
their data, the reversal potential would be greater than -100 mY. Such a large 
hyperpolarisation in membrane potential is unlikely to be achieved by either CFTR 
inhibition or bilateral cr removal under forskolin-stimulated conditions. However, 
the basolateral NBC present in Calu-3 cells may have a stoichiometry of 1 :3, as has 
been previously suggested by microelectrode analysis (Tamada et ai, 2001), which 
could potentially enable NBC reversal under these conditions. 
The potential for a basolateral CrIHC03- exchanger being involved in the H2-DIDS-
sensitive re-acidification upon GlyH-101 inhibition of CFTR also seems unlikely 
under these conditions, as forskolin inhibits basolateral AE activity (see chapter 4 for 
further discussion). pHj experiments carried out in the absence of bilateral cr under 
~ forskolin-stimulated conditions, suggested that the effects of apical AE activity on pHj 
could be masked by an acidification produced by a H2-DIDS-sensitive basolateral cr-
dependent transporter. Since external cr removal would be likely to favour HC03-
entry via a CrlHC03 - exchanger, a basolateral AE fulfilling this role appears doubtful. 
These results bear some similarities to the anion exchange profile of human nasal 
epithelial (HNE) cells (Paradiso, et ai 2003). Fluorimetry studies in HNE cells 
showed the presence of both apical and basolateral 'AE activities', using a cr 
removal and addition technique. Apical cr removal produced only a transient 
alkalinisation in pHj. The hypothesis behind this transient response was that cr 
120 
removal at the apical membrane could potentially reach the basolateral membrane and 
thus affects the H2-DIDS-sensitive basolateral AE present in these cells. The addition 
of basolateral H2-DIDS enhanced this alkalinisation and blocked the re-acidificatfon 
back to baseline, which could then only be achieved by the re-addition of apical Cr. 
The constitutively active apical AE activity present in HNE cells was attributed to cr 
dependent HC03- transport by CFTR, due to its insensitivity to H2-DIDS and 
inhibition by the CFTR inhibitor DPC. Unfortunately DPC was not tested in the 
presence of basolateral H2-D1DS, so the involvement of a basolateral AE in the DPC 
inhibition of the apical alkalinisation cannot be ruled out. 
Another possible explanation for the effects of basolateral cr removal on apical AE 
activity is that [CrJi could be depleted under these conditions, which would abolish 
the cr gradient necessary for apical AE reversal. Basolateral cr removal could trigger 
cr efflux across the basolateral membrane, via a basolateral H2-D1DS-sensitive anion 
channel, such as an ORCC. Patch-clamp experiments using forskolin and the PKA 
inhibitor H-89, identified a cAMP/PKA-dependent basolateral ORCC in Calu-3 cells 
~ (Szkotak et ai, 2003). siRNA studies on 36cr flux have proposed that this basolateral 
cr conductance is mediated by a member of the bestrophin family of putative cr 
channels (Duta et ai, 2004). Therefore basolateral cr channels are likely to be active 
under forskolin-stimulated conditions and could influence apical AE activity. 
Since in the presence ofbasolateral H2-DIDS and apical GlyH-101, apical cr removal 
can still evoke a large alkalinisation in pHi and a further re-acidification following 
apical cr re-addition, then it would appear that apical Cr-dependent HC03- transport 
can be mediated independently of CFTR. 
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3. PP 1 inhibition reveals a CFTR-independent apical AE activity. 
Okadiac acid (OA) inhibition ofPPl (as confinned by okadaic acid dose-response and 
the lack of inhibition by PP2A inhibitor fostriecin) revealed an apical AE activity 
under non-stimulated conditions. This apical AE activity had a similar profile to that 
seen under forskolin-stimulated conditions; it was insensitive to H2-DIDS and was 
only able transport monovalent anions in exchange for HC03 -. Although no difference 
was seen in the rate of AE activity driven by chloride, fonnate or iodide, the small 
magnitude and rate of re-acidification under these conditions made it difficult to 
detect any subtle differences. Importantly, in OA treated Calu-3 cells, the CFTR pore 
blocker GlyH-101 could not inhibit apical AE activity under non-stimulated 
conditions. Apical AE activity was also present in non-stimulated CFTR KD Calu-3 
cells. As Pendrin is constitutively active in FRT cells, the okadaic acid experiments 
may suggest that the apical AE present in forskolin-stimulated Calu-3 cells is 
inhibited under non-stimulated conditions by dephosphorylation involving PPI. 
~ Forskolin enhanced the apical AE activity in OA treated cells, through a CFTR-
dependent mechanism, although the level of AE activity was still lower than in 
untreated Calu-3 cells. As the forskolin-stimulated AE activity in fostriecin treated 
cells was also reduced compared to untreated cells and 100 nM okadaic acid can also 
inhibit PP2A, this reduction maybe due to PP2A inhibition. One possible explanation 
is that by enhancing the activity of the basolateral NKCC, PP2A inhibition by 
fostriecin would potentially increase [Cni. thus reducing the rate of the CrIHC03-
exchanger in the forward direction (Cr uptake in exchange for HC03- exit) by 
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decreasing the cr gradient. Although how PP2A inhibition would reduce the overall 
magnitude ofthe alkalinisation caused by AE reversal is more difficult to determine. 
4. Pendrin KD Calu-3 cells exhibit a reduce rate of apical AE activity. 
The hypothesis that Pendrin CrIHC03- exchange contributes to HC03- transport 
across the apical membrane of Calu-3 cells was supported by the finding that the rate 
of apical AE activity was reduced in Pendrin KD Calu-3 cells. Western blot analysis 
of CFTR protein expression showed no difference between WT and A4 KD cells, 
which suggests that this decrease in HC03- transport across the apical membrane of 
A4 KD Calu-3 cells was due to a decrease in Pendrin expression rather than CFTR. 
However, despite a 90% knockdown of Pendrin mRNA expression in A4 KD cells, 
the mean alkalinisation induced by apical Cl removal was not significantly different to 
WT Calu-3 cells, although the rate of apical AE activity was reduced. If the apical AE 
is SLC26A4, then another mechanism is likely to be contributing to the transport of 
~ HC03- in these cells, such as a second CrlHC03- exchanger (as seen in pancreatic 
duct cells) or CFTR itself. 
3.11.2 Role ofCFTR in Calu-3 cell HC01- transport 
My experiments in CFTR transfected FRT cells highlighted the potential of CFTR to 
transport HC03- in response to apical cr removal. Therefore under the conditions 
tested CFTR is likely to be involved in transporting HC03 - across the apical 
membrane of Calu-3 cells. Certainly from the Cr-dependence experiments, with 
changes in apical [Cn of bathing solutions still producing an alkalinisation in pHi at 
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concentrations that would not favour CrIHC03 - exchanger reversal «30 mM), there 
is evidence to suggest that another transport pathway contributes to Cr-dependent 
H C03 -transport. 
While it is difficult to distinguish between CFTR HC03- transport and CFTR 
regulating Cr/HC03- exchange activity, it is clear that CFTR has an important role to 
play in mediating apical HC03 - transport in Calu-3 cells. Three independent lines of 
evidence support this hypothesis: 
1. Although basolateral H2-DIDS addition overcame the apparent inhibition of 
apical AE by GlyH-101 in WT Calu-3 cells, the rate of apical AE activity in 
the presence of both apical GlyH-lOI and basolateral H2-DIDS was 
significantly slower compared to activity in the absence or presence of 
basolateral H2-DIDS alone. However, this result may also reflect differences 
in [Cn gradients under the two conditions, rather than simply HC03- transport 
byCFTR . 
2. In okadaic acid treated cells, apical AE activity was enhanced by forskolin-
stimulation, through a GlyH -10 I-sensitive mechanism. 
3. Apical AE activity was significantly reduced in CFTR KD Calu-3 cells, 
compared to WT cells. 
Therefore I propose that CFTR has a role in regulating apical CrIHC03- exchange 
activity and/or contributing to Cr-dependent HC03 - transport in Calu-3 cells. CFTR 
inhibitor studies also suggest that CFTR maybe important in regulating basolateral 
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HC03- transport. For these reasons the role of CFTR in regulating basolateral cr 
IHC03 - exchange was investigated in Calu-3 cells. 
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4. Basolateral Cr/HCO£ exchange activity in Calu-3 cells 
4.1 Introduction 
There are two families of genes encoding for Cr/HC03 - exchangers: SLC26 and 
SLC4. As already demonstrated in chapter 3, several members of the SLC26 family 
are expressed in Calu-3 cells, including SLC26A4 (Pendrin), which is localised to the 
apical membrane. Previous transport models of Calu-3 cells included the basolateral 
SLC4A2 Cr/HC03- exchanger (AE2; Lofting et aI, 2000). Together with the 
electrogenic Na+-HC03- cotransporter NBCl, AE2 is involved in basolateral HC03-
transport which regulates pHi in Calu-3 cells and, in addition to the NKCC, also 
mediates basolateral cr uptake (Lofting et aI, 2000; Inglis et aI, 2002). 
The SLC4 family of 10 genes encode for HC03- transport proteins that playa vital 
role in mediating Na+ and/or Cr-dependent HC03- across many tissues and cell types 
(Pushkin and Kurtz, 2006). The SLC4 transporter family includes three types of 
HC03- transporters: Na+-independent CrlHC03- exchangers (AE), Na+-HC03-
cotransporters (NBC) and Na+-driven Cr/HC03- exchangers (NDCBE). SLC4Al 
(AEl), -A2 (AE2), -A3 (AE3) and -A9 (AE4), were reported as electroneutral cr 
IHC03- exchangers (Romero, 2005). AEI is expressed in red blood cells (Hunter, 
1977) and renal collecting duct a-intercalated cells of the collecting duct (Verlander et 
aI, 1988). AE2 is expressed broadly in epithelia including the gastric mucosa (Stuart-
Tilley et aI, 1994), colon (Gawenis et aI, 2010), kidney (Alper et aI, 1997) and 
respiratory tracts (Dudeja et aI, 1999). AE3 is expressed in the brain and heart (Kopito 
et aI, 1989). AE4 expression is less well characterised, but appears to be mainly in the 
kidney (Parker et aI, 2001). 
126 
RT-PCR analysis of cells from various segments of the tracheobronchial tree detected 
the expression of AE2 and brain-AE3 isoforms, but not AEI or cardiac-AE3 isoforms 
(AI-Bazzaz et ai, 2001). The levels of AE2 mRNA expression were shown to' be 
similar from the trachea all the way down to the small bronchi, with 
immunohistochemical analysis indicating that AE2 is specific to airway epithelial 
cells. 
The activity of AE2 expressed in Xenopus oocytes, as measured by 36cr influx and 
efflux studies, was activated by exposure to alkaline media and inhibited by exposure 
to acidic media (Humphreys et ai, 1994). Subsequent studies in Xenopus oocytes 
revealed that AE2 is regulated by both external and internal pH, which is sensed by 
(His) residues within the AE2 COOH-terminal transmembrane domain and regions of 
its NH2-terminal cytoplasmic domain (Zhang et ai, 1996; Stewart et ai, 2001; Stewart 
et ai, 2007). The extracellular pH (PHo) at which AE2 activity is half-maximal 
[pHo(50)] was measured at -6.9 by AE2-mediated 36CI- efflux studies, with truncation 
of the NH2-terminal cytoplasmic domain shifting pHo(50) by -0.7 pH units and 
.. abolishing the pHi sensitivity of AE2 (Stewart et ai, 2001). 
4.2 PronIe of basolateral Cr/HCOJ- exchanger 
4.2.1 HrD1DS sensitivity 
As described in chapter 3, Calu-3 cells appear to exhibit a basolateral CrIHC03-
exchange activity under non-stimulated conditions, which is abolished upon increases 
in [cAMP]i. As shown in Figure 4.01, removal of basolateral cr (substituted with 
gluconate) produced an alkalinisation in pHi of 0.45 ± 0.02 pH units (n=4). This 
response to cr removal was abolished by the generic anion exchange inhibitor H2-
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DIDS (P<0.05, paired t-test; n=4; Figure 4.02), consistent with the presence of a 
basolateral DIDS-sensitive AE (SLC4A2), as previously reported in Calu-3 cells 
(Loffing et ai, 2000). However, the inhibition of the basolateral AE by H2-DIDS, may 
be due to the acidification of pHi induced by the addition of H2-DIDS (0.12 ± 0.03 pH 
units, at a rate of 0.05 ± 0.01 pH units min-I; n=4). As basolateral H2-DIDS addition 
will also inhibit the basolateral Na+-HC03- cotransporter (NBC), this acidification is 
consistent with the inhibition of HC03 - uptake via the NBC. However, since the 
subsequent removal of H2-DIDS from the perfusate resulted in the restoration of 
basolateral AE activity without a significant recovery in pHi, it is unlikely that the H2-
DIDS-sensitivity of the basolateral AE is indirectly due to intracellular acidification. 
Baso OCI- Baso ocr Baso ocr 
KRB/HC03- KRB/HC03- +H2-DlDS KRB/HC03-7 .. ~----------~ __ ~~ __ ~~~~ __ ~~ ________ ~ __ ~ 
Time(s) 
Figure 4.01- Inhibition of basolateral AE by HrDIDS. The effect ofbasolateral HrDIDS (500f.lM) 
, on changes in pH; following the removal ofbasolateral cr in Calu-3 cells. 
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Figure 4.02- H2-DIDS sensitivity of basolateral AE activity. The effect ofbasolateral Hr DIDS (500 
f.lM) on mean alkalinisation of pH; following removal of basolateral cr (A) and the mean rate of re-
acidification upon re-addition of cr in Calu-3 cells (B). n=4. Paired observations. A: *P<0.05 
compared to Baso OCr. B: *P<0.05 compared to Baso OCr. 
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4.2.2 Bumetanide sensitivity 
As the removal of extracellular cr may affect other basolateral cr transporters, such 
as the Na+/K+I2Cr co-transporter (NKCCl), which may result in changes in [Cr]i 
andlor pHi, the effects of basolateral cr removal in the presence of the NKCC 
inhibitor bumetanide was also tested. Basolateral AE activity was unaffected by 
inhibiting cr uptake through the basolateral NKCC, following the addition of 
bumetanide (20 )lM) to the basolateral bathing solution (P>0.05; n=3; Figure 4.03). 
Calu-3 cells exposed to basolateral zero cr in the presence of bumetanide showed a 
similar alkalinisation in pHi and rate of re-acidification upon cr re-addition, to 
untreated cells (+Bumetanide= 0.42 ± 0.01 pH units min-I; untreated= 0.38 ± 0.04 pH 
units min-I). Bumetanide also had no significant effect on the inhibition of the 
basolateral AE by forskolin. 
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Figure 4.03- The effect of NKCC inhibition on basolateral AE activity. The effects of NKCC 
inhibitor bumetanide (20 flM) on mean alkalinisation of pHi following removal of basolateral cr. in 
non-stimulated and forskolin-stimulated Calu-3 cells. n=3. Non-stimulated and forskolin-stimulated 
Calu-3 cell experiments ran in parallel. Baso vs +Bumetanide and +FSK vs +FSK+Bumetanide 
represent paired observations. 
4.2.3 HC03--dependence 
The bicarbonate dependence of the basolateral AE was tested through removal of 
external HC03-, using HEPES buffered solutions. In HC03--free conditions the 
removal of basolateral cr did not produce an alkalinisation, but instead caused a small 
acidification in pHi of 0.07 ± 0.04 pH units (P<0.05; n=4; data not shown). Addition 
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of forskolin abolished any significant effect on pHi following basolateral cr removal 
in HC03 --free conditions. These results suggest that there is little or no OH- transport 
by the basolateral exchanger. 
Studies have shown that the basolateral AE2 is sensitive to acetazolamide because of 
its association with the cytoplasmic form of carbonic anhydrase (CA) II (Vince & 
Reinhart, 2000), therefore it was important to test the effects of CA on basolateral cr 
1HC03- exchange activity. The complete inhibition ofbasolateral AE by HC03-IC02 
removal from the bathing medium could not be mimicked by the CA inhibitor 
acetazolamide in the presence of HC03 - . However, acetazolamide did produce a 
slight inhibition of the basolateral AE (Figure 4.04). The mean change in pHi upon 
basolateral cr removal was reduced from 0.28 ± 0.01 pH units to 0.17 ± 0.02 pH 
units (P<O.Ol; n=5), representing a mean inhibition of 38 ± 9% in the presence of 
acetazolamide (100 IlM). In the absence of HC03- production by CA, intracellular 
HC03- concentrations are likely to be maintained by uptake through the NBC, thus 
sustaining basolateral Cr/HC03- exchange. 
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Figure 4.04- The effect of carbonic anhydrase inhibition on basolateral AE activity. The effects of 
carbonic anhydrase inhibitor acetazolamide (ATZ; 100 11M) on mean alkalinisation of pH; following 
removal of basolateral cr (A) and the mean rate of re-acidification upon re-addition of cr in Calu-3 
cells (B). n=5. A: *P<O.Ol compared to Baso OCr. B: *P<O.OOI compared to Baso OCr. 
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4.2.4 Na+-dependence 
To examine the Na+ dependence of the basolateral AE, extracellular Na+ was replaced 
with NMDG. Na+ removal initially produced an acidification in pHj of 0.37 ± O.OI'pH 
units. Like H2-DIDS, extracellular Na+ removal is likely to inhibit the basolateral 
NBC, thus depleting the intracellular HC03 - concentration and acidifying pHj. 
Basolateral AE activity was completely abolished following the removal of external 
Na+ (P<O.Ol; n=5; Figure 4.05). This result may represent a direct Na+-dependence of 
the basolateral CrlHC03- exchanger or it may reflect an indirect effect of the 
acidification produced by inhibition of the NBC. 
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Figure 4.05- Na+-dependence of basolateral AE activity. The effect of bilateral Na+ removal (NaCl 
replaced by NMDGCI) on the mean alkalinisation (pH j ) produced by apical chloride removal (A) and 
the rate of re-acidification upon apical chloride re-addition in forskolin-stimulated Calu-3 cells (B). 
n=5. Paired observations. A: *P<O.OI compared to Baso ocr. B: *P<O.OI compared to Baso ocr. 
4.3 Mechanism of basolateral CrlHCO~- exchange inhibition by cAMP 
The activity of the basolateral exchanger as shown by the removal of basolateral cr, 
produced an alkalinisation in pHj of 0.43 ± 0.01 pH units under non-stimulated 
conditions (n=35; Figures 4.06 & 4.07A). The rate of basolateral AE activity was 
measured at 0.52 ± 0.03 pH units min-1 upon re-addition of basolateral cr (Figure 
4.07B). Basolateral AE activity was completely abolished following the addition of 
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cAMP agonist forskolin (P<O.Ol; n=35), but dideoxyforskolin had no effect (P>O.05; 
n=3). 
Figure 4.06- Forskolin-induced inhibition of basolateral AE activity. The effects of forskolin (FSK; 
5 ~M) on changes in pHi following the removal of basolateral chloride in Calu-3 cells. Basa ocr 
denotes the removal ofCr (replaced with gluconate) from the basolateral solution. 
A B 
* 
Figure 4.07- Inhibition of basolateral AE by forskolin . Mean alkalinisation (PHi) produced by 
basolateral chloride removal (A) and the rate of re-acidification upon basolateral chloride re-addition 
(B), in non-stimulated and forskolin-stimulated (FSK) Calu-3 cells. n=35. Paired observations. A: 
*P<O.OI compared to Baso OCr. B: *P<O.OOI compared to Baso OCr. 
The inhibition of the basolateral AE activity was also seen in cells stimulated by 
basolateral VIP and bilateral ADO, confirming that increases in [cAMP]i were 
responsible for the forskolin-induced basolateral AE inhibition (Figure 4.08). 
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Figure 4.08- Inhibition of basolateral AE by cAMP agonists. The effect of apical forskolin (FSK; 5 
)lM), basolateral vasoactive intestinal peptide (VIP; 150 nM) and bilateral adenosine (ADO; 10 )lM) on 
the percentage mean alkalinisation in pHi following the removal of basolateral cr in Calu-3 cells. pHi 
responses in the presence of FSK, VIP and ADO compared to control baso ocr responses. n=4. 
Agonists ran in parallel in separate experiments. *P<O.OOI compared to Baso ocr. 
As shown in chapter 3 (see section 3.2), application of ADO to both the apical and 
basolateral membranes, inhibited basolateral AE and stimulated apical AE activity, as 
seen in forskolin experiments. However, when ADO was applied to either the apical 
or basolateral membranes alone, basolateral AE activity was reduced, but no longer 
eliminated (Figure 4.09). Basolateral ADO reduced the mean alkalinisation produced 
by basolateral cr removal by 40.5 ± 9.2% (P<O.Ol; n=3). Apical ADO addition did 
not significantly inhibit the basolateral AE (P>0.05; n=3), despite the apical AE being 
fully activated. These results suggest that activation of apical AE alone is not 
sufficient to inhibit basolateral AE activity and that local changes in cAMP 
concentration at both membranes are required to produce a 'switch' in AE activity. 
From the adenosine experiments there appeared to be a correlation between the extent 
of the acidification in pHi produced by the agonist and the amount of inhibition of the 
basolateral AE. The addition of bilateral adenosine (10 IlM) produced the greatest 
mean acidification of 0.23 ± 0.01 pHi units and also the greatest inhibition of the 
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basolateral AE (rate % inhibition = 94.7 ± 4.9%). By contrast the addition of 
adenosine (10 )lM) to either the apical or basolateral membranes alone produced 
smaller initial acidifications (0.10 ± 0.05 and 0.06 ± 0.04 pHi units, respectively) and a 
significantly decreased inhibition of the basolateral AE (rate % inhibition = 24.6 ± 
14.5% and 41.7 ± 4.1 %, respectively). 
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Figure 4.09- Membrane dependent adenosine inhibition of basolateral AE. The effect of bilateral, 
apical only and basolateral only adenosine (ADO; 10 IlM) addition on the percentage mean change in 
pHi produced by basolateral chloride removal (A) and the percentage rate of re-acidification upon 
basolateral chloride re-addition in Calu-3 cells (B). pHi responses in the presence of bilateral ADO, 
apical ADO and basolateral ADO compared to control baso ocr responses. n=3. Each condition ran 
in parallel in separate experiments. A: *P<O.OOI compared to Baso OCr. tP<O.Ol compared to Baso 
ocr. B: *P<O.OOI compared to Baso OCr. 
An alternative way of examining forskolin inhibition of the basolateral AE was to 
apply forskolin under basolateral zero cr conditions (Figure 4.10). Like stimulation 
of the apical AE, forskolin addition in the absence ofbasolateral cr did not produce a 
gradual change in pHi. Under basolateral zero cr conditions, forskolin produced a 
rapid acidification in pHi of a similar magnitude to the acidification produced by cr 
re-addition (+FSK = 0.47 ± 0.01 pH units; +cr = 0.48 ± 0.02 pH units; P>0.05; n=4). 
The rate of re-acidifcaition was also similar to that produced upon re-addition of 
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basolateral cr (+FSK = 0.62 ± 0.10 pH units min-I; +cr = 0.74 ± 0.25 pH units min-I; 
P>0.05; n=4). 
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Figure 4.10- Forskolin-induced acidification in basolateral zero Cr. The effect of the addition of 
forskolin (5 J.lM) on changes in pHi when applied during basolateral zero cr conditions. 
The acidification produced by forskolin (5 J..lM) in the absence of basolateral cr 
occurred after 17 ± 2 s (n=4; Figure 4.10). When compared to the time delay between 
forskolin addition in the absence of apical cr and the resulting alkalinisation in pHi 
(38 ± 4 s; P<O.Ol; n=4; Figure 3.07), it would appear that forskolin inhibits the 
basolateral AE prior to stimulating apical AE activity. 
Potential downstream targets of cAMP were tested to investigate the mechanisms 
involved in the inhibition of the basolateral AE in Calu-3 cells. Despite PKA being 
involved in apical AE stimulation (see Figure 3.08), neither the PKA inhibitor H-89 
nor the general protein kinase inhibitor staurosporine showed any significant effect on 
basolateral AE activity under non-stimulated conditions, or forskolin-induced 
inhibition ofthe basolateral AE (P>0.05; Figure 4.11). 
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Figure 4.11- PKA-independent basolateral AE activity. The effect of PKA inhibitor H-89 (50 ~M; 
n=8) and of protein kinase inhibitor staurosporine (l ~M; n=4) on the percentage mean change in pHj 
produced by apical chloride removal (A) and the percentage rate of re-acidification upon apical 
chloride re-addition in non-stimulated and forskolin-stimulated Calu-3 cells (B). pHj responses in the 
presence of H-89 and staurosporine compared to control baso ocr responses (±FSK). n=4. H-89 and 
staurosporine experiments ran in parallel. 
Similarly, protein tryrosine kinases (inhibited using genistein), PI3-kinase (inhibited 
using LY294002) and Epac (stimulated using agonist 8CPT-2Me-cAMP) did not 
show any involvement in the inhibition of the basolateral AE by forskolin (P>O.05; 
Figure 4.12). 
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Figure 4.12- Inhibition of the basolateral AE by forskolin is not affected by ge . t. p . 
DIS em, 13 kinase 
or Epac. The effects of genistein (30 flM ), PI3 kinase inhibitor (LY294002 ' 20 11M) dE' 
, ,... an pac agolllst 
8CPT-2Me-cAMP (50 flM) on the mean change in pHi produced by apical chloride removal (A) and 
the rate of re-acidification upon apical chloride re-addition in non-stimulated and fiorskol' ti' I 
m-s ruu ated 
Calu-3 cells (B). pHi responses in the presence of genistein, L Y and 8CPT -2Me-cAMP (±FSK) 
compared to control baso ocr (±FSK) responses. n=4. Genistein, LYand 8CPT-2Me-cAMP ran in 
parallel. 
4.4 Effects of Ca2+ on basolateral Cr/HC03- exchange activity 
Raising intracellular Ca2+ using thapsigargin (200 nM) appeared to inhibit the 
basolateral AE, however subsequent experiments with cells pre-loaded with the Ca2+ 
chelator BAPTA-AM (50 ~M) revealed that the effects of thapsigargin were 
independent of changes in [Ca2+]i (Figure 4.13). Ca2+ measurements in Calu-3 cells 
confirmed that BAPTA-AM blocks thapsigargin induced rises in [Ca2+]i (see Figure 
3.16). The Ca2+ -independent inhibition of the basolateral AE by thapsigargin may be 
due to the acidification of pHi upon thapsigargin addition (highly variable), which was 
seen in both untreated and BAPTA-AM loaded Calu-3 cells, although the mechanisms 
involved in this acidification are unknown. Another Ca2+ agonist, carbachol (1 0 ~M), 
had no effect on basolateral AE activity (P>0.05; n=4). The PKC agonist DOG (5 
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JlM) also had no significant effect, suggesting that Ca2+ signalling is not involved in 
the inhibition ofthe basolateral CrlHC03 -exchanger. 
Figure 4.13- The effects of intracellular Ca2+ on basolateral AE activity. The effects of Ca2+ 
agonists thapsigargin (Thaps; 200 nM) ±Ca2+ chelator BAPTA-AM (50 IlM), carbachol (CCH; 10 IlM) 
and PKC agonist DOG (5 IlM), on the mean change in pHi following the removal of basolateral cr in 
Calu-3 cells. pHi responses in the presence ofThaps, Thaps+BAPTA-AM, CCH and DOG compared to 
control baso ocr responses. n=4. Thaps, Thaps+BAPTA-AM, CCH and DOG experiments ran in 
parallel. 
4.5 Regulation of basolateral Cr/HCOJ- exchange by CFfR 
To test whether CFTR is involved in the inhibition of the basolateral AE, the apical 
membrane ofCalu-3 cells were exposed to the CFTR pore blocker GlyH-101 (Figure 
4.14). Under non-stimulated conditions GlyH-101 had no affect on the mean 
alkalinisation produced by the removal of basolateral cr (P>0.05; n=4; Figure 
4.15A), but the rate of re-acidification decreased from 0.46 ± 0.07 to 0.26 ± 0.04 pH 
units min-I (P<0.05; n=4; Figure 4.15B). Interestingly following forskolin stimulation 
in the presence ofGlyH-IOI , the basolateral AE was no longer abolished by forskolin, 
with 56.1 ± 19.9% of the AE induced pHi change still present (P<0.05; n=4). This 
would suggest that cAMP inhibition of basolateral CrlHC03 - exchange is mediated, 
in part, through an apical CFTR-dependent mechanism. 
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Figure 4.14- GlyH-10l prevents the forskolin-induced inhibition of basolateral AE. The effects of 
apical GlyH-lOl (10 /-lM) on changes in pHi following the removal ofbasolateral cr in non-stimulated 
and forskolin-stimulated (5 /-lM) Calu-3 cells. 
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Figure 4.15- The effect of CFTR inhibition on basolateral AE activity. The effects of CFTR 
inhibitor GlyH-lOl (10 /-lM) on mean alkalinisation of pHi following removal ofbasolateral cr (A) and 
the mean rate of re-acidification upon re-addition of cr (B), in non-stimulated and forskolin-stimulated 
Calu-3 cells. n=4. Paired observations. A: *P<0.05 compared to Baso OCr. B: *P<0.05 compared to 
Baso ocr. 
4.5.1 CFTR KD cells 
To further investigate the role of CFTR in regulating basolateral CrIHC03 - exchange 
activity, experiments were conducted on CFTR-KD Calu-3 cells. The removal of 
basolateral cr under non-stimulated condition produced an alkalinisation of 0.46 ± 
0.01 pH units (P>0.05 compared to WT Calu-3 cells; n=4; Figure 4.16A). The 
basolateral AE present in these cells showed a similar sensitivity to H2-DIDS as WT 
Calu-3 cells (mean alkalinisation in response to basolateral ocr was almost 
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completely inhibited; from 0.33 ± 0.04 to 0.02 ± 0.01 pH units; P<0.05; n=3). 
Significantly, the rate of basolateral AE activity was reduced in CFTR-KD cells by 
31.9 ± 10.4%, compared to WT Calu-3 cells (P<0.05; n=4; Figure 4.16B). 
Furthermore, forskolin was now unable to fully inhibit the basolateral AE (Figure 
4.17). These results in CFTR-KD Calu-3 cells bear a striking resemblance to the 
effects ofCFTR inhibition by GlyH-101 in WT Calu-3 cells (Figure 4.15). 
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Figure 4.16- WT vs. CFTR KD Calu-3 cell basolateral AE activities. Comparison of the mean 
alkalinisation of pHi following removal of basolateral cr (A) and the mean rate of re-acidification upon 
re-addition of cr (B), between non-stimulated WT and CFTR KD Calu-3 cells. n=4. WT and CFTR 
KD Calu-3 cell experiments ran in parallel. B: *P<O.05 compared to Baso ocr. 
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Figure 4.17 - Forskolin does not fully inhibit basolateral AE in CFTR KD cells. The effects of 
forskolin (FSK; 5 !J.M) on the mean alkalinisation of pHi following removal of basolateral cr (A) and 
the mean rate of re-acidification upon re-addition of cr (B), in CFTR KD Calu-3 cells. n=4. Paired 
observations. A: *P<O.05 compared to Baso OCr. B: *P<O.05 compared to Baso OCr. 
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4.6 Basolateral AE in SLC26A4 & SLC26A9 knockdown Calu-3 cells 
To investigate if either SLC26A4 or SLC26A9 expression could also influence the 
basolateral AE (like CFTR), AE activity was measured in A4 and A9 knockdown 
Calu-3 cells. Both A4 and A9 KD cells produced an alkalinisation in pHi following 
basolateral cr removal and subsequent re-acidification upon cr re-addition of a 
similar magnitude and rate compared to control cyclophilin B KD cells. However, like 
CFTR KD cells, basolateral AE activity was no longer completely inhibited by 
forskolin in both A4 and A9 KD Calu-3 cells. Forskolin reduced the mean 
alkalinisation in response to basolateral zero cr by 44 ± 12% in A4 KD cells (P<O.OI; 
n=4; Figure 4.18) and 50 ± 11 % in A9 KD cells (P<O.OOI; n=5; Figure 4.19). The 
rate ofbasolateral AE measured upon cr re-addition in both A4 and A9 KD cells was 
not significantly inhibited by forskolin-stimulation (P>0.05). 
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Figure 4.18- The effect of Pendrin KD on basolateral AE activity. Comparison of the mean 
alkalinisation of pHi following removal of basolateral cr (A) and the mean rate of re-acidification upon 
re-addition of cr (B), between control cyclophilin B KD and Pendrin Knockdown (A4 KD) Calu-3 
cells, under non-stimulated and forskolin-stimulated (5 liM) conditions. n=4. WT and A4 KD cell 
experiments carried out in parallel. A: *P<O.Ol compared to Baso OCHFSK. B: *P<O.05 compared to 
Baso OCHFSK. 
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Figure 4.19- The effect of SLC26A9 KD on basolateral AE activity. Comparison of the mean 
alkalinisation of pHi following removal of basolateral cr (A) and the mean rate of re-acidification upon 
re-addition of cr (B), between control cyclophilin B KD and SLC26A9 Knockdown (A9 KD) Calu-3 
cells, under non-stimulated and forskolin-stimulated (5 f.lM) conditions. n=5. WT and A9 KD cell 
experiments carried out in parallel. A: *P<O.OI compared to Baso OCr+FSK. B: *P<O.05 compared to 
Baso OCHFSK. 
The alkalinisation in pHi following basolateral cr removal in forskolin-stimulated A9 
KD cells was abolished by H2-DIDS addition (0.02 ± 0.03 pH units; n=3) and the 
removal of basolateral Na+ (replaced with NMDG; -0.04 ± 0.06 pH units; n=3), 
suggesting that the basolateral AE present under non-stimulated and forskolin-
stimulated conditions may be the same exchanger as that measured in WT Calu-3 
cells. 
4.7 Regulation of basolateral Cr/HCOJ- exchange by protein phosphatase activity 
As shown previously in chapter 3 (see Figure 3.46), Calu-3 cells pre-treated for 60 
minutes with the protein phosphatase inhibitor okadaic acid, produced a 'switch' in 
AE activity, completely inhibiting basolateral AE and activating an apical AE activity 
under non-stimulated conditions. Basolateral cr removal failed to produce a 
significant change in pHi under either non-stimulated or forskolin-stimulated 
conditions in the presence of okadaic acid (P<O.OI; n=4; Figure 4.20). 
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Figure 4.20- Inhibition of basolateral AE by okadaic acid. The effects of okadaic acid (100 nM) on 
the mean changes in pH; following the removal of basolateral cr in non-stimulated and forskolin-
stimulated WT Calu-3 cells. n=4. OA treated and untreated Calu-3 cell experiments ran in parallel. 
*P<O.Ol compared to Baso ocr. 
The inhibition of basolateral zero Cr-induced pHi changes by okadaic acid was only 
seen when using higher concentrations of the inhibitor (100 nM and 500 nM). Pre-
treatment with 10 nM okadaic acid failed to inhibit the basolateral AE (P>0.05; n=3; 
Figure 4.21). 
Figure 4.21- Dose-response of okadaic acid induced inhibition of basolateral AE. Dose-response 
effect of okadaic acid (0, 10, 100 nM) on mean changes in pH; following the removal ofbasolateral cr 
in non-stimulated WT Calu-3 cells. n=3. OA treatments were carried out in separate experiments that 
were run in parallel. *P<O.Ol compared to Baso OCr. 
The dose-response of okadaic acid inhibition of basolateral AE activity appeared to 
reflect the inhibition of PP1 rather than PP2A, according to the specificity of okadaic 
acid for the two protein phosphatases (okadaic acid PP2A lCso ~0.5 nM; PP1 lCso ~50 
nM). This was confinned by pre-treating cells with the PP2A specific inhibitor 
fostriecin, which had no effect on the basolateral AE (P>0.05; n=4; Figure 4.22). 
However, PP2A inhibition appeared to restore some basolateral AE activity under 
forskolin stimulated conditions (see Figure 4.22). 
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Figure 4.22- The effects of PP2A inhibition on basolateral AE activity. The effects of fostriecin 
(IOO nM) on the mean changes in pHi following the removal of basolateral cr in non-stimulated and 
forskolin-stimulated WT Calu-3 cells. n=4. Fostriecin treated and untreated Calu-3 cell experiments 
were run in parallel. 
The role of CFTR in the okadaic acid-induced inhibition of basolateral AE was 
investigated by using CFTR KD Calu-3 cells. Okadaic acid-treated CFTR KD cells 
exhibited a decrease in the alkalinisation produced by basolateral cr removal under 
non-stimulated conditions (from 0.39 ± 0.06 to 0.13 ± 0.03 pH units; P<O.Ol; n=4; 
Figure 4.23), which could not be further inhibited by forskolin. The incomplete 
inhibition ofbasolateral AE by okadaic acid in CFTR KD cells reflects the importance 
of CFTR in the regulation of the 'switch' in AE activity and in particular its role in 
the inhibition of the basolateral exchanger. 
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Figure 4.23- Inhibition of basolateral AE by okadaic acid in CFTR KD Calu-3 cells. The effects of 
okadaic acid (100 nM) on the mean changes in pH; following the removal of basolateral cr in non-
stimulated and forskolin-stimulated CFTR KD Calu-3 cells. n=4. OA treated and untreated CFTR KD 
Calu-3 cell experiments were run in parallel. *P<O.OI compared to Baso ocr. tP<0.05 compared to 
Baso OCr. 
4.8 Discussion 
4.8.1 Profile ofbasolateral CrlHC03 - exchange in Calu-3 cells 
While initial experiments with the AE inhibitor H2-D1DS supported the presence of 
AE2 on the basolateral membrane of Calu-3 cells, its inhibition following the removal 
of Na+ from the bathing solution does not, as AE2 is known to be Na+-independent. 
The inhibition of the basolateral AE in Na+-free conditions may indirectly be due to 
the acidification of pHi upon N a + removal (due to inhibition of the basolateral NBC). 
This would correlate with AE2, which has been shown to be inhibited by acidic 
intracellular conditions (Stewart et aI, 2001). However, experiments with H2-DIDS 
and KD (CFTR, A4 &A9) Calu-3 cells suggest otherwise. H2-DIDS addition 
produced an acidification of pHi and inhibited the basolateral AE. Basolateral cr 
IHC03- exchange was restored following removal of H2-D1DS, without a recovery in 
pHi. In CFTR KD, A4 KD and A9 KD Calu-3 cells, basolateral AE could not be fully 
inhibited under forskolin-stimulated conditions, despite a forskolin-induced 
acidification of a similar magnitude (~pHi change) to WT Calu-3 cells. 
Basolateral CrlHC03 - exchange might be mediated by a member of the SLC26 family 
rather than the AE family. For instance in gastric parietal cells (Petrovic et aI, 2003) 
and intercalated cells of the outer medullary collecting duct (Petrovic et aI, 2004), 
SLC26A7, which is expressed in Calu-3 cells (see Figure 3.55), is thought to play an 
important role in HC03- transport across the basolateral membrane of parietal cells, a 
role presumed to be filled by AE2 (on the basis of previous functional studies 
demonstrating mediation of CrIHC03- exchange and its basolateral localization; 
Rossman et aI, 2001). SLC26A7 knockout mice show reduced gastric acid secretion, 
proposed to be due to either impaired HC03- secretion across the basolateral 
membrane or reduced cr entry into the parietal cell (Xu et aI, 2009). SLC26A 7 
displays many of the same transport characteristics as AE2 and sensitivity to DIDS, 
which can cause SLC26A 7 to be misidentified as AE2. Importantly, SLC26A 7 has 
been shown to mediate CrlHC03 - exchange when expressed in Xenopus oocytes at 
both acidic and alkiali pHj (Petrovic et aI, 2003). This was determined by pHj (as 
measured by BCECF fluorescence) experiments in oocytes injected with SLC26A7 
cRNA, which produced an alkalinisation in pHj in response to cr removal from the 
HC03--buffered bathing solution, consistent with the reversal of a CrIHC03-
exchanger. Switching back to a Cr-containing solution produced a re-acidification of 
pHi, suggesting that SLC26A 7 is active at alkali pHj. These responses could be 
completely inhibited by the addition of 500 JlM H2-DIDS. Removal of HC03- from 
the perfusate, resulted in an intracellular acidification in both control and SLC26A7-
injected oocytes, with HC03 - re-addition only producing a recovery of pHj in 
SLC26A7-injected oocytes. Therefore, SLC26A7-mediated CrIHC03- exchange 
might explain the presence of basolateral AE in Calu-3 cells under acidic pHj. 
However, the same study failed to detect SLC26A 7 mRNA expression in mouse lung 
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tissue by Northern blot analysis, and like AE2, it mediates Na+-independent cr 
IHC03- exchange. Current measurements in Xenopus oocytes and HEK cells 
transfected with SLC26A 7 suggested that SLC26A 7 functions as a cr channel, since 
the magnitude of the cr current was unaffected by HC03 -, indicating that SLC26A 7 is 
impenneable to HC03 - (Kim et ai, 2005). Therefore it is still unclear whether 
SLC26A 7 functions as an anion channel or exchanger, or both. SLC26A 7 might 
potentially be involved in the basolateral CrlHC03 - exchange activity present in Calu-
3 cells either alone or together with co-expressed AE2, provided that the apparent 
Na+-dependence of the basolateral AE is indirectly due to inhibition/reversal of the 
basolateral NBC. Since AE2 can be inhibited by a much lower concentration of 
DIDS than SLC26A7 (ICso = 126 JlM; Petrovic et ai, 2003), a dose-response of the 
H2-D1DS inhibition of basolateral AE activity in Calu-3 cells might be useful to 
distinguish between the two exchangers. 
However, the apparent Na+-dependence of the basolateral AE may favour the 
presence of a Na+-driven CrlHC03- exchanger (NDCBE). NDCBE'S are not well 
characterised. The first NDCBE was cloned from Drosophila, the Na+-driven anion 
exchanger 1 (NDAE1) and was shown to mediate DIDS-sensitive transport of Cr-, 
Na+, H+, and HC03- (Romero et ai, 2000). RT-PCR studies failed to detect mRNA for 
NDAE1 in Calu-3 cells, but also failed to detect NDAE1 in rat kidney, in which Na+-
dependent CtIHC03- exchange activity had previously been detected (Inglis et ai, 
2002). Northern blot analysis showed SLC4A8 (NDCBE1) mRNA expression in 
regions of the human brain, testis, kidney and ovary (Grichtchenko et ai, 2001). 
Cloning ofNDCBE1 from the human brain and expression in Xenopus oocytes, led to 
NDCBE1 being characterised as a DIDS-sensitive electroneutral Na+-driven cr 
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IHC03- exchanger. Unlike Drosophila NDAEl, NDCBEl is HC03--dependent. 
Subsequent RT-PCR studies have detected SLC4A8 expression (identified in this 
study as NBC3) in Calu-3 cells while investigating the presence of electrogenic 
NBC's (Kriendler et ai, 2006). Therefore the possible involvement of a basolateral 
NDCBE in regulating Calu-3 cell pHi and mediating basolateral cr uptake cannot be 
ruled out. As it would difficult to distinguish between AE2 and NDCBE using 
inhibitors (both are H2-DIDS-sensitive), knockdown of the basolateral NBCl would 
allow the Na + -dependence of the basolateral AE to be assessed independently of NBC 
in pHi experiments. 
4.8.2 Regulation ofbasolateral crlHcoJ.- exchange 
From the CFTR inhibitor and knockdown cell studies I would conclude that the 
cAMP inhibition of the basolateral AE is mediated via a CFTR-dependent 
mechanism. However, as SLC26A4 and SLC26A9 KD Calu-3 cells exhibited a 
similar dysregulation of basolateral AE to CFTR KD cells, this would suggest that 
basolateral AE regulation is linked to more than just CFTR activity. A common factor 
~ such as cr transport via these apical transporters could alter [Cr]i and thus inhibit the 
basolateral AE. 
SLC4 CrlHC03- exchangers have been previously shown to be active under cAMP-
stimulated conditions in several tissues, such as AE2 in the murine proximal colon 
(Gawenis et ai, 2010). However, basolateral CrIHC03- exchange was demonstrated to 
be inhibited by elevation of intracellular cAMP in guinea pig pancreatic duct cells, 
where basolateral H2-DIDS-sensitive chloride transport (as assessed by intracellular 
cr measurements using a cr sensitive fluoroprobe) was abolished following 
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stimulation with forskolin (lshiguro et ai, 2002). As H .. 89 and 8CPT-2Me-cAMP, 
failed to either cause basolateral AE inhibition or overcome its inhibition by forskolin, 
it appears that the cAMP-dependent inhibition of the basolateral AE in Calu-3 cells is 
through a PKA and Epac-independent mechanism. Interestingly, PPI inhibition in 
okadaic acid-treated cells abolished basolateral CrIHC03 - exchange, suggesting that a 
cAMP-dependent process may inhibit AE by phosphorylation and that PPI is 
involved in regulation of the basolateral AE under non-stimulated conditions. 
Inhibition of the basolateral CUHC03- exchanger is important for HC03- secretion 
under stimulated conditions as active basolateral AE would deplete [HC03-]i and thus 
greatly impair basolateral-to-apical HC03 - secretion. CFTR KD cells exhibit residual 
basolateral AE activity following forskolin-stimulation, highlighting the potential for 
impaired basolateral AE inhibition in CF serous cells, as dysregulation of CrIHC03-
exchange would be predicted to reduce HC03 - and fluid secretion and contribute to 
the pathological changes observed in CF submucosal glands . 
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5. Air-liquid interface vs submerged Calu-3 and HBE cell 
cultures 
5.1 Introduction 
The majority of previous experiments on Calu-3 cells grown on permeable supports 
have been carried on cell monolayers exposed to air, whereby cultures are initially 
grown in the presence of media on both membranes until confluent, at which point 
media is removed from the apical surface (Shen et aI, 1994; Lee et aI, 1998; Devor et 
aI, 1999). This culturing method is known as air-interface or air-liquid interface 
(ALI). ALI is known to markedly improve the differentiation of primary human 
bronchial epithelial (HBE) cell cultures (Yamaya et aI, 1992) and increase CFTR 
expression at the cell surface (in Madin-Darby canine kidney cells; Bebok et aI, 
2001), and has therefore been applied to other airway derived cell lines, including 
Calu-3 cells. This is surprising, given that Calu-3 cells are a cell line of airway serous 
submucosal gland (adenocarcinoma) origin, a location that would suggest liquid 
covered conditions in vivo. 
Several studies have compared submerged and ALI cultured Calu-3 cells, with many 
focussing on the permeability characteristics of the two culture types with regard to 
drug delivery (Forbes & Ehrhardt, 2005). A number of these studies incorrectly 
associated Calu-3 cells with surface bronchial epithelial cells (Grainger et aI, 2006). 
However, Calu-3 cells do not represent a good model for most airway surface 
epithelial cells, which have much lower expression ofCFTR compared to Calu-3 cells 
but also highly express the epithelial Na+ channel (ENaC) and exhibit cilia on their 
apical surface. Surface cells of the upper airways are primarily involved in absorption 
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ofNa+ and fluid (Smith & Welsh, 1992), whereas submucosal gland serous cells are 
involved in HC03-, cr and fluid secretion. 
The overall morphology of submerged and ALI grown Calu-3 mono layers were 
reported to be similar as detected by light microscopy, scanning electron microscopy 
(SEM) and immunocytochemical analysis (Fiegel et aI, 2003). Calu-3 cells grown 
under both conditions form tight mono layers consisting of closely apposed cuboidal 
cells in a 'cobblestone' like morphology. Tight junctional proteins ZO-l and occludin 
showed regular expression along the intercellular junctions of both mono layers. 
Several investigators have reported the presence of cilia on Calu-3 cell mono layers 
grown under ALI, consistent with an airway surface-like morphology (Florea et aI, 
2003; Grainger et aI, 2006). Cilia have also been observed under submerged 
conditions, although cilia were much shorter and thicker compared to those present in 
ALI cultures and have been seen in relatively few studies (Patal et aI, 2002). In 
general, cilia are not widely reported to be present in submerged grown Calu-3 cells, 
nor were cilia present in primary cell cultures derived from the acini of human 
~ tracheobronchial submucosal glands (Yamaya et aI, 1992), and thus submerged Calu-
3 cells better represent the morphology of serous submucosal gland cells in vivo. 
As the Calu-3 cell line is a heterogeneous population of both serous and mucus 
secreting cells, mucus production, as determined by staining of glycoproteins 
typically found in mucus, has been observed in both submerged (Pezron et aI, 2002) 
and ALI Calu-3 cultures (Fiegel et aI, 2003). Comparison of mucus secretion using 
this method showed greater staining on the surface of ALI grown mono layers, with 
relatively little staining in submerged cell layers (Grainger et aI, 2006). These results 
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would suggest that a thick layer of mucus forms on the surface of ALI grown cells, 
whereas mucus secreted under submerged conditions disperses into the apical media 
and is removed by changing the media. 
Transepithelial electrical resistance (TEER) is routinely used to determine the 
integrity of confluent epithelial monolayers cultured on permeable supports, due to 
the presence of functional intercellular tight junctions. Most commonly TEER is 
measured using chopstick electrodes attached to an epithelial voltohmmeter (EVOM), 
but TEER can also be determined by Us sing chamber studies. TEER values varied 
greatly between different studies and were as low as -350 n.cm2 (peak TEER, 8 days 
post-seeding; Wan et ai, 2000) to >2000 n.cm2 in submerged Calu-3 monolayers (7 
days post-seeding; Fiegel et ai, 2003) and from ~300 n.cm2 (peak TEER, 9 days post-
seeding; Grainger et ai, 2006) to -1100 n.cm2 in ALI grown Calu-3 monolayers 
(peak TEER, 8 days post-seeding; Mathias et ai, 2002). While many studies 
comparing TEER in submerged and ALI grown Calu-3 mono layers reported much 
higher TEER in submerged cultures (Fiegel et ai, 2003; Grainger et ai, 2006), some 
.. have also observed the opposite (Florea et ai, 2003). One difficulty with determining 
the TEER of ALI grown mono layers is that the apical membrane must be rehydrated 
in culture medium in order to measure TEER with chopstick electrodes. As re-
addition of apical media would likely affect TEER itself, the time given to allow 
TEER values to stabilise will undoubtedly affect measurements and thus may explain 
some of the variability in TEER values from different studies (rehydration time= 30 
mins, peak TEER -550 n.cm2, 9 days post-seeding, Foster et ai, 2000; rehydration 
time not mentioned, peak TEER -1100 n.cm2, 8 days post-seeding, Mathias et ai, 
2002; both measured by EVOM). Other cell culture factors such as seeding densities, 
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transwell coatings and serum supplements also complicate comparisons between 
different studies (Forbes & Ehrhardt, 2005). Although a recent study looking at the 
effects of cell passage number in Calu-3 cells grown under ALI, found that TEER was 
not significantly affected by passage number (compared passage no. 30, 36 & 40 in 
Calu-3 mono layers 2-21 days post-seeding; Haghi et aI, 2010). Therefore, while it has 
been suggested ALI grown Calu-3 cells best represents in vivo submucosal gland cells 
due to similarities in TEER (primary acini cells of human tracheobronchial 
submucosal glands TEER -580 n.cm2; Yamaya et aI, 1992), vast differences in 
culture methods and large TEER variability between different studies, makes 
evaluations based on TEER measurements very difficult. 
Ussing chamber studies revealed a six-fold increase in Calu-3 cell basal Isc in cells 
grown at ALI compared to submerged cultures (Singh et aI, 1997). This is perhaps 
due to differences in CFTR expression between the two culture conditions (Beb6k et 
aI, 2001), as RT-PCR analysis showed a large decrease in CFTR mRNA expression in 
submerged Calu-3 monolayers, compared to those at ALI (Guimbellot et aI, 2008). 
.. The same study concluded that CFTR expression was diminished in submerged 
cultures due to hypoxia, as several hypoxia-inducible genes were upregulated under 
these conditions. 
Due to apparent differences in ciliogenesis, mucus secretion, TEER and short-circuit 
current between submerged and ALI grown Calu-3 cell cultures, the effects of cell 
culture methods on Calu-3 AE activity was investigated. AE expression and activity 
was also examined in ALI grown primary HBE cells, primarily as HBE cells are 
known to secrete HC03-, but also as a comparison to ALI grown Calu-3 cells. 
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5.2 Quantitative real-time peR 
~ 
Calu-3 cells were seeded at -2.5x105 cm-2 on semi-permeable supports and grown for 
5-14 days until confluent and resistant monolayers were formed. Calu-3 monolayers 
were fed bilaterally with media for the first 5 days post-seeding, after which cells 
were taken to ALI by removing apical media or continued under submerged 
conditions. Calu-3 cells cultured on transwell inserts under submerged conditions 
typically reached a stable resistance of between 800-1000 Q.cm2 after 5-7 days post-
seeding (see methods, Figure 2.02). ALI cultured Calu-3 monolayers reached a stable 
resistance of between 400-600 Q.cm2 after 2 days in the absence of apical media (7 
days post-seeding). ALI grown mono layers produced a thick layer of mucus across 
the apical surface, which was removed by washing the cells with PBS when replacing 
media and prior to experiments. A mucus layer did not form in submerged cultures, 
however, consistent with previous reports (Grainger et aI, 2006). 
The relative mRNA expression of potential SLC26 CrIHC03 - exchangers was 
.. investigated in submerged and ALI grown cells (Figure 5.01). Both A6 and A9 
mRNA expression was elevated in ALI grown Calu-3 cells, compared to submerged 
cells. However, Pendrin (A4) mRNA expression in ALI cultures declined relative to 
submerged Calu-3 cells. Although mRNA expression may not be comparable to 
actual protein expression, these results suggested that SLC26 expression in Calu-3 
cells was affected by growth conditions. 
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Figure 5.01- SLC26 mRNA expression in submerged and ALI grown Calu-3 cells. Quantative RT-
PCR (Taqman) analysis of SLC26-A4, -A6 and -A9 expression in WT Calu-3 cells grown on transwell 
supports, under submerged (SUB) and air-liquid interface (ALI) conditions, relative to standard curve 
and normalised to GAPDH expression (%). n=3. 
The expression of SLC26 transporters in primary cultures of HBE cells was also 
examined, to compare with their expression in Calu-3 cells (Figures 5.02, 5.03 & 
5.04). HBE cell mono layers were grown on transwell inserts for 7 days under 
submerged conditions until confluent (termed Day 0) and then under ALI for a further 
7-14 days. The findings were considerably different to the expression profiles found 
in Calu-3 cells (see Figure 3.55). Although SLC26A2 and A6 were still highly 
expressed, there was a marked increase in the expression of SLC26A4. Also 
differences in expression could be seen between growth conditions, with SLC26A9 
being more highly expressed under submerged conditions (Figures 5.02) in 
comparison with ALI (Figures 5.03 & 5.04). Like Calu-3 cells, no SLC26A3 
expression could be detected in HBE cells under any growth condition. Interestingly, 
in light of the apparent role of Pendrin as an apical Cl"/HC03 - exchanger in Calu-3 
cells, SLC26A4 mRNA expression increased in a time-dependent manner in HBE 
cells grown under ALI. A similar SLC26 mRNA profile was obtained in HBE cells 
from another donor. The expression of SLC26A2, A4, A6 and All in ALI grown 
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HBE cells was similar to those previously reported from global gene mlcroarray 
analysis in HBE cells (Pedemonte et ai, 2007). 
SLC26 Isoforms in DO HBECs 
Figure 5.02- SLC26 mRNA expression in submerged HBE cells. Quantative RT-PCR (Taqman) 
analysis of SLC26 expression in HBE cells grown on transwell inserts under submerged conditions for 
7 days, relative to standard curve and nonnalised to GAPDH expression (%). n=3. 
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SLC26 Isoforms in 07 HBECs 
Figure 5.03- SLC26 mRNA expression in HBE cells grown under ALI for 7 days. Quantative RT-
PCR (Taqman) analysis of SLC26 expression in HBE cells grown on transwell inserts under ALI for 7 
days (following 7 days submerged), relative to standard curve and nonnalised to GAPDH expression 
(%), n=3 , 
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Figure 5.04- SLC26 mRNA expression in HBE cells grown under ALI for 14 days. Quantative RT-
PCR (Taqman) analysis ofSLC26 expression in HBE cells grown on transwell inserts under ALI for 14 
days (following 7 days submerged), relative to standard curve and normalised to GAPDH expression 
(%). n=3. 
5.3 Calu-3 cell short-circuit current measurements 
Contrary to previous short-circuit current experiments (Singh et ai, 1997), no 
significant difference was observed in Ise between submerged and ALI grown Calu-3 
cells monolayers under any of the conditions tested (P>O.05; n=4; Figures 5.05 & 
5.06), although ALI grown cells may have produced greater Ise had more experiments 
been performed. Forskolin failed to enhance Ise above basal levels in either 
submerged or ALI grown cultures (P>O.05; n=4). However, the presence of the Ca2+ 
agonist thapsigargin induced a six-fold increase in basal Isc in both cultures, which 
could be diminished by addition of the NKCC inhibitor piretanide, but not by the 
CFTR inhibitor GlyH-lOl. These results are consistent with the large bumetanide-
sensitive elevation in Ise produced by thapsigargin and the more variable effects of 
forskolin on Ise, seen previously in Calu-3 cells (Moon et ai, 1997), albeit through a 
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CFTR-independent mechanism. Under thapsigargin-stimulated conditions, elevated 
[Ca2+]i could increase K + conductance via activation of calcium-activated K + 
channels, which would increase the electrical driving force for cr to exit the cell. 
Since forskolin failed to produce a significant change in Isc, this may suggest that 
forskolin-stimulated HC03 - secretion from Calu-3 cells is electroneutral, consistent 
with apical CrlHC03- exchange activity, or that under the conditions employed there 
was no electrochemical driving force for net anion secretion. 
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Figure 5.05- Isc measurements in submerged and ALI grown Calu-3 cell monolayers. The effects 
offorskolin (FSK; 10 11M), thapsigargin (Thaps; 200 oM), GlyH-101 (10 11M) and piretanide (10 11M) 
on short-circuit current (Isd in submerged (SUB) and air-liquid interface (ALI) grown Calu-3 cell 
mono layers. 
158 
* * 
1::1 SUB 
Figure 5.06- Isc measurements in .submerged and ALI grown Calu-3 cell monolayers. The effects 
offorskolin (FSK; lO~M), thapsigargin (Thaps; 200 nM), GlyH-IOI (10 ~) and piretanide (10 ~) 
on mean short-circuit current (Isc) in submerged (SUB) and air-liquid interface (ALI) grown Calu-3 
cell monolayers. n=4. Paired observations. Forskolin and thapsigargin were applied bilaterally. GlyH-
101 and piretanide were applied only to the apical and basolateral membranes respectively. SUB: 
*P<O.OOI .compared to basal, +FSK and +Piretanide. ALI: tP<O.OOI compared to basal and +FSK. 
5.4 Cr/HCO}- exchange activity in Calu-3 cells 
pHi experiments perfonned on supports grown at ALI for 2 days (7 days post seeding-
including initial 5 days submerged) showed a similar switch from basolateral AE 
under non-stimulated conditions, to apical AE activity following forskolin-
stimulation. However, both basolateral and apical anion exchange activities produced 
relatively small increases in pHj in response to the removal of cr compared to Calu-3 
cells that were grown fully submerged (Figure 5~07) . 
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Figure 5.07 - AE activity in ALI grown Calu-3 cells. The effects of forskolin (5 /lM) on changes in 
pHi following the independent removal of apical and basolateral chloride in ALI grown Calu-3 cells. 
Interestingly, both basolateral and apical AE could be significantly enhanced in ALI 
grown Calu-3 monolayers following re-submersion in apical media. The mean 
alkalinisation in pHi produced by apical cr removal in forskolin-stimulated ALI cells 
increased from 0.04 ± 0.02 to 0.53 ± 0.05 pH units after 24 hours re-submersion in 
apical media (P<O.OOl; n=4; Figure 5.08). However, neither the mean change in pHi 
nor the rate of apical AE activity of ALI cells reached that of the apical AE present in 
Calu-3 cells maintained under submerged conditions, even 48 hours after re-
submersion in media (P<0.05; n=4). 
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Figure 5.08 - Apical AE activity is partially restored in ALI grown Calu-3 cells following re-
submersion. Comparison of the mean changes in pHi following the removal of apical chloride (A) and 
the rate of re-acidification following chloride re-addition (B), in forskolin-stimulated submerged (SUB) 
and air-liquid interface (ALI) grown Calu-3 cells, and the effects of re-submersion on ALI grown Calu-
3 cells. SUB= 7 days submerged post-seeding. ALI= 5 days submerged + 2 days ALI (7 days post-
seeding). SUB + 11+2= 8/9 days submerged post-seeding. ALI + 11+2 SUB= ALI grown cells re-
submerged for 112 days (8/9 days post-seeding). n=4. A: *P<O.OOI compared to SUB. tP<O.OI 
compared to SUB+ l. +P<O.05 compared to SUB+2. B: *P<O.OI compared to SUB. tP<O.05 compared 
to SUB+ l. +P<O.05 compared to SUB+2. 
Basolateral Cr/HC03- exchange was fully restored and maintained at levels similar to 
submerged cells, following the re-addition of apical media for 24 hours to ALI grown 
Calu-3 cells (P>O.05; n=4; Figure 5.09). 
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Figure 5.09 - Basolateral AE activity is fully restored in ALI grown Calu-3 cells following re-
submersion. Comparison of the mean changes in pHi following the removal of basolateral chloride (A) 
and the rate of re-acidification following chloride re-addition (B), in non-stimulated submerged (SUB) 
and air-liquid interface (ALI) grown Calu-3 cells, and the effects ofre-submersion on ALI grown Calu-
3 cells. n=4. See Figure 5.08 for further information. A: *P<O.OO I compared to SUB. B: *P<O.OO I 
compared to SUB. 
Despite fluctuations in basolateral and apical AE activities in ALI Calu-3 cells, the 
intracellular acidification produced by forskolin addition remained similar to that of 
fully submerged cells (P>O.05; n=4; Figure 5.10). 
A B 
Figure 5.10 - Forskolin-induced acidification is present in both submerged and ALI grown Calu-
3 cell monolayers. Comparison of the mean acidification (A) and rate of acidification (B) in pHi 
produced by forskolin (5 11M) addition, in submerged (SUB) and air-liquid interface (ALI) grown 
Calu-3 cells, and the effects of re-submersion on ALI grown Calu-3 cells. n=4. See Figure 5.08 for 
further information. 
5.5 crlHco~- exchange activity in Wild-type and CF HBE cells 
The airway surface liquid (ASL) lining the bronchial lumen is tightly regulated by 
Na+ absorption through ENaC and CI- secretion through CFTR in surface bronchial 
cells, providing the osmotic gradients necessary for the regulation of fluid absorption 
and/or secretion, and thus, maintaining an optimal ASL volume. ENaC-mediated Na + 
absorption is enhanced in response to ASL expansion, largely due to dilution of 
soluble protease inhibitors enabling the stimulation of ENaC by membrane bound 
channel activating proteases (Myerburg et ai, 2006; Tarran et ai, 2006). Thus, HBE 
cells grown under submerged conditions (apical surface volume: 300 III HC03-
buffered solution) display enhanced ENaC-mediated Isc compared to cells grown 
under ALI (Myerburg et ai, 2006; Myerburg et al, 2010). CFTR, in addition to 
mediating cr secretion required for fluid secretion, is also known to inhibit Na + 
absorption through ENaC in response to an increase in cAMP-stimulation by 
decreasing the open channel probability of ENaC (Stutts et ai, 1997; Konstas et ai, 
2003). However, ENaC could also be inhibited in Xenopus oocytes co expressed with 
the cr channel CIC-O, suggesting that it is not CFTR per se that inhibits ENaC, but 
~ rather the changes in [Cr]j resulting from its activation (Konig et ai, 2001). 
Dysregulation of ENaC in CF HBE cells results in Na+ hyperabsorption, which 
together with defective cr secretion through CFTR contributes to the dehydrated 
ASL seen in CF (Tarran et ai, 2005). 
As inflammation may acidify the ASL, which would impair airway defence, 
homeostasis of ASL pH is likely to be another important role of the surface bronchial 
cells. Several acid and base transporters are known to be expressed throughout the 
human airway (small, medium and large bronchi, and trachea) including NHE1, AE2 
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and brain AE3 isoform mRNA (Dudeja et ai, 1999). NBC3 and NBC4 isoform 
mRNA have also been detected in lung (Pushkin et ai, 2000). pHi experiments 
(performed under HEPES-buffered conditions) in the HBE cell line, 16HBEI40:-, 
demonstrated that the apical ATP induced acidification in pHi could be partially 
blocked by amiloride or apical Na + removal, suggesting the involvement of an apical 
NHE (Urbach et ai, 2002). Similarly, pHi experiments in human nasal epithelial 
(HNE) cells bathed in HEPES-buffered solution showed a Na + -dependent (and cr-
independent), amiloride-sensitive recovery from an NR. + acid load, reportedly due to 
NHE, in both wild-type and CF HNE cells (Paradiso, 1992). Also, H+-K+-ATPase 
activity was present in HBE cells as assessed by ouabain-sensitive pH microelectrode 
measurements and like NHE activity, its activity was present in both WT and CF cell 
cultures (Coakley et ai, 2003). cr substitution (for gluconate) pHi studies in rat 
alveolar type II epithelial cells, revealed the presence of a Na+-independent, DIDS-
sensitive (0.5 mM) basolateral CrlHC03- exchange activity under HC03--buffered 
conditions, proposed to be mediated by AE2 (Lubman et aI, 1995). Although the same 
study found that removal of apical cr had no effect on pHi. As the AE2 CrIHC03-
" exchanger and NBC are likely to be restricted to the basolateral membrane, as is the 
case in Calu-3 cells, they will only contribute indirectly to luminal secretion by 
regulating pHi (Falkenberg & Jakobsson, 2010). While NHE and H+-K+-ATPase may 
contribute to secretion ofH+ across the apical membrane, secretion ofHC03- might be 
mediated by CFTR and/or an anion exchanger, which is of particular importance 
given the evidence that ASL [HC03 -] was shown to be greater in WT than CF HBE 
cell cultures (Coakley et aI, 2003). 
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In pHi experiments performed on tracheal epithelial cells exhibiting the physiological 
features ofCF (with no functional CFTR; CFT-l cells), cr substitution studies under 
HC03--buffered and HC03--free conditions, showed the presence ofa DIDS-sensitive 
apical CrIHC03 - exchange activity, which could be enhanced by transfecting cells 
with WT CFTR (CFT-WT cells; Wheat et ai, 2000). However, the activity of the 
apical AE could not be further increased by forskolin, suggesting it was already 
maximally active or not functionally linked to CFTR. Expression of the basolateral 
AE2 mRNA was unchanged in CFT-WT cells compared to CFT-l cells, however 
SLC26A3 expression was upregulated in CFT -WT cells, suggesting that SLC26A3 
mediated the constitutive CrIHC03- exchange activity seen in these cells. In contrast, 
pHi experiments in HNE cells, found that apical cr removal produced an 
alkalinisation in pHi that was sensitive to the cr channel inhibitor DPC, and could be 
enhanced by forskolin-stimulation (Paradiso et ai, 2003). As this response to cr 
removal was absent in CF HNE cells, the authors concluded that CFTR was 
responsible for mediating the changes in pHi. 
However, the high expression of SLC26A4 seen in these HBE cells (Figures 5.03 & 
5.04) raises the possibility that an apical CrIHC03 - exchanger mediates cr absorption 
and HC03- secretion in surface airway cells. In type B and non-A, non-B intercalated 
cells of the kidney, Pendrin is involved in NaCI absorption together with ENaC, the 
expression of which is reduced in Pendrin-null mice, suggesting a role for Pendrin in 
regulating the protein abundance and/or function of ENaC (Kim et ai, 2007). 
SLC26A4 expression in HBE cells may also represent a role for Pendrin in secretion 
of SCN-, a molecule with antimicrobial activity, due to a correlation between 
enhanced e1ectroneutral CrlSCN- exchange and an up-regulation of SLC26A4 
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expression (as detennined by global anion transporter gene expression microarrays 
and real-time RT-PCR) in IL-4 treated HBE cells (Pedemonte et ai, 2007). Therefore 
the potential expression of an apical CrIHC03 - exchanger, as well as the reported 
basolateral AE, was investigated in HBE cells. 
HBE cells (passage 1) grown on transwells under submerged conditions for 7 days 
showed no pHi response to either apical or basolateral cr removal (n=2). After a 
further 14 days growth under air-liquid interface, HBE cells produced a mean 
alkalinisation of 0.19 ± 0.03 pH units, from a basal pHi of 7.17 ± 0.10, following 
apical cr removal (n=5; Figures 5.11 & 5.12). Upon the re-addition of apical cr, 
HBE cells re-acidified at a rate of 0.11 ± 0.02 pH units min- l (n=5). Forskolin addition 
produced no significant change in pHi (P>0.05; n=5). The changes in pHi seen upon 
removal and re-addition of apical cr were unaffected by forskolin stimulation 
(P>0.05; n=5). Contrary to previous reports detailing AE2 expression in the 
tracheobrochial tree (Dudeja et ai, 1999), HBE cells did not exhibit any significant 
change in pHi in response to basolateral cr removal under either non-stimulated or 
~ forskolin-stimulated conditions, suggesting basolateral CrIHC03 - exchange was 
absent/not active under these conditions. Interestingly, mRNA expression studies in 
HNE cells, showed a progressive decrease in AE2 expression levels over time (AE2 
mRNA expression decreased 4-fold from time of cell seeding to 28 days after 
confluence; Shin et ai, 2007), consistent with the lack of basolateral AE activity seen 
in these HBE cells grown for 21 days post-seeding. 
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Figure 5.11 - pHi experimental trace of constitutively active apical AE activity in HBE ceUs. The 
effects of forskolin (5 ,....M) on changes in pH j following the independent removal of apical and 
basolateral chloride in ALI grown HBE cells. 
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Figure 5.12 - Human bronchial epithelial cells displayed a constitutively active apical AE activity. 
Mean alkalinisation (pH j ) produced by chloride removal (A) and the rate of re-acidification upon 
chloride re-addition (B) in HBE cells, under non-stimulated and forskolin-stimulated (FSK; 5 ,....M) 
conditions. n=5. 
The apical AE activity present in forskolin-stimulated HBE cells was insensitive to 
the CFTR pore blocker GlyH-101, consistent with changes in pHi driven by a 
constitutively active apical CrlHC03- exchanger, rather than cr dependent HC03-
flux through CFTR or the 'CFTR-like' channel SLC26A9 (P>O.05; n=3; Figure 
5.13). GlyH-101 addition had no affect on HBE cell pHi (P>O.05; n=3). 
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Figure 5.13 - CFTR-independent apical AE activity in human bronchial epithelial cells. The effect 
of apical CFTR inhibitor GlyH-IOI (10 f.lM) on the mean alkalinisation in pH; following the removal 
of apical chloride (A) and the rate of re-acidification in pH; upon apical chloride re-addition (B), in 
forskolin-stimulated (5 f.lM) HBE cells. n=3. 
Interestingly, HBE cells derived from a deltaF508 CF lung transplant patient (kindly 
provided by Dr Chris Ward, Newcastle University), grown on transwells for 7 days 
under ALI (following 7 days submerged in media), showed no apical or basolateral 
CrlHC03- exchange activity, under either non-stimulated or forskolin-stimulated 
conditions (n=5; Figure 5.14). The basal pHi ofCF HBE cells (7.52 ± 0.10 pH units) 
was more alkali than that ofWT HBE cells (n=5; P<0.05). 
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Figure 5.14 - Absence of AE activity in CF human bronchial epithelial cells. The effects of 
forskolin (5 f.lM) on changes in pH; following the independent removal of apical and basolateral 
chloride in CF HBE cells. 
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5.6 Discussion 
5.6.1 ALI vs submerged Calu-3 cell monolayers: best model for submucosal glands? 
From the ALI and submerged pHi experiments it is apparent that apical AE activity in 
Calu-3 cells is dependent on growth conditions and variations in SLC26 mRNA 
expression may suggest that these differences are due to changes in CrIHC03-
exchanger expression. Since Calu-3 cell monolayers grown under ALI develop a thick 
layer of mucus across the apical surface, despite washing the monolayers prior to the 
start of experiments, it is possible that a remaining layer of mucus may impede access 
to the apical membrane and thus changes in the composition of the apical bathing 
solution (i.e. removal of Cn may not reach the membrane and affect apical AE. 
However, as the basolateral AE was also nearly abolished under ALI conditions, it is 
unlikely that the differences in AE activity seen between submerged and ALI grown 
Calu-3 cultures are simply due to a mucus layer blocking access to the membrane. I 
would postulate that changes in expression of apical HC03 - transporters, such as 
elevated levels of CFTR (which I have previously shown to regulate the basolateral 
AE present in Calu-3 cells), may have an inhibitory effect on basolateral CrIHC03-
" exchange activity and/or expression in ALI grown Calu-3 cells. As well as ALI grown 
monolayers reportedly resembling a more surface airway cell morphology, the thick 
layer of mucus covering their surface may actually create conditions closer to those 
observed in CF airways, both of which do not lend this method of cell culture to 
creating a monolayer with properties of the serous submucosal glands in vivo. 
Therefore I believe that Calu-3 cells cultured under submerged conditions better 
represent serous cell anion exchange activity. 
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5.6.2 Apical AE activity in primary surface airway cells and regulation by CFTR 
The changes in pHi following apical cr removal in ALI grown HBE cells, are 
consistent with the presence of a constitutively active apical CrIHC03 - exchanger on 
the apical surface of the airway lumen, as was previously proposed in experiments 
using CFT -WT cells (Wheat et aI, 2000). Wheat and colleagues concluded that 
SLC26A3 (DRA) was responsible for mediating the CrIHC03 - exchange activity 
observed in CFT -WT cells. However, the mRNA expression studies (Figures 5.02, 
5.03 & 5.04) showed that DRA was not expressed in HBE cells, suggesting another 
AE protein may mediate the Cr-dependent changes in pHi, such as the highly 
expressed Pendrin. As the CFT -WT cells were grown on coverslips and as such were 
not polarised, together with the fact that the CFT -I cells were derived from a 
deltaF508 CF patient prior to transfection with WT CFTR, makes it difficult to 
directly compare the results of CFT -WT cell and polarised HBE cells, and may 
explain the differences in SLC26 transporter expression. This is the first time, to the 
best of my knowledge, that apical Cr/HC03- exchange has been demonstrated in 
primary HBE cells . 
Although inhibition of CFTR anion conductance in wild-type HBE cells did not result 
in a loss of apical CrlHC03 -exchange activity, the absence of functional CFTR in CF 
HBE cells appeared to inhibit AE activity, either by dysregulation of a coupled 
exchanger present in the apical membrane (as is the case with ENaC) and/or by a 
reduction in exchanger expression. Therefore, like Calu-3 cells, CFTR appears to play 
an important role in regulating apical CrlHC03 -exchange activity in HBE cells. 
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Regulation of apical CrIHC03 - exchangers by CFTR has been extensively studied in 
the pancreas, which may offer insight into differences in apical AE activity in WT and 
CF HBE cells. Studies in CFP AC-l cells, a human pancreatic ductal adenocarcinoma 
cell line that is homozygous for the deltaF508 CFTR mutation, found that introducing 
WT CFTR (using a recombinant Sendai virus vector) caused the upregulation of 
apical CrIHC03- exchange activity (Rakonczay et ai, 2008). In uninfected CFPAC-l 
cells, removal of apical cr from the apical membrane had no affect on pHi (as 
determined by BCECF micro fluorimetry measurements). In contrast, apical cr 
removal produced a marked alkalinisation in cells expressing WT CFTR, in the 
presence of cAMP. This response could be inhibited by 0.5 mM H2-DIDS, but not by 
CFTRinh-172, consistent with SLC26A6 CrIHC03 - exchange activity. Interestingly, 
semi-quantative RT-PCR revealed that CFTR transduction did not increase SLC26A6 
expression or induce SLC26A3 expression (A3 expression was not detected in either 
cell type), ruling out the possibility that changes in SLC26A61A3 expression were 
responsible for the upregulation of AE activity in WT CFTR transfected cells 
(Rakonczay et ai, 2008). Therefore it was postulated that CFTR expression, rather 
~ than cr transport by CFTR, is required for apical CrlHC03- exchange in pancreatic 
duct cells (Rakonczay et ai, 2008). These results correspond with the differences seen 
in WT and CF HBE cells and suggest that CFTR expression is crucial for apical AE 
activity in surface airway epithelial cells. 
In CF, the potential hyperacidic pH ofthe dehydrated ASL (Coakley et ai, 2003; Song 
et ai, 2006) may involve a culmination of a reduction in HC03- secretion through an 
apical CrlHC03 - exchanger in the airway submucosal glands, together with a loss of 
ASL pH homeostasis in the airway lumen through an apical CrIHC03- exchanger in 
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surface bronchial cells, due to the doWnregulation of AE activity by reduced CFTR 
expression. 
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6. Fluid and Mucus secretion 
6.1 Introduction 
The osmotic gradient created by cr and HC03 - secretion from serous submucosal 
gland (SMG) cells, provides the driving force for water secretion via aquaporin water 
channels. Aquaporin-5 (AQP5) is proposed to be the primary water channel involved 
in transmonolayer fluid transport, due to its localisation in serous gland cells, and the 
fact that fluid secretion from the SMG of the mouse nasopharynx was reduced two-
fold in AQP5 null mice, as determined by dilution of a radioactive fluid volume 
marker (Song & Verkman, 2001). 
Calu-3 cells have been previously shown to secrete fluid under open-circuit 
conditions, with confluent mono layers secreting the equivalent of 120% (under basal 
conditions; rate of fluid secretion = 2.7 ± 0.5 Illlcm2/h) to 550% (in the presence of 
both forskolin and thapsigargin; rate of fluid secretion = 12.2 ± 1.0 Illlcm2/h) of the 
estimated Calu-3 cell volume each hour (volume of Calu-3 cells on a 1.12 cm2 
transwell insert is -2 Ill), as measured using an oil-immersion optical technique 
(Irokawa et ai, 2004). These experiments showed that basal Calu-3 cell fluid secretion 
could be abolished by a combination of bumetanide addition and replacement of 
HC03 - with a HEPES-buffered solution to bathe the cells, suggesting that basal fluid 
secretion was mediated by both cr and HC03- secretion. Forskolin addition (5 IlM) 
increased both the rate (by 64%) and the [HC03-] (to 80 mM) of the Calu-3 cell fluid 
secretion, which could be prevented by replacement ofHC03-with HEPES, indicating 
that the increase in fluid secretion by forskolin was mediated by an increase in HC03-
secretion. Whereas, thapsigargin-stimulated fluid secretion (333 nM; 213% compared 
to basal secretion) could be completely inhibited by treating Calu-3 cells with 
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bumetanide, consistent with thapsigargin increasing Calu-3 fluid secretion by 
activating cr secretion. Overall, the study showed a positive correlation between the 
rate and [HC03 -] of Calu-3 cell fluid secretion. However, relatively few studies have 
been conducted on SMG secretions in intact airways due to difficulties in isolating 
SMG secretions from the total airway surface liquid. Earlier studies of single SMG 
secretion rates in sheep showed a similar decrease in mucus volume in the presence of 
bumetanide or in the absence of HC03- from carbachol-stimulated glands (100 et aI, 
2001b). HC03- removal also reduced basal gland secretions by half. However, pH 
measurements taken at the mouth of carbachol, forskolin or VIP-stimulated porcine 
SMG duct, only showed a pH of 7.2, relative to a bath pH of 7.4 (100 et aI, 2002). In 
CF, SMG secretions in response to agonists that raise intracellular cAMP levels, such 
as VIP, are absent and overall mucus secretions mediated by acetylcholine-induced 
increases in [Ca2+]i are thicker (Wine & Joo, 2004). 
Mucins, the glycosylated proteins contained within mucus secretions of the SMG, are 
secreted by mucous cells, of which MUC5B was proposed to be predominant mucin 
~ type secreted (Shanna et aI, 1998). Electron microscopic studies of Calu-3 cell 
monolayers revealed 1 /-lm diameter round granules in -30-40% of cells, which 
closely resembled mucin granules of airway mucous goblet cells, that were found to 
contain the secretory mucin MUC5AC (Kreda et aI, 2007). RT-PCR analysis of 
mucins commonly expressed in airway epithelia, showed that Calu-3 cells expressed 
both MUC5AC and MUC5B, which are known to be expressed in airway goblet cells 
(Kreda et aI, 2005). Interestingly, inflammatory cytokine IL-13, has been shown to 
induce mucus production from primary human tracheal cells (Nakao et aI, 2008). IL-
13 was proposed to cause mucus overproduction via the up-regulation of Pendrin, as 
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detected by microarray analysis. Pendrin was found to induce MUC5AC expression, 
plus the enforced expression of Pendrin in mouse airway epithelial cells in vivo 
resulted in mucus overproduction. This effect of IL-13 on mucus production may be 
compounded by the finding that AQP5 expression is completely abolished by the 
cytokine in human airway epithelial cells (Skorwron-zwarg et ai, 2007). Similarly IL-
1 P addition increased MUC5AC, but MUC5B, secretion from human 
tracheobronchial cell cultures in a dose- and time-dependent manner (Gray et ai, 
2004). Recent studies measuring mucus secretion in segments of the mouse intestine 
found that mucin release was dependent on the presence of HC03- in the bathing 
medium, as detected by a periodic acid Schiff (PAS) assay (Garcia et ai, 2009). In the 
absence of HC03- mucin secretion was approximately halved and inhibition ofCFTR 
(using the CFTR pore blocker GlyH-lOl) completely abolished stimulated mucin 
release. From these results it was hypothesised that CFTR-dependent HC03- secretion 
is important for mucin release, as HC03 -may displace bound shielding Ca2+ ions from 
mucins following exocytosis, thus enabling normal mucin expansion and 
disaggregation to form mucus (De Lisle, 2009; Garcia et ai, 2009) . 
Therefore fluid and mucin secretions from Calu-3 cell mono layers were investigated, 
in order to understand the physiological role of HC03 - transport by apical Cr/HC03-
exchange and CFTR in these cells. 
6.2 cAMP and Ca2+-mediated fluid secretion 
Non-stimulated wild-type Calu-3 monolayers, submerged in HC03 --buffered Krebs 
solution, increased the apical fluid volume from 200 III to 210 ± I lll/cm2124 h 
(P<0.05; n=6; Figure 6.01). Forskolin addition (5 IlM) increased the rate of fluid 
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secretion approximately five-fold, to 54 ± 3 f.,tllcm2/24 h (P<O.OOI; n=6). Cr-free and 
HEPES-buffered Krebs solutions were used to investigate the cr- and HC03--
dependence of the Calu-3 fluid secretions, respectively. Bilateral cr removal 
abolished any fluid secretion produced under non-stimulated conditions and reduced 
forskolin-stimulated secretion by 88 ± 22% (P<O.OOI; n=6). No significant fluid 
secretion was observed from Calu-3 monolayers bathed in HEPES-buffered Krebs 
solutions under either non-stimulated or forskolin-stimulated conditions (P>O.05; 
n=6). These results would suggest that both basal and forskolin-stimulated Calu-3 
fluid secretions are cr- and HC03--dependent. 
• 
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Figure 6.01 - cr and HC03- dependent Calu-3 cell fluid secretion is enhanced by forskolin 
stimulation. The effect of bilateral cr and HC03- removal, using Cr-free HC03--buffered (OCr) and 
HEPES-buffered Krebs (HEPES) solutions, on WT Calu-3 apical fluid secretion under non-stimulated 
and forskolin-stimulated (+FSK) conditions over 24 hours, compared to secretions in standard HC03--
buffered Krebs solution (KRB). Forskolin (5 )lM) was applied to both the apical and basolateral 
solutions. Changes in apical fluid volume are expressed as a percentage compared to the starting 
volume of200)l1. n=6. *P<O.OOI compared to KRB. tP<O.OI compared to KRB .• P<O.OOI compared 
to KRB+FSK. 
Krebs solutions were used instead of media for fluid secretion studies, as this allowed 
alterations to be made to the composition of the external fluid bathing the cells (such 
as cr removal). To ensure the changes in apical fluid volume were not due to 
differences in the composition of the media and Krebs solutions, such as osmolarity, 
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fluid secretion measurements were also carried out on Calu-3 cells bathed in media 
(using the same protocol as Krebs bathed cells- 200 J.11 of media on the apical surface 
of the transwell and 1 ml of media in the basolateral compartment). Non-stimulated 
Calu-3 cells bathed in media, produced a similar change in apical fluid volume to 
those bathed in HC03--buffered Krebs solution (9 ± 2 J.11/cm2/24 h;' P>0.05; n=3). 
Forskolin addition (5 J.1M) increased the rate of fluid secretion from Calu-3 cells 
bathed in media to 46 ± 8 J.11/cm2124 h (P>0.05 compared to forskolin-stimulated 
Calu-3 cell secretion in HC03--buffered Krebs solution; n=3). As the mean changes in 
apical fluid volume was not significantly different between Calu-3 monolayers bathed 
media and monolayers bathed in HC03--buffered Krebs solution, under either non-
stimulated or forskolin-stimulated conditions, it was ascertained that Calu-3 fluid 
secretion was not significantly affected by removing cells from culture media and 
bathing them in Krebs solution.' 
The concentration of forskolin required for maximal fluid secretion from WT Calu-3 
cells was determined by applying a range of forskolin concentrations between 0.1 J.1M 
.. and 10 J.1M (Figure 6.02). Application of 0.1 J.1M or 0.3 J.1M forskolin did not produce 
a significant change in fluid secretion compared to basal levels (P>0.05; n=3). Fluid 
secretion was enhanced at concentrations offorskolin of 0.7 J.1M (P<O.OI compared to 
o J.1M FSK control; n=3) and above (1 J.1M- 10 J.1M FSK; P<O.OOI compared to 0 J.1M 
FSK; n=3). 3 J.1M was the lowest forskolin concentration to significantly increase fluid 
secretion above that produced by 0.1 J.1M and 0.3 J.1M forskolin (P<O.OOI and P<O.OI 
respectively; n=3), to a level that could not be further enhanced by increasing the 
concentration (P>0.05; n=3). 5 J.1M forskolin was used in subsequent fluid secretion 
experiments to ensure maximal forskolin-stimulated fluid secretion and to enable 
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compansons to be made between fluid secretion measurements and apical AE 
activity. 
Figure 6.02 - Forskolin-stimulated fluid secretion dose-response in WT Calu-3 cells. The effect of 
increasing forskolin concentration (0.1, 0.3 , 0.7, 1, 3, 7 and 10 !lM) on WT CaIu-3 apical fluid 
secretion (% change in volume), bathed in HC03--buffered Krebs solution over 24 hours. n=3. *P<O.OI 
compared to 0 !lM FSK and P<0.05 compared to 0.1 !lM FSK. tP<O.OOI compared to 0 !lM FSK and 
0.1 !lM FSK..P<O.OI compared to 0.3 !lM FSK. 
Fluid secretion could also be enhanced by the Ca2+ agonist thapsigargin, to levels 
similar to those produced by forskolin (55 ± 1 ~I/cm2124 h compared to 56 ± 1 
~1/cm2124 h; P>O.05; n=3; Figure 6.03). In comparison, carbachol only stimulated a 
small increase in fluid secretion above basal levels (from 10 ± I ~I/cm2124 h to 19 ± 2 
~I/cm2/24 h; P<O.001; n=3). This maybe due to this agonist only causing a transient 
increase in intracellular calcium. Like forskolin, both thapsigargin and carbachol 
stimulated fluid secretion could be completely abolished by HC03 - removal (P<O.OO I; 
n=3). As thapsigargin and carbachol are likely to mediate their effects via Ca2+, rather 
than the cAMP-PKA pathway which is known to predominately regulate CFTR, it is 
uncertain whether CFTR is the principal apical transporter driving fluid secretion in 
Calu-3 cells. However, if CFTR is constitutively active in these cells, then anion 
efflux through CFTR could be predominately controlled by changes in cell membrane 
potential induced by alteration of basolateral Ca2+ -dependent K+ conductances, which 
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has been previously proposed to explain anion secretion responses to the elevation of 
[Ca2+]i in both Calu-3 cells (Moon et ai, 1997) and primary human SMG cells 
(Yamaya et ai, 1993). Alternatively, it is possible that alternative cr channels, such as 
Ca2+ -activated cr channels (CaCC) are also present in the apical membrane of Calu-3 
cells. This hypothesis is supported by recent whole cell patch clamp experiments 
performed on primary human SMG cells, which found that ionomycin-induced cr 
currents present in both serous and mucous cells could be blocked by the CaCC 
inhibitor flufenamic acid (Fisher et ai, 2010). The same study also found evidence of 
the CaCC TMEM16A mRNA expression in both the mucous and serous cells of the 
human tracheal glands (Fisher et ai, 2010). 
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Figure 6.03 - cAMP and Ca2+ stimulated Calu-3 cell fluid secretion. The effects of forskolin (FSK; 
5 11M), thapsigargin (Thaps; 200 nM) and carbachol (CCH; 10 11M) addition on apical fluid secretion 
(% change in volume) in WT Calu-3 cells in HC03--buffered (KRB) and HC03--free (HEPES) Krebs 
solutions over 24 hours_ n=3. *P<O.OOI compared to KRB. 
In order to determine whether exposmg Calu-3 cells to a HC03--free, HEPES-
buffered solution for 24 hours (used to investigate the HC03- dependence of the Calu-
3 fluid secretions) affected CFTR-dependent HC03- transport, as CFTR expression 
has been shown to be drastically reduced under such conditions (Baudouin-Legros et 
ai, 2008), cells were incubated with HEPES and HC03--buffered solutions for 24 
hours and then studied in pHi experiments to look for differences in anion exchange 
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activity (Figure 6.04). As the changes in pHi mediated by apical cr removal and re-
addition in forskolin-stimulated Calu-3 cells were CFTR-dependent, then a large 
reduction in CFTR expression (similar to CFTR KD cells) would be expected to result 
in a decrease in apical AE activity. However, no significant change in apical AE 
activity was observed in Calu-3 cells exposed to HC03 - or HEPES-buffered Krebs 
solutions for 24 hours, compared to control cells kept in media (P>0.05; n=5). 
Therefore CFTR activity does not appear to be significantly reduced in cells bathed in 
HEPES solution, or any change in CFTR expression/activity in HEPES bathed cells is 
not sufficient to significantly affect apical AE activity, suggesting the differences in 
the rate of Calu-3 fluid secretion, between HC03 - and HEPES-buffered Krebs 
solutions, were a result of changes in HC03 -rather than CFTR. 
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Figure 6.04 - Exposing Calu-3 cells to HCO]--free Krebs solution for 24 hours has no affect on 
apical AE activity. Comparison of mean changes in pHi following the removal of apical chloride (A) 
and the rates of re-acidification upon apical chloride re-addition (B) under forskolin-stimulated 
conditions in Calu-3 cells grown in media (control) and cells bathed in HC03- (KRB) or HEPES-
buffered Krebs solution for 24 hours. n=5. 
To investigate the basolateral transporters involved in Calu-3 cell fluid secretion, cells 
were exposed to the anion transport inhibitor H2-D1DS and the NKCC inhibitor 
bumetanide (Figure 6.05). Neither basolateral H2-DIDS nor bumetanide addition 
significantly altered the basal fluid secretion of Calu-3 cells over 24 hours (P>0.05; 
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n=3). As both HC03- and cr uptake through the basolateral NBC and NKCC are 
inhibited under these conditions, this result would suggest another mechanism must 
be driving basal Calu-3 fluid secretion, such as the intracellular generation of HC03-
by carbonic anhydrase, or that these inhibitors are not 100% effective over such a long 
time course (24 h). Although it should be noted that changes in the volume of fluid 
secreted under non-stimulated conditions were so small that this assay may not be 
able to detect partial inhibition at these levels. However, both inhibitors significantly 
decreased forskolin and thapsigargin stimulated fluid secretion. Basolateral H2-DIDS 
and bumetanide decreased forskolin-stimulated secretion by 29 ± 3% (P<0.05; n=3) 
and 54 ± 2% (P<O.OOl; n=3) respectively. Thapsigargin-stimulated apical fluid 
secretions were decreased by 54 ± 15% in the presence of basolateral H2-DIDS 
(P<O.OOl; n=3) and by 67 ± 8% with basolateral bumetanide (P<O.OOl; n=3). These 
results suggest that Na +, K+ and cr uptake via the basolateral NKCC and HC03-
uptake via the basolateral NBC and/or CrlHC03- exchanger support overall luminal 
fluid secretion from Calu-3 cells under cAMP or Ca2+ stimulated conditions. 
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Figure 6.05 - Basolateral H2-DIDS and bumetanide impair apical Calu-3 cell fluid secretion. The 
effects of basolateral inhibitors H2_DIDS (500 11M) and bumetanide on basal, forskolin-stimulated and 
thapsigargin-stimulated on apical fluid secretion (% change in volume) in WT Calu-3 cells bathed in 
HC03- -buffered Krebs solution (KRB) for 24 hours. n=3. *P<0.05 compared to +FSK. tP<O.OOI 
compared to +FSK. ·P<O.OOI compared to +Thaps. 
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Thapsigargin-stimulated fluid secretion, could be driven by Ca2+ -activated cr 
secretion, as bumetanide would lower [CrJi by inhibiting the basolateral NKCC, and 
H2-DIDS may also reduce [CrJi by inhibiting cr uptake via a basolateral CrIHC03-
exchanger. However, since thapsigargin-mediated fluid secretion is abolished by 
external HC03- removal (see Figure 6.03), this would suggest that thapsigargin 
enhances Calu-3 fluid secretion by stimulating both cr and HC03- secretion. 
Similar results were obtained in pHi experiments on murine submucosal gland serous 
acinar cells, which demonstrated that a transient, HC03--dependent, acidification in 
pHi was produced upon stimulation with carbachol, consistent with HC03- secretion 
(Lee et ai, 2008). Carbachol stimulated acinar cells produced an acidification in pHi 
that was absent in HC03--free media and could be strongly inhibited through either 
the elimination of the driving forces for HC03- efflux by ion substitution (altering the 
extracellular cr and K+ concentrations to clamp cell membrane potential to the 
equilibrium potential for HC03-; reduced acidification by -80%) or the addition of the 
cr channel inhibitor niflumic acid (reduced acidification by -70%). [Ca2+]i 
measurements confirmed that carbachol stimulated an increase in [Ca2+]i in these 
cells. Interestingly, exposure to the Na+/H+ exchanger (NHE) inhibitor 
dimethylamiloride (DMA) increased the magnitude of the carbachol-induced 
acidification. From these results it was hypothesised that serous acinar cells secrete 
fluid in response to increases in [Ca2+]j, which is driven by both HC03- and cr 
secretion, with HC03- secretion sustained in part by the activation of the basolateral 
NHE (by removal of H+ to maintain an alkali pHi). 
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As no apical Cr/HC03- exchange activity is observed in thapsigagrin or carbachol 
stimulated Calu-3 cells (see section 3.3), would suggest that Ca2+-stimulated HC03-
secretion is mediated through another apical exit pathway, or that the effects of apical 
AE activity on pHi is masked by the effects of other acid/base transporters, such as the 
basolateral NHE, under these conditions. 
6.3 Role of CFTR in fluid and mucus secretion from Calu-3 cells 
To detennine the role played by apical CFTR in Calu-3 cell fluid secretion, 
experiments were performed using the CFTR pore blocker GlyH-10l and studied on 
CFTR KD Calu-3 cells. In the presence of GlyH-10l, non-stimulated Calu-3 cells 
absorbed rather than secreted fluid (-4 ± 1 Ill/cm2124 h; P<O.OOI; n=3; Figure 6.06A), 
suggesting that basal Calu-3 fluid secretion involves CFTR. Forskolin-stimulated 
fluid secretion could be partially inhibited by GlyH-10l (60 ± 7% inhibition), but to 
levels significantly greater than control levels (P<O.OOI, n=3), suggesting the presence 
of CFTR-independent cAMP-stimulated fluid secretion or that the inhibitor was not 
100% effective under these conditions. The pH of secreted fluid under non-stimulated 
conditions was not significantly different to that of the bathing Krebs solution at the 
start of the experiment (compared to pH 7.4; P>0.05; n=3), but pH did significantly 
increase to 7.8 ± 0.1 following forskolin-stimulation (P<O.OOI; n=3; Figure 6.06B). 
Interestingly, despite altering the volume of fluid secretion, GlyH-101 addition had no 
effect on the pH of secreted fluid under either non-stimulated or forskolin-stimulated 
conditions (P>0.05; n=3). 
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Figure 6.06 - Calu-3 cell fluid secretion volume, but not pH, is inhibited by CFTR 
pore blocker 
GlyH-lOl. The effect ofCFTR inhibition by GlyH-IOI (10 flM) on apical fluid seCretl'o I 
. . . n vo ume (% 
change in volume; A) and pH (B) 111 basal and forskohn-stlmulated WT Calu-3 cells 2 
over 4 hours. 
n=3. Fluid volume and pH measurements represent paired observations from same t 
ranswells. A: 
*P<O.OOI compared to KRB. tP<O.OOI compared to +FSK. B: *P<O.OOI compared to KRB and 
KRB+GlyH-lOl. 
Under non-stimulated conditions, CFTR KD Calu-3 cells failed to increase the 
volume of apical fluid (200 Ill) over 24 hours (P>0.05; n=4; Figure 6.07). However 
, 
like WT Calu-3 cells, CFTR KD cells absorbed fluid under basal conditions in the 
presence of GlyH-101 (-2 ± 0.5 Ill/cm2124 h; P<0.05; n=4). CFTR KD Calu-3 cells 
secreted significantly less fluid compared to WT cells under forskolin and 
thapsigargin-stimulated conditions (34 ± 3% and 88 ± 12% compared to WT, 
respectively; P<O.OOI; n=4). Both forskolin and thapsigargin-stimulated fluid 
secretion from WT and CFTR KD Calu-3 cells were significantly inhibited by the 
addition of GlyH-101 (P<O.OOI; n=4). However, like GlyH-IOI addition in WT cells, 
CFTR KD had no significant effect on the pH of apical fluid secretion under either 
non-stimulated or forskolin-stimulated conditions, compared to WT Calu-3 cells 
(P>0.05; n=3; Figure 6.08). 
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Figure 6.07 - CFTR-dependent fluid secretion from Calu-3 cells. Comparison of the effect of CFTR 
inhibitor GlyH-lOl (10 1lM) on basal, forskolin-stimulated (5 1lM) and thapsigargin-stimulated (200 
nM) apical fluid secretion (% change in volume) in WT and CFTR KD Calu-3 cells over 24 hours. n=3. 
WT vs CFTR KD Calu-3 cells: P<O.OOI under all conditions tested. WT Calu-3 cells: *P<O.OOI 
compared to KRB. tP<O.OOl compared to KRB+FSK. ·P<O.OOI compared to KRB+Thaps. CFTR KD 
cells: *P<0.05 compared to KRB. tP<O.OOl compared to KRB+FSK. ·P<O.OOI compared to 
KRB+Thaps. 
Figure 6.08 - Reduced CFTR expression has no affect on the pH of Calu-3 cell fluid secretion. 
Comparison of the pH of the apical fluid secreted by WT and CFTR knockdown (KD) Calu-3 cells, 
under non-stimulated (KRB) and forskolin-stimulated (+FSK; 5 ~M), over 24 hours. n=3. *P<O.OOI 
compared to WT KRB and KD KRB. 
Both WT and CFTR KD Calu-3 cells continued to steadily increase the apical fluid 
volume over 72 hours (Figure 6.09). Interestingly, after 48 hours, there was a net gain 
in the apical fluid volume of non-stimulated CFTR KD cells (10 ± 1 J..Ll cm-2 after 48 
hours; n=3). 
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Figure 6.09 - Comparison of basal and forskolin-stimulated apical fluid secretion in WT and 
CFTR KD Calu-3 cells over 72 hours. Volume of apical fluid secreted above 200 ~l at start of 
experiment in non-stimulated and forskolin-stimulated (5 1lM), WT and CFTR knockdown (KD) Calu-
3 cells after 24, 48 and 72 hours (~l cm-2). n=3. 
Interestingly, the addition of thapsigargin and forskolin together had a synergistic 
effect on the volume of apical fluid secreted by CFTR KD (P<O.001; n=3), but not 
WT Calu-3 cells (P>O.05; n=3; Figure 6.10). This may suggest that both agonists 
individually produce a maximal rate of fluid secretion in WT Calu-3 cells. 
The secreted fluid was also analysed for mucin, using a PAS assay (see methods 
section 2.6.3), which showed that the glycoprotein (mainly mucin) content of CFTR 
KD Calu-3 cell secretions was significantly reduced compared to WT cells under all 
conditions (P<O.001 ; n=3; Figure 6.11). In WT Calu-3 cells, mucin secretion was 
unaffected by forskolin-stimulation, compared to basal secretions (P>O.05; n=3), but 
was enhanced by thapsigargin addition (P<O.05; n=3). By contrast, CFTR KD Calu-3 
cells produced a similar level of mucin secretion under non-stimulated, forskolin-
stimulated and thapsigargin-stimulated conditions (P>O.05; n=3). 
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Figure 6.10 - Synergistic effect of forskolin and thapsigargin stimulation in CFTR KD Calu-3 
ceUs. WT and CFTR KD Calu-3 cell fluid secretion (% change in volume) over 24 hours, under 
forskolin and thapsigargin-stirnulated conditions. n=3. WT vs CFTR KD Calu-3 cells: P<O.OO I under 
all conditions tested, except +FSK+Thaps P>O.05. WT Calu-3 cells: *P<O.OO I compared to KRB. 
CFTR KD cells: *P<O.OOI compared to KRB. tP<O.OOI compared to +FSK and +Thaps. 
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Figure 6.11 - Reduced mucin secretion from CFTR KD Calu-3 ceUs. WT and CFTR KD Calu-3 
cell glycoprotein (mainly mucin) secretion over 24 hours, under forskolin and thapsigargin-stimulated 
conditions (Jlg/ml). n=3. Mucin secretion represents paired experiment with fluid secretion 
measurements in Figure 6.10. WT vs CFTR KD Calu-3 cells: P<O.OOI under all conditions tested. WT 
Calu-3 cells: *P<0.05 compared to KRB and +FSK. 
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6.4 Pendrin KD Calu-3 cell fluid secretion 
The role of Pendrin in overall Calu-3 cell fluid secretion was investigated using 
Pendrin KD Calu-3 cells. Pendrin KD had no significant effect on either the volume 
or pH of secreted fluid under basal conditions compared to control cyclophilin B KD 
Calu-3 cells (P>0.05; n=3; Figure 6.12). However, while Pendrin KD Calu-3 cells 
produced an increase in fluid volume (P<0.05; n=3) and pH (P<O.Ol; n=3) in response 
to forskolin addition, less fluid was secreted compared to cyclophilin B KD cells 
(P<0.05; n=3) and the pH of secreted fluid was also less alkali (PH 7.54 ± 0.01' , 
P<O.OOl; n=3). 
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Figure 6.12 - Reduced volume and pH of forskolin-stimulated fluid secretion from Pendrin KD 
Calu-3 cells. Apical fluid secretion volume (% change in volume; A) and pH (B) in basal and 
forskolin-stimulated cyclophilin B (control) KD and Pendrin (A4) KD Calu-3 cells over 24 hours. n=3. 
Fluid volume and pH measurements represent paired observations from same transweIIs. A: *P<O.05 
compared to control KD+FSK. B: *P<O.OI compared to control KD+FSK. 
6.5 Fluid secretion from okadaic acid treated Calu-3 cells 
As previously shown in chapter 3 (section 3.6), okadaic acid activates an apical cr 
IHC03- exchange activity under non-stimulated conditions. To investigate if this AE 
activity could contribute to basal Calu-3 cell HC03 - secretion, apical fluid secretion 
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from Calu-3 cells was studied in the presence of okadaic acid. Interestingly, okadaic 
acid treatment enhanced the pH of the apical fluid from 7.37 ± 0.02 to 7.77 ± 0.02 pH 
units (P<O.OOl; n=4; Figure 6.13), without producing a significant change in the 
overall volume of fluid secreted (P>0.05; n=4). Forskolin-stimulation increased both 
the volume and pH of apical fluid from okadaic acid treated Calu-3 cells to levels 
similar to untreated cells (P>0.05; n=4). 
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Figure 6.13 - Okadaic acid increases Calu-3 ceO fluid secretion pH, but not volume. Apical fluid 
secretion volume (% change in volume; A) and pH (B) in untreated and okadaic acid (OA) treated 
Calu-3 cells under basal and forskolin-stimulated over 24 hours. n=4. Fluid volume and pH 
measurements represent paired observations from same transwells. B: *P<O.OO 1 compared to KRB. 
tP<O.05 compared to +FSK. • P<O.O I compared to OA+FSK. 
6.6 Cytokine treated Calu-3 cell fluid secretion 
Since inflammatory cytokines have been previously shown to alter SMG fluid 
secretion, the effect of interleukin (IL)- 1 p, 4, 13 and 17 A treatment on fluid secretion 
from Calu-3 cells was examined. IL-l p treatment had no significant effect on basal 
Calu-3 fluid secretion, but decreased the volume of forskolin-stimulated secretion 
over 24 hours (P<O.OOl ; n=3; Figure 6.14). No significant change in apical fluid 
volume was seen in non-stimulated IL-4 treated Calu-3 cells after 24 hours (P>0.05; 
n=3), which increased above untreated Calu-3 cells after 48 hours (P<O.OOl; n=3; 
Figure 6.15). Despite studies showing that AQP5 expression is lost in primary airway 
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epithelial cells exposed to IL-13 (Skorwron-zwarg et aI, 2007), IL-13 treatment 
actually enhanced both basal and forskolin-stimulated fluid secretion from Calu-3 
cells over 48 hours (P<O.OOl; n=3). IL-17A exposure had no effect on Calu-3 cell 
fluid secretion under basal or forskolin-stimulated conditions over 24 hours, but 
significantly reduced secretion under both conditions after 48 hours (P<O.OOl; n=3). 
~ 
"g. 
.!: 
., 
'" c .. 
~ 
(.) 
Figure 6.14 - The effects of interleukin 1P, 4, 13 & 17A on basal and forskolin-stimulated apical 
fluid secretion in WT Calu-3 cells over 24 hours. Changes in apical fluid volume (%) from Calu-3 
cells pre-treated with cytokine IL-IP (20 ng/ml), IL-4 (10 ng/ml), IL-13 (10 nglml) and IL-17A (50 
nglml) , compared to untreated WT Calu-3 cells (Control), under non-stimulated and forskolin-
stimulated conditions over 24 hours. n=3. *P<O.OOI compared to Control+FSK. 
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Figure 6.15 - The effects of interleukin IP, 4, 13 & 17A on basal and forskolin-stimulated apical 
fluid secretion in WT Calu-3 cells over 48 hours. Changes in apical fluid volume (%) from Calu-3 
cells pre-treated with cytokine IL-IP (20 ng/ml), IL-4 (10 nglml), IL-13 (10 ng/ml) and IL-17A (50 
ng/ml) , compared to untreated WT Calu-3 cells (Control), under non-stimulated and forskolin-
stimulated conditions over 48 hours. n=3. *P<O.OOI compared to Control. tP<O.OI compared to 
Control. +P<O.OOI compared to Control+FSK. 
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6.7 Discussion 
These results show that Calu-3 fluid secretion is dependent on both CFTR and 
Pendrin expression. CFTR inhibitor and knockdown studies suggest that CFTR is 
involved in net fluid secretion under both non-stimulated and forskolin-stimulated 
conditions. However, CFTR activity did not appear to alter or contribute to pH 
changes in the secreted fluid, consistent with the presence of CFTR-independent 
HC03 - secretion under both conditions. Pendrin, which can mediate apical CrIHC03-
exchange independently of CFTR (as suggested by pHi experiments), could be 
involved in HC03 - secretion under forskolin-stimulated conditions, as indicated by pH 
fluid measurements in Pendrin KD Calu-3 cells. The role of apical CrIHC03-
exchange activity in HC03 - secretion from Calu-3 cells was highlighted by the 
increase in fluid pH in okadiac acid treated Calu-3 cells. However, since there was no 
change in the overall volume secreted by okadaic acid treated cells, compared to 
untreated Calu-3 cells, this result suggests that HC03- and fluid secretion are not 
necessarily coupled. Since CF submucosal glands lack functional CFTR and/or apical 
Cr/HC03 - exchange and exhibit a dehydrated ASL, the reduced volume and pH of 
secreted fluid observed in CFTR and Pendrin KD cells, suggests that cr and/or 
HC03 - secretion through these transporters is an underlying mechanism involved in 
SMG fluid secretion. 
The differences seen in the mucin content of fluid secreted by WT and CFTR KD 
Calu-3 cells are not consistent with a reliance of mucin secretion on CFTR-dependent 
HC03 - secretion, as the pH of the secreted fluid was similar in the two cell types. The 
reduced volume of fluid secretion in CFTR KD cells may suggest a coupling of mucin 
and fluid secretion in Calu-3 cells, although the synergistic effect of thapsigargin and 
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forskolin on fluid but not mucin secretion in CFTR KD Calu-3 cells, would suggest 
otherwise. 
A previous study by Babu and colleagues (Babu et ai, 2004), measuring the rate of 
apical fluid secretion over 24 hours from ALI grown Calu-3 cells by micropipette, 
found much lower rates of secretion under both non-stimulated (-2 Jll/cm2124 h 
compared to 10 ± 1 Jll/cm2124 h in the present study) and forskolin-stimulated (5 JlM) 
conditions (13 ± 2 Jll/cm2/24 h compared to 54 ± 3 Jll/cm2/24 h in the present study 
using 50 JlM forskolin). As cells were grown on transwells under ALI for 11 days, the 
differences in Calu-3 fluid secretion compared to the present study could be due to 
differences in apical transporter expression and/or activity, as highlighted by the 
reduction in apical AE activity in ALI grown Calu-3 cells (see chapter 5). However, 
measurements of fluid secretion from ALI grown Calu-3 cells using the 'virtual 
gland' technique showed much greater rates of fluid secretion (Irokawa et ai, 2004). 
Calu-3 cell fluid secretion from the 'virtual gland' were quantified by applying a thin 
film of apical fluid (10 JlI) to cells on a snapwell filter, with a plastic barrier placed on 
top containing a 0.6 mm hole to serve as a virtual duct, conveying secreted fluid into 
an oil filled collection chamber. The diameter of the spherical bubble of fluid that 
forms was measured optically every 30 minutes and converted to volume. Under these 
conditions, non-stimulated Calu-3 cells secreted fluid at a consistent rate of 2.7 ± 0.5 
JlI/cm2/h over 6 hours (compared to -0.4 Jll/cm2/h in the present study). The rate of 
secretion increased to 4.0 ± 0.4 JlI/cm2/h following the addition of 5 JlM forskolin 
(compared to -2.3 JlI/cm2/h in the present study) and to 6.4 ± 0.9 Jll/cm2/h upon 
thapsigargin (333 nM) stimulation (compared to -2.3 JlI/cm2/h in the present study). 
As the current study did not quantify fluid secretion volumes over a shorter time-
1Q1 
course, it is difficult to ascertain whether fluid secretion was constant over 24 hours. 
However, measuring apical fluid secretion using a 1 III Gilson pipette would not be 
accurate enough to measure the small volumes of fluid secreted over an hour. As the 
apical fluid volume (200 Ill) used in the present study is large in comparison to 
previous studies (0-10 Ill), the hydrostatic pressure placed upon the cell monolayer 
may affect secretion rates. However, removing all apical fluid, while reducing the 
potential hydrostatic pressure, would render the apical membrane inaccessible for the 
addition of inhibitors such as GlyH-lOl. Another limitation of this method is that it is 
difficult to measure the pH of the apical fluid, as the HC03 --buffered solution 
gradually alkalinises when removed from the C02 gassed incubator. This could be 
overcome by using micro chambers, such as those used by lrokawa and colleagues, 
which contain a miniature pH electrode (Irokawa et ai, 2004). 
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7. Concluding Discussion 
7.1 Summary of findings 
The aim of this thesis was to investigate the potential role of SLC26 CrIHC03-
exchange in airway epithelia. Fluorescence microscopy measurements showed cr-
dependent changes in pHi, consistent with CrIHC03 -exchange activity, observed on 
the apical membrane of the serous submucosal gland cell line, Calu-3. Using 
pharmacological inhibitors and assessing the anion selectivity of this apical anion 
exchange activity, revealed a CFTR-independent CrIHC03- exchanger with a profile 
similar to SLC26A4 (Pendrin). These data were supported by immunocytochemical 
analysis, which demonstrated Pendrin expression localised to the apical membrane of 
Calu-3 cells. Changes in pHi consistent with the activity of a CFTR-independent 
apical CrlHC03- exchanger were also identified in primary human bronchial epithelial 
cells. Quantative real time-PCR analysis of the SLC26 gene family, revealed the 
expression of several SLC26 members, including SLC26A4, in both Calu-3 and 
human bronchial epithelial cells, suggesting that SLC26 anion exchangers maybe 
present in both the glandular and surface epithelia of the airways. Okadaic acid 
treatment activated CFTR-independent apical CrlHC03- exchange in non-stimulated 
Calu-3 cells, under which conditions Calu-3 cells alkalinised the pH of the fluid 
bathing the apical membrane (which was not apparent in non-treated cells), without 
stimulating fluid secretion above basal levels. These results are consistent with 
Pendrin mediating electroneutral apical CrIHC03- exchange, which contributes to the 
HC03- content ofCalu-3 cell fluid secretions. 
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7.2 Apical CrlHCOl- exchanger in Calu-3 cells 
The results of the current study have demonstrated for the first time, the presence of 
an apical CrIHC03- exchange activity in forskolin-stimulated Calu-3 cells, with an 
anion selectivity and pharmacological profile consistent with SLC26A4 (Pendrin). As 
this apical AE is active under forskolin-stimulated conditions, in the presence of both 
basolateral H2-DIDS and CFTR inhibitor GlyH-101 (Figures 3.37 & 3.38) suggests 
that apical HC03- transport can be mediated independently of CFTR, contrary to 
previous Calu-3/SMG studies (Illek et ai, 1997; Krouse et aI, 2004; Thiagarajah et ai, 
2004). The difference between these results and previous hypotheses of SMG serous 
cell secretion, could perhaps be due to the regulation of basolateral CrIHC03-
exchange activity by CFTR, since in the absence of an apical CFTR conductance (by 
GlyH-10l inhibition), an active basolateral AE will 'short-circuit' the supply of 
HC03- for secretion across the apical membrane and thus mask the effects of the 
apical CrlHC03- exchanger. As the changes in pHi in the presence of both of these 
inhibitors is likely to reflect Cr-dependent HC03- transport mediated by apical cr 
IHC03- exchange activity alone, further pharmacological studies of this response 
under these conditions will be necessary for a more complete profile of this apical AE 
to be established. Another important difference is that many studies of polarised Calu-
3 cells were made with cells grown at air-liquid interface (ALI), under which 
conditions apical AE activity is diminished (see chapter 5). 
7.3 cAMP- and CFTR-dependent regulation of crlHcoJ- exchange activity in 
I 
Calu-3 cells 
I . The hypothesis proposed by many investigators, that Calu-3 cell HC03- transport 
requires CFTR, rather than implicating CFTR as the sole source of apical HC03-
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secretion, may instead reflect its regulatory role within these cells. Like other epithelia 
expressing both SLC26 CrlHC03- exchangers and CFTR, such as the pancreas, apical 
CrlHC03- exchange in Calu-3 cells appears to be regulated by CFTR, as indicated by 
the reduced rate of apical AE activity seen in CFTR knockdown Calu-3 cells (Figure 
3.42). However, CFTR also seems to have a role in the regulation of basolateral cr 
IHC03 - exchange activity, as indicated by the partial inhibition of basolateral AE 
under forskolin-stimulated conditions in WT Calu-3 cell treated with GlyH-101 or in 
CFTR KD Calu-3 cells (see section 4.5). These results suggest that CFTR plays a 
central role in mediating the switch in Calu-3 cells from pHi regulatory to HC03-
secretory modes, following an elevation in cAMP. Co-immunoprecipitation of CFTR 
and Pendrin would be useful to determine whether a direct structural interaction exists 
between the proteins in Calu-3 cells. 
The mechanisms by which increased cAMP levels mediate this 'switch' in AE 
activity (inhibition of basolateral AE and stimulation of apical AE activity) was 
assessed using a range of protein kinase and protein phosphatase inhibitors. The 65% 
inhibition of apical CrIHC03- exchange activity in the presence of PKA inhibitor H-
89 (Figure 3.08), in forskolin-stimulated Calu-3 cells, is consistent with CFTR 
regulation of the exchanger, as CFTR activity requires PKA phosphorylation. 
However, if CFTRIPKA activity was the sole stimulant of apical CrIHC03 -exchange, 
then one may have expected complete inhibition of apical AE activity by H-89. 
Therefore, either PKA is not fully inhibited under these conditions by H-89 or the 
general protein kinase inhibitor staurosporine (Figure 3.09), or another pathway is 
involved in the regulation of the apical AE. As protein phosphatase 1 (PPI) inhibition 
by okadaic acid activates an apical AE under non-stimulated conditions, with 
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properties similar to the apical AE seen in the presence of forskolin, I would propose 
that it is regulated by another, PKAlCFTR-independent, mechanism (see section 3.6). 
Although (the identity of) this mechanism may not simply be cAMP inhibition of 
PPI-dependent dephosphorylation, as inhibition of protein phosphatase activity by 
okadaic acid could also produce a corresponding decrease in protein kinase activity. 
The presence ofbasolateral Cr/HC03- exchange activity in forskolin-stimulated Calu-
3 cells, when CFTR is inhibited by GlyH-101, highlights the potential dominant effect 
of CFTR, under cAMP-elevated conditions. Since Calu-3 cells exhibit only 
basolateral AE activity under non-stimulated conditions, and under forskolin-
stimulated conditions, when CFTR is active, only CFTR-dependent apical AE activity 
is seen, it could be argued that the high expression of CFTR in these cells dominates 
the effects of cr removal on pHi and thus masks the effects of both the basolateral 
and apical CrlHC0 3 - exchangers. However, the results from these pHi measurements 
in Calu-3 cells are not consistent with a dominant effect of highly expressed CFTR, 
rather than a regulatory process, as basolateral AE activity is still present in forskolin-
stimulated SLC26A4/A9 knockdown Calu-3 cells, despite stimulation of CFTR-
dependent apical AE activity. Also in WT Calu-3 cells stimulated with apical 
adenosine, basolateral AE is still fully active (see Figure 4.09). Therefore I believe 
my results are consistent with CFTR-dependent regulation and/or changes in anion 
gradients (i.e. cr or HC03-), which inhibits basolateral CrIHC03- exchange activity 
under forskolin-stimulated conditions, rather than a dominant effect of active 
transporters. 
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The regulation of the basolateral CrIHC03 - exchanger by CFTR under [CAMP]i 
elevated conditions, fits with the role of the basolateral AE in maintaining pHi. Under 
forskolin-stimulated conditions, it would be necessary to inhibit the basolateral AE to 
avoid 'short-circuiting' HC03- secretion across the apical membrane via CFTR and 
apical CrIHC03- exchange, and therefore acidifying pHi even further. Whereas, upon 
the inhibition ofCFTR (by GlyH-lOl), basolateral AE is active, potentially in order to 
prevent an alkali load within the cell, due to HC03- accumulation from HC03- uptake 
through the basolateral NBC. 
The exact mechanisms involved in the cAMP/CFTR-dependent inhibition of the 
basolateral AE are not clear, although one potential mechanism is the efflux of HC03-
across the apical membrane upon forskolin stimulation, producing an intracellular 
acidification, which could inhibit the basolateral CrIHC03 - exchanger. Further 
experiments, such as the addition of a weak acid to Calu-3 cells, are required to 
establish the pH -dependence of the basolateral AE. Regulation via protein kinase 
phosphorylation is not apparent, as neither PKA inhibitor H-89 nor the general protein 
kinase inhibitor staurosporine had any effect on the basolateral AE activity (Figure 
4.11). However, as PPI inhibition by okadaic acid abolished basolateral CrIHC03-
exchange under non-stimulated conditions, regulation of the basolateral AE may 
involve protein phosphatase dephosphorylation (Figure 4.20). 
Based on the results of this thesis, the mechanisms regulating the cAMP-dependent 
'switch' from basolateral to apical Cr/HC03- exchange activity is summarised in 
Figure 7.01. 
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Figure 7.01 - Co-ordinated CFTR-dependent regulation of apical and basolateral CrIHC03-
exchangers in cAMP-stimulated Calu-3 cells. Summary of the potential mechanisms regulating the 
cAMP-dependent 'switch' in AE activity in Calu-3 cells, as detennined by protein kinase (PK) and 
protein phosphatase (PP) inhibitor studies on the apical and basolateral Cr-dependent changes in pHj. 
Green lines indicate stimulatory regulation- cAMP elevation activates PKA, which in turn stimulates 
CFTR and may also stimulate apical SLC26 CrIHC03- exchange. Yellow arrow indicates the potential 
reciprocal regulation of CFTR and the apical CrIHC03- exchanger. Red lines indicate inhibitory 
regulation- cAMP elevation inhibits a basolateral CrIHC03- exchanger, believed to be AE2, indirectly 
through stimulation of CFTR, or directly by a PKAlPKC-independent mechanism, such as inhibition of 
PPI. 
7.4 Role of apical CrIHC03- exchange in the airways 
An insight into the potential role of the apical CrlHC03 -exchanger present in Calu-3 
cells was determined by looking at the apical fluid secretion from these cells (see 
chapter 6). From the pHi experiments, the exchanger would be predicted to facilitate 
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HC03 - secretion across the apical membrane under forskolin-stimulated conditions. 
This hypothesis was verified by the finding that the pH of Calu-3 fluid secretions was 
lower in forskolin-stimulated Pendrin knockdown cells (compared to WT Calu-3 
cells) and could be enhanced by okadaic acid treatment in non-stimulated WT Calu-3 
cells, which coincides with reduced and stimulated apical AE activity respectively. 
Furthermore, CFTR knockdown or inhibition by GlyH-101 had no affect on the pH of 
forskolin-stimulated Calu-3 fluid secretion, but both reduced the volume of secreted 
fluid, consistent with cr secretion, as apposed to HC03 -secretion, through CFTR. cr 
secretion through CFTR would be predicted to support apical CrIHC03-exchange, by 
maintaining an inward cr gradient (low [Cni) driving the exchanger. 
Overall, the results obtained from pHi and fluid secretion experiments in Calu-3 cells 
suggest HC03- secretion across the apical membrane can be mediated independently 
of CFTR, through an apical SLC26 CrlHC03 - exchanger under cAMP-stimulated 
conditions, with a profile consistent with Pendrin. Although the electrogenicity of the 
apical AE is uncertain, the high cr concentration (-90 mM; Jayaraman et ai, 2001a) 
present in SMG secretions in vivo, would be adequate to drive HC03- secretion 
through either a 1: 1 or 2: 1 Cr/HC03 -exchanger to generate a [HC03 -] similar to those 
seen in native tissue (-20 mM; Jayaraman et ai, 2001a). 
Similarly in human (surface) bronchial epithelial cells, apical CrIHC03- exchange 
activity was observed, which was not affected by CFTR inhibitor GlyH-101, 
highlighting that CrlHC03- exchange maybe present in other regions of the airways, 
outside the SMG (see section 5.5). The fact that apical AE activity is absent in CF 
HBE cells, may indicate that dysregulation of airway CrIHC03 -exchange contributes 
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to the apparent acidic ASL observed in CF airways, due to a lack of HC03 - secretion 
from serous SMG cells and surface airway cells. 
7.5 Future experiments 
The presence of an apical CrlHC03- exchanger in airway epithelia could have 
important implications for CF, since it may provide a CFTR-independent source of 
HC03- in the airways. In addition to the potential future experiments described above, 
it would be beneficial to study the role of Pendrin in native serous submucosal gland 
tissue, using a methodology similar to those outlined in this thesis. For instance, 
intracellular and extracellular pH measurements, in the presence of CFTR inhibitors 
and basolateral H2-DIDS, in order to isolate the effects of the exchanger on pH. 
The physiological role of the apical CrIHC03 - exchanger in the airway submucosal 
glands could also be investigated in Pendrin knockout mice, in which to date many 
studies have focussed on Pendrin's role in the inner ear. However, as Pendrin 
knockout mice do not develop hypothyroidism, as seen in Pendred syndrome, another 
knockout animal may need to be developed to provide a model which better 
represents Pendrin's role in humans. As Pendrin has also been shown to be expressed 
in primary bronchial epithelial cells and my data is consistent with an apical cr 
IHC0 3 - exchange activity in these cells, then studying bronchial epithelial cells 
obtained from lung brushings in patients with Pendred syndrome would provide the 
most ideal way of studying the role of Pendrin in surface cells of the airways. 
In order to better understand the regulation of the apical CriH C03 -exchanger present 
in Calu-3 cells by CFTR, it would be useful to determine whether a structural 
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interaction exists between Pendrin and CFTR. This could be achieved by co-
immunoprecipitation of the two proteins or, as Pendrin and CFTR may interact via a 
STAS-R domain interaction, by studying apical CrIHC03- exchange activity in Calu-3 
cells in which the R-domain ofCFTR has been deleted. 
The most important of all potential future experiments, would be to assess apical cr 
1HC03- exchange in CF serous SMG cells (such as the deltaF508 CF tracheobronchial 
cell lines CFSMEo- and 6CFSMEo-; da Paula et ai, 2005), since a novel agonist of 
Pendrin could stimulate HC03- secretion through the exchanger and alleviate some of 
the HC03--dependent pathological changes observed in CF airways, such as the 
impaired function of mucins in dehydrated mucus secretions. 
202 
References 
Ahdieh, M., Vandenboos, T. and Youakim, A (2001) 'Lung epithelial barrier 
function and wound healing are decreased by IL-4 and IL-13 and 
enhanced by IFN-y', Am J Physio! Cell Physio!, 281, (6), pp. C2029-2038. 
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., 
Shibuya, M. and Fukami, Y. (1987) 'Genistein, a specific inhibitor of 
tyrosine-specific protein kinases', J Bio! Chem, 262, (12), pp. 5592-5595. 
AI-Bazzaz, F. J., Hafez, N., Tyagi, S., Gailey, C. A, Toofanfard, M., Alrefai, W. A, 
Nazir, T. M., Ramaswany, K. and Dudeja, P. K. (2001) 'Detection of cr-
HC03- and Na + -H+ exchangers in human airways epithelium', J Pancreas, 
2, (4), pp. 285-290. 
Alper, S. L. (2006) 'Molecular physiology of SLC4 anion exchangers', Exp Physiol, 
91, (1), pp. 153-161. 
Alper, S. L. (2009) 'Molecular physiology and genetics of Na+-independent SLC4 
anion exchangers', J Exp Bio!, 212, (11), pp. 1672-1683. 
Alper, S. L., Stuart-Tilley, A K., Biemesderfer, D., Shmukler, B. E. and Brown, D. 
(1997) 'Immunolocalization of AE2 anion exchanger in rat kidney', Am J 
Physio! Rena! Physio!, 273, (4), pp. F601-614. 
Amlal, H., Petrovic, S., Xu, J., Wang, Z., Sun, X., Barone, S. and Soleimani, M. 
(2010) 'Deletion of the anion exchanger SIc26a4 (pendrin) decreases 
apical Cr/HC03- exchanger activity and impairs bicarbonate secretion in 
kidney collecting duct', Am J Physio! Cell Physio!, 299, (1), pp. C33-41. 
203 
Anderson, M. P., Berger, H. A, Rich, D. P., Gregory, R J., Smith, A E. and 
Welsh, M. J. (1991a) 'Nucleoside triphosphates are required to open the 
CFTR chloride channel', Cell, 67, (4), pp. 775-784. 
Anderson, M. P., Gregory, R J., Thompson, S., Souza, D. W., Paul, S., Mulligan, 
R C., Smith, A E. and Welsh, M. J. (1991b) 'Demonstration that CFTR is 
a chloride channel by alteration of its anion selectivity', Science, 253, 
(5016), pp. 202-205. 
Aravind, L. and Koonin, E. V. (2000) 'The STAS domain - a link between anion 
transporters and antisigma-factor antagonists', CUff Bio!, 10, (2), pp. R53-
R55. 
Avella, M., Loriol, C., Boulukos, K., Borgese, F. and Ehrenfeld, J. (2010) 
'SLC26A9 stimulates CFTR expression and function in human bronchial 
cell lines', J Cell Physio!. (published online prior to journal publication). 
Babu, P. B. R, Chidekel, A, Utidjian, L. and Shaffer, T. H. (2004) 'Regulation of 
apical surface fluid and protein secretion in human airway epithelial cell 
line Calu-3', Biochem Biophys Res Comms, 319, (4), pp. 1132-1137. 
Ballard, S. T. and Inglis, S. K. (2004) 'Liquid secretion properties of airway 
submucosal glands', J Physio!, 556, (1), pp. 1-10. 
Ballard, S. T., Trout, L., Bebok, Z., Sorscher, E. J. and Crews, A (1999) 'CFTR 
involvement in chloride, bicarbonate, and liquid secretion by airway 
submucosal glands', Am J Physio! Lung Cell Mo! Physio!, 277, (4), pp. 
L694-699. 
Basbaum, C. B., Jany, B. and Finkbeiner, W. E. (1990) 'The Serous Cell', An Rev 
Physio!, 52, (1), pp. 97-113. 
204 
Baudouin-Legros, M., Hamdaoui, N., Borot, F., Fritsch, J., Ollero, M., Planelles, 
G. and Edelman, A (2008) 'Control of basal CFTR gene expression by 
bicarbonate-sensitive adenylyl cyclase in human pulmonary cells', Cell 
Physiol Biochem, 21, (1-3), pp. 075-086. 
Bear, C. E., Duguay, F., Naismith, A L., Kartner, N., Hanrahan, J. W. and 
Riordan, J. R (1991) 'cr channel activity in Xenopus oocytes expressing 
the cystic fibrosis gene', J BioI Chem, 266, (29), pp. 19142-19145. 
Bebok, Z., Tousson, A, Schwiebert, L. M. and Venglarik, C. J. (2001). 'Improved 
oxygenation promotes CFTR maturation and trafficking in MOCK 
monolayers', Am J Physiol Cell Physiol, 280, pp. C135-145. 
Becq, F., Jensen, J., Chang, X. 8., Savoia, A, Rommens, J. M., Tsui, L. C., 
Buchwald, M., Riordan, J. R and Hanrahan, J. W. (1994) 'Phosphatase 
inhibitors activate normal and defective CFTR chloride channels, Proc Nat! 
Acad Sci U.S.A., 91, (19), pp. 9160-9164. 
Berger, H. A, Travis, S. M. and Welsh, M. J. (1993) 'Regulation of the cystic 
fibrosis transmembrane conductance regulator cr channel by specific 
protein kinases and protein phosphatases', J BioI Chem, 268, (3), pp. 
2037-2047. 
Bertrand, C. A, Zhang, R, Pilewski, J. M. and Frizzell, R A (2009) 'SLC26A9 is 
a constitutively active, CFTR-regulated anion conductance in human 
bronchial epithelia', J Gen Physiol, 133, (4), pp. 421-438. 
Bhaskar, K. R, Gong, D. H., Bansil, R, Pajevic, S., Hamilton, J. A, Turner, B. S. 
and LaMont, J. T. (1991) 'Profound increase in viscosity and aggregation 
of pig gastric mucin at low pH', Am J Physiol Gastrointest Liver Physiol, 
261, (5), pp. G827-832. 
205 
Bissig, M., Hagenbuch, B., Stieger, B., Koller, T. and Meier, P. J. (1994) 
'Functional expression cloning of the canalicular sulfate transport system 
of rat hepatocytes', J BioI Chem, 269, (4), pp. 3017-3021. 
Boucher, R. C., Stutts, M. J., Knowles, M. R., Cantley, L. and Gatzy, J. T. (1986) 
'Na + transport in cystic fibrosis respiratory epithelia. Abnormal basal rate 
and response to adenylate cyclase activation', J Clin Invest, 78, (5), pp. 
1245-1252. 
Brouillard, F., Bouthier, M., Leclerc, T., Clement, A, Baudouin-Legros, M. and 
Edelman, A (2001) 'NF-kappa B mediates up-regulation of CFTR gene 
expression in Calu-3 cells by interleukin-1beta', J BioI Chem, 276, (12), pp. 
9486-9491. 
Brown, AM., Riddoch, F. C., Robson, A, Redfern, C. P. F. and Cheek, T. R. 
(2005) 'Mechanistic and functional changes in Ca2+ entry after retinoic 
acid-induced differentiation of neuroblastoma cells', Biochem J, 388, 
pp.941-948. 
Caohuy, H., Jozwik, C. and Pollard, H. B. (2009) 'Rescue of deltaF508-CFTR by 
the SGK1/Nedd4-2 signaling pathway', J BioI Chem, 284, (37), pp. 25241-
25253. 
Chang, M.-H., DiPiero, J., Sonnichsen, F. D. and Romero, M. F. (2008) 'Entry to 
"formula tunnel" revealed by SLC4A4 human mutation and structural 
model', J BioI Chem, 283, (26), pp. 18402-18410. 
206 
Chappe, F., Loewen, M. E., Hanrahan, J. W. and Chappe, V. (2008) 'Vasoactive 
intestinal peptide Increases cystic fibrosis transmembrane conductance 
regulator levels in the apical membrane of calu-3 cells through a protein 
kinase C-dependent mechanism', J Pharmacol Exp Ther, 327, (1), pp. 
226-238. 
Chappe, V., Hinkson, D. A, Zhu, T., Chang, X. B., Riordan, J. R. and Hanrahan, 
J. W. (2003) 'Phosphorylation of protein kinase C sites in NBD1 and the R 
domain control CFTR channel activation by PKA', J Physiol, 548, (1), pp. 
39-52. 
Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A, 
Q'Riordan, C. R. and Smith, A. E. (1990) 'Defective intracellular transport 
and processing of CFTR is the molecular basis of most cystic fibrosis', Cell, 
63, (4), pp. 827-834. 
Chernova, M. N., Jiang, L., Friedman, D. J., Darman, R. B., Lohi, H., Kere, J., 
Vandorpe, D. H. and Alper, S. L. (2005) 'Functional comparison of mouse 
SLC26A6 anion exchanger with human SLC26A6 polypeptide variants', J 
BioI Chern, 280, (9), pp. 8564-8580. 
Chijiwa, T., Mishima, A, Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., 
Toshioka, T. and Hidaka, H. (1990) 'Inhibition of forskolin-induced neurite 
outgrowth and protein phosphorylation by a newly synthesized selective 
inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-
bromocinnamylamino )ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D 
pheochromocytoma cells', J BioI Chern, 265, (9), pp. 5267-5272. 
Clancy, J. P., Ruiz, F. E. and Sorscher, E. J. (1999) 'Adenosine and its 
nucleotides activate wild-type and R117H CFTR through an A2B receptor-
coupled pathway', Am J Physiol Cell Physiol, 276, pp. 361-369. 
207 
Clary-Meinesz, C., Mouroux, J., Cosson, J., Huitorel, P. and Blaive, B. (1998) 
'Influence of external pH on ciliary beat frequency in human bronchi and 
bronchioles', Eur Respir J, 11, (2), pp. 330-333. 
Coakley, R D., Grubb, B. R, Paradiso, AM., Gatzy, J. T., Johnson, L. G., Kreda 
S. M., O'Neal, W. K. and Boucher, R C. (2003) 'Abnormal surface liquid 
pH regulation by cultured cystic fibrosis bronchial epithelium', Proc Natl 
Acad Sci U.S.A., 100, (26), pp. 16083-16088. 
Communi, D., Paindavoine, P., Place, G. A, Parmentier, M., Boeynaems, J. M. 
(1999) 'Expression of P2Y receptors in cell lines derived form human lung', 
Br J Pharmacol, 127, (2), pp. 562-568. 
Courtney, J. M., Ennis, M. and Elborn, J. S. (2004) 'Cytokines and inflammatory 
mediators in cystic fibrosis', J Cyst Fibros, 3, (4), pp. 223-231. 
Cuthbert, A W. and MacVinish, L. J. (2003) 'Mechanisms of anion secretion in 
Calu-3 human airway epithelial cells by 7,8-benzoquinoline', Br J 
Pharmacol, 140, (1), pp. 81-90. 
da Paula, A C., Ramalho, AS., Farinha, C. M., Cheung, J., Maurisse, R., 
Gruenert, D. C., Ousingsawat, J., Kunzelmann, K. and Amaral, M. D. 
(2005) 'Characterization of novel airway submucosal gland cell models for 
cystic fibrosis', Cell Physiol Biochem, 15, (6), pp. 251-262. 
Davis, P. B. (2006) 'Cystic fibrosis since 1938', Am J Respir Crit Care Med, 173, 
(5), pp. 475-482. 
de Lisle, R C. (2009) 'Pass the bicarb: the importance of HC03- for mucin 
release', J Clin Invest, 119, (9), pp. 2535-2537. 
208 
, 
de Rooij, J., Zwartkrius, J. T., Verheijen, M. H. G., Cool, R H., Nijman, S. M. B., 
Wittinghofer, A and Bos, J. L. (1998) 'Epac is a Rap1 guanine-nucleotide-
exchange factor directly activated by cyclic AMP', Nature, 396, pp. 474-
477. 
Derand, R, Montoni, A, Bulteau-Pignoux, L., Janet, T., Moreau, B., Muller, J. M. 
and Becq, F. (2004). 'Activation of VPAC1 receptors by VIP and PACAP-
27 in human bronchial epithelial cells induces CFTR-dependent chloride 
secretion', Br J Pharmacol, 141, 4, pp. 698- 708. 
Devor, D. C., Singh, A K., lambert, L. C., Deluca, A, Frizzell, R A and Bridges, 
R J. (1999) 'Bicarbonate and chloride secretion in Calu-3 human airway 
epithelial cells', J Gen Physiol, 113, (5), pp. 743-760. 
Di Virgilio, F., Fasolato, C. and Steinberg, T. H. (1988) 'Inhibitors of membrane 
transport system for organic anions block fura-2 excretion from PC12 and 
N2A cells', Biochem J, 256, (3), pp. 959-963. 
Divangahi, M., Balghi, H., Danialou, G., Comtois, AS., Demoule, A, Ernest, S., 
Haston, C., Robert, R, Hanrahan, J. W., Radzioch, D. and Petrof, B. J. 
(2009) 'lack of CFTR in skeletal muscle predisposes to muscle wasting 
and diaphragm muscle pump failure in cystic fibrosis mice', PLoS Genet, 5, 
(7), pp. e1000586. 
Dorwart, M. R, Shcheynikov, N., Wang, Y., Stippec, S. and Muallem, S. (2007) 
'SlC26A9 is a cr channel regulated by the WNK kinases', J Physiol, 584, 
(1), pp. 333-345. 
Dorwart, M. R, Shcheynikov, N., Yang, D. and Muallem, S. (2008) 'The solute 
carrier 26 family of proteins in epithelial ion transport', Physiol, 23, (2), pp. 
104-114. 
209 
Dossena, S., Maccagni, A., Vezzoli, V., Bazzini, C., Garavaglia, M. L., Meyer, G., 
Furst, J., Ritter, M., Fugazzola, L., Persani, L., Zorowka, P., Storelli, C., 
Beck-Peccoz, P., Botta, G. and Paulmichl, M. (2005) 'The expression of 
wild-type pendrin (SLC26A4) in human embryonic kidney (HEK 293 
Phoenix) cells leads to the activation of cationic currents', Eur J Endocrino/, 
153, (5), pp. 693-699. 
Dossena, S., Vezzoli, V., Cerutti, N., Bazzini, C., Tosco, M., Sironi, C., 
Rodighiero, S., Meyer, G., Fascio, U., FOrst, J., Ritter, M., Fugazzola, L., 
Persani, L., Zorowka, P., Storelli, C., Peccoz, P., BottA, G. and Paulmichl, 
M. (2006) 'Functional characterization of wild-type and a mutated form of 
SLC26A4 identified in a patient with pendred syndrome', Cell Physiol 
Biochem, 17, (5-6), pp. 245-256. 
Dubin, R. F., Robinson, S. K. and Widdicombe, J. H. (2004) 'Secretion of 
lactoferrin and lysozyme by cultures of human airway epithelium', Am J 
Physiol Lung Cell Mol Physio/, 286, (4), pp. L750-755. 
Dudeja, P. K., Hafez, N., Tyagi, S., Gailey, C. A., Toofanfard, M., Alrefai, W. A., 
Nazir, T. M., Ramaswamy, K. and AI-Bazzaz, F. J. (1999) 'Expression of 
the Na+/H+ and Cr/HC03- exchanger isoforms in proximal and distal 
human airways', Am J Physiol Lung Cell Mol Physio/, 276, (6), pp. L971-
978. 
Duta, V., Szkotak, A. J., Nahirney, D. and Duszyk, M. (2004) 'The role of 
bestrophin in airway epithelial ion transport', FEBS Lett, 577, (3), pp. 551-
554. 
210 
Egan, M., Flotte, T., Afione, S., Solow, R, Zeitlin, P. L., Carter, B. J. and Guggino, 
W. B. (1992) 'Defective regulation of outwardly rectifying cr channels by 
protein kinase A corrected by insertion of CFTR', Nature, 358, (6387), pp. 
581-584. 
Engelhardt, J. F., Yankaskas, J. R, Ernst, S. A, Yang, Y., Marino, C. R, 
Boucher, R C., Cohn, J. A and Wilson, J. M. (1992) 'Submucosal glands 
are the predominant site of CFTR expression in the human bronchus', Nat 
Genet, 2, (3), pp. 240-248. 
Everett, L. A, Glaser, B., Beck, J. C., Idol, J. R, Buchs, A, Heyman, M. a., 
Adawi, F., Hazani, E., Nassir, E., Baxevanis, A D., Sheffield, V. C. and 
Green, E. D. (1997) 'Pendred syndrome is caused by mutations in a 
putative sulphate transporter gene (PDS)" Nat Genet, 17, (4), pp. 411-422. 
Falkenberg, C. V. and Jakobsson, E. (2010) 'A biophysical model for integration 
of electrical, osmotic, and pH regulation in the human bronchial epithelium', 
Biophys J, 98, (8), pp. 1476-1485. 
Fanning, A. S. and Anderson, J. M. (1999) 'PDZ domains: fundamental building 
blocks in the organization of protein complexes at the plasma membrane', 
J Clin Invest, 103, (6), pp. 767-772. 
Feranchak, A P., Roman, R M., Doctor, R B., Salter, K. D., Toker, A and Fitz, J. 
G. (1999) 'The lipid products of phosphoinositide 3-kinase contribute to 
regulation of cholangiocyte ATP and chloride transport', J BioI Chem, 274, 
(43), pp. 30979-30986. 
Feschenko, M. S., Stevenson, E., Nairn, A C. and Sweadner, K. J. (2002) 'A 
novel cAMP-stimulated pathway in protein phosphatase 2A activation', J 
Pharm Exp Therap, 302, (1), pp. 111-118. 
211 
Fiegel, J., Ehrhardt, C., Schaefer, U. F., Lehr, C.-M. and Hanes, J. (2003) 'Large 
porous particle impingement on lung epithelial cell monolayers- toward 
improved particle characterization in the lung', Pharm Res, 20, (5), Pp. 
788-796. 
Fischer, H., IIlek, B., Sachs, L., Finkbeiner, W. E. and Widdicombe, J. H. (2010) 
'CFTR and Ca-activated CI channels in primary cultures of human airway 
gland cells of serous or mucous phenotype', Am J Phys;ol Lung Cell Mol 
Phys;o/, pp. ajplung.00421.2009. 
Flemstrom, G. and Isenberg, J. I. (2001) 'Gastroduodenal mucosal alkaline 
secretion and mucosal protection', News Phys;ol Sci, 16, (1), pp. 23-28. 
Florea, B. I., Cassara, M. L., Junginger, H. E. and Borchard, G. (2003) 'Drug 
transport and metabolism characteristics of the human airway epithelial 
cell line Calu-3', J Control Release, 87, (1-3), pp. 131-138. 
Forbes, B. and Ehrhardt, C. (2005) 'Human respiratory epithelial cell culture for 
drug delivery applications', Euro J Pharm B;opharm, 60, (2), pp. 193-205. 
Foster, K. A., Avery, M. L., Yazdanian, M. and Audus, K. L. (2000) 
'Characterization of the Calu-3 cell line as a tool to screen pulmonary drug 
delivery', IntJPharm, 208, (1-2), pp. 1-11. 
French, P. J., Bijman, J., Bot, A. G., Boomaars, W. E., Scholte, B. J. and de 
Jonge, H. R. (1997) 'Genistein activates CFTR Cfchannels via a tyrOSine 
kinase- and protein phosphatase-independent mechanism', Am J Phys;ol 
Cell Phys;o/, 273, (2), C747-753. 
212 
Gabriel, S. E, Clarke, L. L., Boucher, R C. and Stutts, M. J. (1993) 'CFTR and 
outwardly rectifying chloride channels are distinct proteins with a 
regulatory relationship', Nature, 363, pp. 263-266. 
Gadsby, D. C. and Nairn, A. C. (1999) 'Control of CFTR channel gating by 
phosphorylation and nucleotide hydrolysis', Physiol Rev, 79, (1), pp. 77-
107. 
Garcia, M. A. S., Yang, N. and Quinton, P. M. (2009) 'Normal mouse intestinal 
mucus release requires cystic fibrosis transmembrane regulator-
dependent bicarbonate secretion', J Clin Invest, 119, (9), pp. 2613-2622. 
Gawenis, L. R, Bradford, EM., Alper, S. L., Prasad, V. and Shull, G. E (2010) 
'AE2 Cr/HC03- exchanger is required for normal cAMP-stimulated anion 
secretion in murine proximal colon', Am J Physiol Gastrointest Liver 
Physiol, 298, (4), pp. G493-503. 
Gelman, M. S., Kannegaard, E S. and Kopito, R R (2002) 'A principal role for 
the proteasome in endoplasmic reticulum-associated degradation of 
misfolded intracellular cystic fibrosis transmembrane conductance 
regulator', J BioI Chern, 277, (14), pp. 11709-11714. 
Grainger, C., Greenwell, L., Lockley, D., Martin, G. and Forbes, B. (2006) 
'Culture of calu-3 cells at the air interface provides a representative model 
of the airway epithelial barrier', Pharm Res, 23, (7), pp. 1482-1490. 
Gray, M. A. (2004) 'Bicarbonate secretion: it takes two to tango', Nat Cell BioI, 6, 
pp.292-294. 
213 
Gray, M. A, Greenwell, J. R and Argent, B. E. (1988) 'Secretin-regulated 
chloride channel on the apical plasma membrane of pancreatic duct cells', 
J Memb Bioi, 105, (2), pp. 131-142. 
Gray, M. A., Plant, S. and Argent, B. E. (1993) 'cAMP-regulated whole cell 
chloride currents in pancreatic duct cells', Am J Physio/ Cell Physio/, 264, 
(3), pp. C591-602. 
Gray, M. A, Pollard, C. E., Harris, A, Coleman, L., Greenwell, J. R and Argent, 
B. E. (1990) 'Anion selectivity and block of the small-conductance chloride 
channel on pancreatic duct cells', Am J Physio/ Cell Physio/, 259, (5), pp. 
C752-761. 
Gray, T., Coakley, R, Hirsh, A, Thornton, D., Kirkham, S., Koo, J.-S., Burch, L., 
Boucher, R and Nettesheim, P. (2004) 'Regulation of MUC5AC mucin 
secretion and airway surface liquid metabolism by IL-1J3 in human 
bronchial epithelia', Am J Physio/ Lung Cell Mol Physio/, 286, (2), pp. 
L320-330. 
Greeley, T., Shumaker, H., Wang, Z., Schweinfest, C. W. and Soleimani, M. 
(2001) 'Downregulated in adenoma and putative anion transporter are 
regulated by CFTR in cultured pancreatic duct cells', Am J Physiol 
Gastrointest Liver Physiol, 281, (5), pp. G1301-1308. 
Green, J., Yamaguchi, D. T., Kleeman, C. Rand Muallem, S. (1990) 'Cytosolic 
pH regulation in osteoblasts. Regulation of anion exchange by intracellular 
pH and Ca2+ions', J Gen Physio/, 95, (1), pp. 121-145. 
214 
Grichtchenko, I. I., Choi, I., Zhong, x., Bray-Ward, P., Russell, J. M. and Boron, 
W. F. (2001) 'Cloning, characterization, and chromosomal mapping of a 
human electroneutral Na + -driven CI-HC03 exchanger', J BioI Chem, 276, 
(11), pp. 8358-8363. 
Groneberg, D. A, Hartmann, P., Dinh, Q. T. and Fischer, A (2001) 'Expression 
and distribution of vasoactive intestinal polypeptide receptor VPAC2 
mRNA in human airways', Lab Invest, 81, (5), pp. 749-755. 
Groneberg, D. A., Rabe, K. F. and Fischer, A (2006) 'Novel concepts of 
neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its 
receptors', Euro J Pharm, 533, (1-3), pp. 182-194. 
Grynkiewicz, G., Poenie, M. and Tsien, R Y. (1985) 'A new generation of Ca2+ 
indicators with greatly improved fluorescence properties', J BioI Chem, 
260, (6), pp. 3440-3450. 
Guimbellot, J. 5., Fortenberry, J. A, Siegal, G. P., Moore, B., Wen, H., Venglarik, 
C., Chen, Y.-F., Oparil, 5., Sorscher, E. J. and Hong, J. S. (2008) 'Role of 
oxygen availability in CFTR expression and function', Am J Respir Cell 
Mol BioI, 39, (5), pp. 514-521. 
Haas, M. (1994) 'The Na-K-CI cotransporters', Am J Physiol Cell Physiol, 267, (4), 
pp. C869-885. 
Haghi, M., Young, P. M., Traini, D., Jaiswal, R, Gong, J. and Bebawy, M. (2010) 
'Time- and passage-dependent characteristics of a Calu-3 respiratory 
epithelial cell model', Drug Dev Ind Pharm, 36, (10), pp. 1207-1214. 
215 
Hasegawa, I., Niisato, N., Iwasaki, Y. and Marunaka, Y. (2006) 'Ambroxol-
induced modification of ion transport in human airway Calu-3 epithelia', 
Biochem Biophys Res Comms, 343, (2), pp. 475-482. 
Hassan, H. A, Mentone, S., Karniski, L. P., Rajendran, V. M. and Aronson, P. S. 
(2007) 'Regulation of anion exchanger SLC26A6 by protein kinase C', Am 
J Physio! Cell Physio!, 292, (4), pp. C1485-1492. 
Hastbacka, J., de la Chapelle, A, Kaitila, I., Sistonen, P., Weaver, A and Lander , 
E. (1992) 'Linkage disequilibrium mapping in isolated founder populations: 
diastrophic dysplasia in Finland', Nat Genet, 2, (3), pp. 204-211. 
Haws, C., Finkbeiner, W. E., Widdicombe, J. H. and Wine, J. J. (1994) 'CFTR in 
Calu-3 human airway cells: channel properties and role in cAMP-activated 
cr conductance', Am J Physio! Lung Cell Mo! Physio!, 266, (5), pp. L502-
512. 
Haws, C., Krouse, M. E., Xia, Y., Gruenert; D. C. and Wine, J. J. (1992) 'CFTR 
channels in immortalized human airway cells', Am J Physio! Lung Cell Mol 
Physio!, 263, (6), pp. L692-707. 
Hegyi, P., Gray, M. A and Argent, B. E. (2003) 'Substance P inhibits bicarbonate 
secretion from guinea pig pancreatic ducts by modulating an anion 
exchanger', Am J Physio! Cell Physio!, 285, (2), pp. C268-276. 
Hegyi, P., Rakonczay, Z. J., Gray, M. A and Argent, B. E. (2004) 'Measurement 
of intracellular pH in pancreatic duct cells: a new method for calibrating the 
fluorescence data', Pancreas, 28, pp. 427-434. 
216 
Hoglund, P., Haila, S., Scherer, S. W., Tsui, L. C., Green, E. D., Weissenbach, J., 
Holmberg, C., de la Chapelle, A. and Kere, J. (1996) 'Positional candidate 
genes for congenital chloride diarrhea suggested by high-resolution 
physical mapping in chromosome region 7q31', Genome Res, 6, (3), pp. 
202-210. 
Holma, B. and Hegg, P. O. (1989) 'pH- and protein-dependent buffer capacity 
and viscosity of respiratory mucus. Their interrelationships and influence 
of health', Sci Tot Enviro, 84, pp. 71-82. 
Hoque, K. M., Woodward, O. M., van Rossum, D. B., Zachos, N. C., Chen, L., 
Leung, G. P. H., Guggino, W. B., Guggino, S. E. and Tse, C. M. (2010) 
'Epac1 mediates protein kinase A-independent mechanism of forskolin-
activated intestinal chloride secretion', J Gen Physio!, 135, (1), pp. 43-58. 
Huang, P., Lazarowski, E. R., Tarran, R., Milgram, S. L., Boucher, R. C. and 
Stutts, M. J. (2001) 'Compartmentalized autocrine signaling to cystic 
fibrosis transmembrane conductance regulator at the apical membrane of 
airway epithelial cells', Proc Nat! Acad Sci U.S.A., 98, (24), pp. 14120-
14125. 
Humphreys, B. D., Jiang, L., Chernova, M. N. and Alper, S. L. (1994) 'Functional 
characterization and regulation by pH of murine AE2 anion exchanger 
expressed in Xenopus oocytes', Am J Physio! Cell Physio!, 267, (5), pp. 
C1295-1307. 
Hunter, M. J. (1977) 'Human erythrocyte anion permeabilities measured under 
conditions of net charge transfer', J Physio!, 268, (1), pp. 35-49. 
Hwang, T. C. and Sheppard, D. N. (1999) 'Molecular pharmacology of the CFTR 
cr channel', Trends Pharm Sci, 20, (11), pp. 448-453. 
217 
Hwang, T. C. and Sheppard, D. N. (2009) 'Gating of the CFTR cr channel by 
ATP-driven nucleotide-binding domain dimerisation', J Physiol, 587, (10), 
pp.2151-2161. 
Hwang, T., C., Wang, F., Yang, I. C. and Reenstra, W. W. (1997) 'Genistein 
potentiates wild-type and delta F508-CFTR channel activity', Am J Physiol 
Cell Physiol, 273, (3), pp. C988-998. 
lIIek, B., Fischer, H. and Machen, T. E. (1996) 'Alternate stimulation of apical 
CFTR by genistein in epithelia', Am J Physiol Cell Physiol, 270, (1), Pp. 
C265-275. 
IIlek, B., Yankaskas, J. R. and Machen, T. E. (1997) 'cAMP and genistein 
stimulate HC03- conductance through CFTR in human airway epithelia' 
, 
Am J Physiol Lung Cell Mo! Physio!, 272, (4), pp. L752-761. 
Inglis, S. K., Finlay, L., Ramminger, S. J., Richard, K., Ward, M. R., Wilson, S. M. 
and Olver, R. E (2002) 'Regulation of intracellular pH in Calu-3 human 
airway cells', J Physio!, 538, (2), pp. 527-539. 
Inglis, S. K., Wilson, S. M. and Olver, R. E (2003) 'Secretion of acid and base 
equivalents by intact distal airways', Am J Physiol Lung Cell Mol Physiol, 
284, (5), pp. L855-862. 
Irokawa, T., Krouse, M. E, Joo, N. S., Wu, J. V. and Wine, J. J. (2004) 'A "virtual 
gland" method for quantifying epithelial fluid secretion', Am J Physio! Lung 
Cell Mo! Physio!, 287, (4), pp. L784-793. 
218 
Ishiguro, H., Namkung, W., Yamamoto, A, Wang, l., Worrell, R. T., Xu, J., Lee, 
M. G. and Soleimani, M. (2007) 'Effect of SLC26A6 deletion on apical cr 
IHC03· exchanger activity and cAMP-stimulated bicarbonate secretion in 
pancreatic duct', Am J Physiol Gastrointest Liver Physiol, 292, (1), pp. 
G447-455. 
Ishiguro, H., Naruse, S., Kitagawa, M., Mabuchi, T., Kondo, T., Hayakawa, T., 
Case, R. M. and Steward, M. C. (2002) 'Chloride transport in 
microperfused interlobular ducts isolated from guinea-pig pancreas', J 
Physiol, 539, (1), pp. 175-189. 
Ishihara, H., Shimura, S., Satoh, M., Masuda, T., Nonaka, H., Kase, H., Sasaki, 
T., Sasaki, H., Takishima, T. and Tamura, K. (1992) 'Muscarinic receptor 
subtypes in feline tracheal submucosal gland secretion', Am J Physiol 
Lung Cell Mol Physiol, 262, (2), pp. L223-228. 
Ito, Y., Mizuno, Y., Aoyama, M., Kume, H. and Yamaki, K. (2000) 'CFTR-
mediated anion conductance regulates Na + -K+ -pump activity in Calu-3 
human airway cells', Biochem Biophys Res Comms, 274, (1), pp. 230-235. 
Jayaraman, S., Joo, N. S., Reitz, B., Wine, J. J. and Verkman, A S. (2001a) 
'Submucosal gland secretions in airways from cystic fibrosis patients have 
normal [Na+] and pH but elevated viscosity', Proc Natl Acad Sci U. S.A., 98, 
(41), pp. 8119-8123. 
Jayaraman, S., Song, Y. and Verkman, A S. (2001 b) 'Airway surface liquid pH in 
well-differentiated airway epithelial cell cultures and mouse trachea', Am J 
Physiol Cell Physiol, 281, (5), pp. C1504-1511. 
219 
Jayaraman, S., Song, Y., Vetrivel, L., Shankar, L. and Verkman, A. S. (2001c) 
'Noninvasive in vivo fluorescence measurement of airway-surface liquid 
depth, salt concentration, and pH', J Clin Invest, 107, (3), pp. 317-324. 
Jiang, Z., Asplin, J. R, Evan, A. P., Rajendran, V. M., Velazquez, H., Nottoli, T. 
P., Binder, H. J. and Aronson, P. S. (2006) 'Calcium oxalate urolithiasis in 
mice lacking anion transporter SLC26A6', Nat Genet, 38, (4), pp. 474-478. 
Joo, N. S., Irokawa, T., Wu, J. V., Robbins, R C., Whyte, R I. and Wine, J. J. 
(2002a) 'Absent secretion to vasoactive intestinal peptide in cystic fibrosis 
airway glands', J BioI Chern, 277, (52), pp. 50710-50715. 
Joo, N. S., Saenz, Y., Krouse, M. E. and Wine, J. J. (2002b) 'Mucus secretion 
from single submucosal glands of pig', J BioI Chern, 277, (31), pp. 28167-
28175. 
Joo, N. S., Wu, J. V., Krouse, M. E., Saenz, Y. and Wine, J. J. (2001) 'Optical 
method for quantifying rates of mucus secretion from single submucosal 
glands', Am J Physiol Lung Cell Mol Physiol, 281, (2), pp. L458-468. 
Kagawa, T., Varticovski, L., Sai, Y. and Arias, I. M. (2002) 'Mechanism by which 
cAMP activates PI-3 kinase and increases bile acid secretion in WIF-B9 
cells', Am J Physiol Cell Physio/, 283, pp. C1655-1666. 
Kang, G., Joseph, J. W., Chepurny, O. G., Monaco, M., Wheeler, M. B., Bos, J. 
L., Schwede, F., Genieser, H. G. & Holz, G. G. (2003) 'Epac-selective 
cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ 
release and exocytosis in pancreatic ~-cells', J BioI Chern, 278, pp. 8279-
8285. 
220 
Kerem, E., Bistritzer, T., Hanukoglu, A., Hofmann, T., Zhou, Z., Bennett, W., 
Maclaughlin, E., Barker, P., Nash, M., Quittell, L., Boucher, R, Knowles, 
M. R, Homolya, V. and Keenan, B. (1999) 'Pulmonary epithelial sodium-
channel dysfunction and excess airway liquid in 
pseudohypoaldosteronism', N Engl J Med, 341, (3), pp. 156-162. 
Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J. and Riches, D. 
W. (1995) 'Early pulmonary inflammation in infants with cystic fibrosis', Am 
J Repir Crit Care Med, 151, (4), pp. 1075-1082. 
Kim, K. H., Shcheynikov, N., Wang, Y. and Muallem, S. (2005) 'SlC26A7 is a cr 
channel regulated by intracellular pH', J BioI Chem, 280, (8), pp. 6463-
6470. 
Kim, Y. H., Pech, V., Spencer, K. B., Beierwaltes, W. H., Everett, L. A., Green, E. 
D., Shin, W., Verlander, J. W., Sutliff, R L. and Wall, S. M. (2007) 
'Reduced ENaC protein abundance contributes to the lower blood 
pressure observed in pendrin-null mice', Am J Physiol Renal Physiol, 293, 
(4), pp. F1314-1324. 
Ko, S. B. H., Shcheynikov, N., Choi, J. Y., luo, X., Ishibashi, K., Thomas, P. J., 
Kim, J. Y., Kim, K. H., lee, M. G., Naruse, S. and Muallem, S. (2002) 'A 
molecular mechanism for aberrant CFTR-dependent HC03- transport in 
cystic fibrosis', EMBO J, 21, (21), pp. 5662-5672. 
Ko, S. B. H., Zeng, W., Dorwart, M. R, luo, x., Kim, K. H., Millen, L., Goto, H., 
Naruse, S., Soyombo, A., Thomas, P. J. and Muallem, S. (2004) 'Gating of 
CFTR by the STAS domain of SlC26 transporters', Nat Cell BioI, 6, pp. 
343-350. 
221 
Konig, J., Schreiber, R, Voelcker, T., Mall, M. and Kunzelmann, K. (2001) The 
cystic fibrosis transmembrane conductance regulator (CFTR) inhibits 
ENaC through an increase in the intracellular cr concentration " EMBO 
Rep, 2, (11), pp. 1047-1051. 
Konstas, A-A, Koch, J.-P. and Korbmacher, C. (2003) 'cAMP-dependent 
activation of CFTR inhibits the epithelial sodium channel (ENaC) without 
affecting its surface expression', Pf/iigers Arch, 445, (4), pp. 513-521. 
Kopito, R R, Lee, B. S., Simmons, D. M., Lindsey, A E., Morgans, C. W. and 
Schneider, K. (1989) 'Regulation of intracellular pH by a neuronal homolog 
of the erythrocyte anion exchanger', Cell, 59, (5), pp. 927-937. 
Kreda, S. M., Mall, M., Mengos, A, Rochelle, L., Yankaskas, J., Riordan, J. R 
and Boucher, R C. (2005) 'Characterization of wild-type and deltaF508 
cystic fibrosis transmembrane regulator in human respiratory epithelia', 
Mol BioI Cell, 16, (5), pp. 2154-2167. 
Kreda, S. M., Okada, S. F., van Heusden, C. A, O'Neal, W., Gabriel, S., 
Abdullah, L., Davis, C. W., Boucher, R C. and Lazarowski, E. R (2007) 
'Coordinated release of nucleotides and mucin from human airway 
epithelial Calu-3 cells', J Physiol, 584, (1), pp. 245-259. 
Kreindler, J. L., Bertrand, C. A, Lee, R J., Karasic, T., Aujla, S., Pilewski, J. M., 
Frizzel, R A. and Kolls, J. K. (2009) 'Interleukin-17A bicarbonate secretion 
in normal human bronchial epithelial cells', Am J Physiol Lung Cell Mol 
Physiol, 296, pp. L257-266. 
222 
Kreindler, J. L., Peters, K. W., Frizzell, R. A. and Bridges, R. J. (2006) 
'Identification and membrane localization of electrogenic sodium 
bicarbonate cotransporters in Calu-3 cells', Biochim Biophys Acta, 1762, 
(7), pp. 704-710. 
Krouse, M. E., Talbott, J. F., Lee, M. M., Joo, N. S. and Wine, J. J. (2004) 'Acid 
and base secretion in the Calu-3 model of human serous cells', Am J 
Physiol Lung Cell Mol Physiol, 287, (6), pp. L 1274-1283. 
Lamprecht, G., Baisch, S., Schoenleber, E. and Gregor, M. (2005) 'Transport 
properties of the human intestinal anion exchanger ORA (down-regulated 
in adenoma) in transfected HEK293 cells', Pfliigers Arch, 449, (5), pp. 
479-490. 
Lansdell, K. A., Cai, Z., Kidd, J. F. and Sheppard, O. N. (2000) 'Two mechanisms 
of genistein inhibition of cystic fibrosis transmembrane conductance 
regulator CI- channels expressed in murine cell line', J Physiol, 524, (2), 
pp.317-330. 
Lee, M. C., Penland, C. M., Widdicombe, J. H. and Wine, J. J. (1998) 'Evidence 
that Calu-3 human airway cells secrete bicarbonate', Am J Physiol Lung 
Cell Mol Physiol, 274, (3), pp. L450-453. 
Lee, M. G., Choi, J. Y., Luo, X., Strickland, E., Thomas, P. J. and Muallem, S. 
(1999) 'Cystic fibrosis transmembrane conductance regulator regulates 
luminal Cr/HC03- exchange in mouse submandibular and pancreatic 
ducts', J BioI Chem, 274, (21), pp. 14670-14677. 
223 
Lee, R. J., Harlow, J. M., Limberis, M. P., Wilson, J. M. and Foskett, J. K. (2008) 
'HC03- secretion by murine nasal submucosal gland serous acinar cells 
during Ca2+-stimulated fluid secretion', J Gen Physiol, 132, (1), pp. 161-
183. 
Li, H. and Sheppard, D. N. (2009) 'Therapeutic potential of cystic fibrosis 
transmembrane conductance regulator (CFTR) inhibitors in polycystic 
kidney disease', BioDrugs, 23, (4), pp. 203-216. 
Li, M., McCann, J. D., Liedtket, C. M., Nairn, A. C., Greengard, P. and Welsh, M. 
J. (1988) 'Cyclic AMP-dependent protein kinase opens chloride channels 
in normal but not cystic fibrosis airway epithelium', Nature, 331, (6154), pp. 
358-360. 
Liedtke, C. M., Wang, X. and Smallwood, N. D. (2005) 'Role for PP2A in the 
regulation of Calu-3 epithelial NKCC1 function', J BioI Chem, 280, (27), pp. 
25491-25498. 
Linsdell, P. and Hanrahan, J. W. (1996) 'Disulphonic stilbene block of cystic 
fibrosis transmembrane conductance regulator cr channels expressed in 
a mammalian cell line and its regulation by a critical pore residue', J 
Physiol, 496, (Pt 3), pp. 687-693. 
Linsdell, P., Tabcharani, J. A., Rommens, J. M., Hou, Y.-X., Chang, X.-B., Tsui, 
L.-C., Riordan, J. R. and Hanrahan, J. W. (1997) 'Permeability of wild-type 
and mutant cystic fibrosis transmembrane conductance regulator chloride 
channels to polyatomic anions', J Gen Physiol, 110, (4), pp. 355-364. 
224 
Lofting, J., Moyer, B. D., Reynolds, D., Shmukler, B. E., Alper, S. L. and Stanton 
, 
B. A. (2000) 'Functional and molecular characterization of an anion 
exchanger in airway serous epithelial cells', Am J Physiol Cell Physiol, 279, 
(4), pp. C1016-1023. 
Lohi, H., Kujala, M., Makela, S., Lehtonen, E., Kestila, M., Saarialho-Kere, U., 
Markovich, D. and Kere, J. (2002) 'Functional characterization of three 
novel tissue-specific anion exchangers SLC26A 7, -A8, and -A9', J BioI 
Chem, 277, (16), pp. 14246-14254. 
Lohi, H., Lamprecht, G., Markovich, D., Heil, A., Kujala, M., Seidler, U. and Kere , 
J. (2003) 'Isoforms of SLC26A6 mediate anion transport and have 
functional PDZ interaction domains', Am J Physiol Cell Physiol, 284, (3), 
pp. C769-779. 
Loriol C, D. S., Avella M, Gabillat N, Boulukos K, Borgese F, Ehrenfeld J. (2008) 
'Characterization of SLC26A9, facilitation of cr transport by bicarbonate', 
Cell Physiol Biochem, 1-4, (22), pp. 15-30. 
Lubman, R. L., Danto, S. I., Chao, D. C., Fricks, C. E. and Crandall, E. D. (1995) 
'Cr-HC03- exchanger isoform AE2 is restricted to the basolateral surface 
of alveolar epithelial cell monolayers', Am J Respir Cell Mol BioI, 12, (2), 
pp.211-219. 
Luo, J., Pato, M. D., Riordan, J. R. and Hanrahan, J. W. (1998) 'Differential 
regulation of single CFTR channels by PP2C, PP2A, and other 
phosphatases', Am J Physiol Cell Physiol, 274, (5), pp. C1397-1410. 
225 
Ma, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J. V. 
and Verkman, A. S. (2002) 'Thiazolidinone CFTR inhibitor identified by 
high-throughput screening blocks cholera toxin-induced intestinal fluid 
secretion', J Clin Invest, 110, (11), pp. 1651-1658. 
Maas, A. H. J. (1970) 'A titrimetric method for the determination of actual 
bicarbonate in cerebrospinal fluid and plasma or serum', Clinica Chimica 
Acta, 29, (3), pp. 567-574. 
MacVinish, L. J., Cope, G., Ropenga, A. and Cuthbert, A. W. (2007) 'Chloride 
transporting capability of Calu-3 epithelia following persistent knockdown 
of the cystic fibrosis transmembrane conductance regulator, CFTR', Br J 
Pharmacol, 150, (8), pp. 1055-1065. 
Mantle, M. and Allen, A. (1978) 'A colourimetric assay for glycoprotein based on 
the periodic acid/Schiff stain.' Biochem Soc Trans, 6, pp. 601-609. 
Marilyn, R. J.-K. (1992) 'Quick and accurate method to convert BCECF 
fluorescence to pHi: Calibration in three different types of cell preparations', 
J Cell Physiol, 151, (3), pp. 596-603. 
Mathia, N. R., Timoszyk, J., Stetsko, P. I., Megill, J. R., Smith, R. L. and Wall, D. 
A. (2002) 'Permeability characteristics of Calu-3 human bronchial epithelial 
cells: in vitro - in vivo correlation to predict lung absorption in rats', J Drug 
Target, 10, (1), pp. 31-40. 
Matsui, H., Grubb, B. R., Tarran, R., Randell, S. H., Gatzy, J. T., Davis, C. W. 
and Boucher, R. C. (1998) 'Evidence for periciliary liquid layer depletion, 
not abnormal ion composition, in the pathogenesis of cystic fibrosis 
airways disease', Cell, 95, (7), pp. 1005-1015. 
226 
Melvin, J. E., Park, K., Richardson, L., Schultheis, P. J. and Shull, G. E. (1999) 
'Mouse down-regulated in adenoma (ORA) is an intestinal Cr/HC0
3
-
exchanger and is up-regulated in colon of mice lacking the NHE3 Na+/H+ 
exchanger', J Bioi Chern, 274, (32), pp. 22855-22861. 
Meyrick, B. and Reid, L. (1970) 'Ultrastructure of cells in human bronchial 
submucosal glands.' J Anat, 107, pp. 281-299. 
Moon, S., Singh, M., Krouse, M. E. and Wine, J. J. (1997) 'Calcium-stimulated cr 
secretion in Calu-3 human airway cells requires CFTR', Am J Physiol Lung 
Cell Mol Physiol, 273, (6), pp. L 1208-1219. 
Mount, D. and Romero, M. (2004) 'The SLC26 gene family of multifunctional 
anion exchangers', Pf/iigers Arch, 447, (5), pp. 710-721. 
Muanprasat, C., Sonawane, N. D., Salinas, D., Taddei, A., Gali etta , L. J. V. and 
Verkman, A. S. (2004) 'Discovery of glycine hydrazide pore-occluding 
CFTR inhibitors', J Gen Physiol, 124, (2), pp. 125-137. 
Myerburg, M. M., Butterworth, M. B., McKenna, E. E., Peters, K. W., Frizzell, R 
A., Kleyman, T. Rand Pilewski, J. M. (2006) 'Airway surface liquid volume 
regulates ENaC by altering the serine protease-protease inhibitor balance: 
a mechanism for sodium hyperabsorption in cystic fibrosis. ' J Bioi Chern, 
281, (38), pp. 27942-27949. 
Myerburg, M. M., Harvey, P. R, Heidrich, E. M., Pilewski, J. M. and Butterworth, 
M. (2010) 'Acute regulation of ENaC in airway epithelia by proteases and 
trafficking', Am J Respir Cell Mol Bioi, pp. 2009-03480C. 
227 
Nagaki, M., Ishihara, H., Shimura, S., Sasaki, T., Takishima, T. and Shirato, K. 
(1994) 'Tachykinins induce a [Ca2+]j rise in the acinar cells of feline 
tracheal submucosal gland', Respir Physio/, 98, (1), pp. 111-120. 
Nagel, G., Hwang, T.-C., Nastiuk, K. L., Nairn, A C. and Gadsbyt, D. C. (1992) 
'The protein kinase A-regulated cardiac cr channel resembles the cystic 
fibrosis transmembrane conductance regulator', Nature, 360, (6399), pp. 
81-84. 
Nakao, I., Kanaji, S., Ohta, S., Matsushita, H., Arima, K., Yuyama, N., Yamaya, 
M., Nakayama, K., Kubo, H., Watanabe, M., Sagara, H., Sugiyama, K., 
Tanaka, H., Toda, S., Hayashi, H., Inoue, H., Hoshino, T., Shiraki, A, 
Inoue, M., Suzuki, K., Aizawa, H., Okinami, S., Nagai, H., Hasegawa, M., 
Fukuda, T., Green, E. D. and Izuhara, K. (2008) 'Identification of pendrin 
as a common mediator for mucus production in bronchial asthma and 
chronic obstructive pulmonary disease', J Immunol, 180, (9), pp. 6262-
6269. 
Namkung, W., Lee, J. A, Ahn, W., Han, W., Kwon, S. W., Ahn, D. S., Kim, K. H. 
and Lee, M. G. (2003) 'Ca2+ activates cystic fibrosis transmembrane 
conductance regulator- and Cr-dependent HC03- transport in pancreatic 
duct cells', J BioI Chern, 278, (1), pp. 200-207. 
Novak, I. and Greger, R. (1988) 'Properties of the luminal membrane of isolated 
perfused rat pancreatic ducts', Pffijgers Arch, 411, (5), pp. 546-553. 
Ohana, E., Yang, D., Shcheynikov, N. and Muallem, S. (2009) 'Diverse transport 
modes by the solute carrier 26 family of anion transporters', J Physiol, 587, 
(10), pp. 2179-2185. 
228 
Ostedgaard, L. S., Baldursson, O. and Welsh, M. J. (2001) 'Regulation of the 
cystic fibrosis transmembrane conductance regulator cr channel by its R 
domain', J BioI Chem, 276, (11), pp. 7689-7692. 
Paradiso, A. M. (1992) 'Identification of Na+-H+ exchange in human normal and 
cystic fibrotic ciliated airway epithelium', Am J Physiol Lung Cell Mol 
Physiol, 262, (6), pp. L757-764. 
Paradiso, A M., Coakley, R D. and Boucher, R C. (2003) 'Polarized distribution 
of HC03- transport in human normal and cystic fibrosis nasal epithelia', J 
Physiol, 548, (1), pp. 203-218. 
Parker, M. D., Ourmozdi, E. P. and Tanner, M. J. (2001) 'Human BTR1, a new 
bicarbonate transporter superfamily member and human AE4 from kidney', 
Biochem Biophys Res Comms, 282, (5), pp. 1103-1109. 
Patel, J., Pal, D., Vangala, V., Gandhi, M. and Mitra, A K. (2002) 'Transport of 
HIV-protease inhibitors across 1 alpha,25di-hydroxy vitamin D3-treated 
Calu-3 cell monolayers: modulation of P-glycoprotein activity'., Pharm Res, 
19, (11), pp. 1696-1703. 
Pedemonte, N., Caci, E., Sondo, E., Caputo, A, Rhoden, K., Pfeffer, U., Di 
Candia, M., Bandettini, R, Ravazzolo, R, Zegarra-Moran, O. and Galietta, 
L. J. V. (2007) 'Thiocyanate transport in resting and IL-4 stimulated human 
bronchial epithelial cells: role of pendrin and anion channels', J Immunol, 
178, (8), pp. 5144-5153. 
Pedemonte, N., Tomati, V., Sondo, E. and Galietta, L. J. V. (2010) 'Influence of 
cell background on pharmacological rescue of mutant CFTR', Am J 
Physiol Cell Physiol, 298, (4), pp. C866-874. 
229 
Petrovic, S., Barone, S., Xu, J., Conforti, L., Ma, L., Kujala, M., Kere, J. and 
Soleimani, M. (2004) 'SLC26A7: a basolateral Cr/HCOs- exchanger 
specific to intercalated cells of the outer medullary collecting duct', Am J 
Physiol Renal Physiol, 286, (1), pp. F161-169. 
Petrovic, S., Ju, X., Barone, S., Seidler, U., Alper, S. L., Lohi, H., Kere, J. and 
Soleimani, M. (2003) 'Identification of a basolateral Cr/HCOs- exchanger 
specific to gastric parietal cells', Am J Physiol Gastrointest Liver Physiol, 
284, (6), pp. G1093-1103. 
Phillips, J. E., Hey, J. A. and Corboz, M. R. (2003) 'Tachykinin NK3 and NK1 
receptor activation elicits secretion from porcine airway submucosal 
glands', BrJ Pharmacol, 138, (1), pp. 254-260. 
Pushkin, A., Abuladze, N., Newman, D., Lee, I., Xu, G. and Kurtz, I. (2000) 
'Cloning, characterization and chromosomal assignment of NBC4, a new 
member of the sodium bicarbonate cotransporter family', Biochimica 
Biophysica Acta, 1493, (1-2), pp. 215-218. 
Pushkin, A. and Krutz, I. (2006) 'SLC4 base (HCOs-, COl-) transporters: 
classification, function, structure, genetic diseases, and knockout models', 
Am J Physiol Renal Physiol, 290, (3), pp. F580-599. 
Quinton, P. M. (1979) 'Composition and control of secretions from tracheal 
bronchial submucosal glands', Nature, 279, (5713), pp. 551-552. 
Quinton, P. M. (1983) 'Chloride impermeability in cystic fibrosis', Nature, 301, 
(5899), pp. 421-422. 
Quinton, P. M. (1990) 'Cystic fibrosis: a disease in electrolyte transport', FASEB J, 
4, (10), pp. 2709-2717. 
230 
Quinton, P. M. (2001) 'The neglected ion: HC03-', Nat Med, 7, (3), pp. 292-293. 
Rakonczay, Z., Hegyi, P., Hasegawa, M., Inoue, M., You, J., lida, A., Ignath, I., 
Alton, E. W., Griesenbach, U., 6vari, G., Vag, J., Da Paula, A C., 
Crawford, R M., Varga, G., Amaral, M. D., Mehta, A, Lonovics, J., Argent, 
B. E. and Gray, M. A. (2008) 'CFTR gene transfer to human cystic fibrosis 
pancreatic duct cells using a Sendai virus vector', J Cell Physio/, 214, (2), 
pp. 442-455. 
Reddy, M. M. and Quinton, P. M. (1999) 'Bumetanide blocks CFTR GCI in the 
native sweat duct', Am J Physio/ Cell Physio/, 276, (1), pp. C231-237. 
Reenstra, W. W., Yurko-Mauro, K., Dam, A, Raman, S. and Shorten, S. (1996) 
'CFTR chloride channel activation by genistein: the role of serine/threonine 
protein phosphatases', Am J Physio/ Cell Physio/, 271, (2), pp. C650-657. 
Reid, L. (1960) 'Measurement of the bronchial mucous gland layer: a diagnostic 
yardstick in chronic bronchitis.' Thorax, 15, pp. 132-141. 
Rich, D. P., Gregory, R J., Anderson, M. P., Manavalan, P., Smith, A E. and 
Welsh, M. J. (1991) 'Effect of deleting the R domain on CFTR-generated 
chloride channels', Science, 253, (5016), pp. 205-207. 
Riordan, J. R, Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R, Grzelczak, 
Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J. L., Drumm, M. L., Iannuzzi, 
M. C., Collins, F. S. and Tsui, L. C. (1989) 'Identification of the cystic 
fibrosis gene: cloning and characterization of complementary DNA', 
Science, 245, (4922), pp. 1066-1073. 
231 
Robert, R., Norez, C. and Becq, F. (2005) 'Disruption of CFTR chloride channel 
alters mechanical properties and cAMP-dependent cr transport of mouse 
aortic smooth muscle cells', J Physiol, 568, (2), pp. 483-495. 
Romero, M. F., Henry, D., Nelson, S., Harte, P. J., Dillon, A. K. and SCiortino, C. 
M. (2000) 'Cloning and characterization of a Na+-driven anion exchanger 
(NDAE1)" J Bioi Chem, 275, (32), pp. 24552-24559. 
Romero, M. F. (2005). 'Molecular pathophysiology of SLC4 bicarbonate 
transporters', Curr Opin Nephrol Hypertens, 14, (5), pp. 495-501. 
Roos, A. and Boron, W. F. (1981) 'Intracellular pH', Physiol Rev, 61, pp. 296-434. 
Royaux, I. E., Wall, S. M., Karniski, L. P., Everett, L. A., Suzuki, K., Knepper, M. 
A. and Green, E. D. (2001) 'Pendrin, encoded by the Pendred syndrome 
gene, resides in the apical region of renal intercalated cells and mediates 
, bicarbonate secretion', Proc Natl Acad Sci U.S.A., 98, (7), pp. 4221-4226. 
Salinas, D., Haggie, P. M., Thiagarajah, J. R., Song, Y., Rosbe, K., Finkbeiner, W. 
E., Nielson, D. W. and Verkman, A. S. (2005) 'Submucosal gland 
dysfunction as a primary defect in cystic fibrosis', FASEB J., 19, (3), pp. 
431-433. 
Schmidt, A., Hughes, L. K., Cai, Z., Mendes, F., Li, H., Sheppard, D. N. and 
Amaral, M. D. (2008) 'Prolonged treatment of cells with genistein 
modulates the expression and function of the cystic fibrosis 
transmembrane conductance regulator', Br J Pharmacol, 153(6), pp. 
1311-1323. 
232 
Schou macher, R A., Shoemaker, R L., Halm, D. R, Tallant, E. A., Wallace, R 
W. and Frizzell, R A. (1987) 'Phosphorylation fails to activate chloride 
channels from cystic fibrosis airway cells', Nature, 330, (6150), pp. 752-
754. 
Schwiebert, E. M., Egan, M. E., Hwang, T. H., Fulmer, S. B., Allen, S. S., Cutting, 
G. Rand Guggino, W. B. (1995) 'CFTR regulates outwardly rectifying 
chloride channels through an autocrine mechanism involving ATP', Cell, 
81, (7), pp. 1063-1073. 
Scott, D. A. and Karniski, L. P. (2000) 'Human pendrin expressed in Xenopus 
laevis oocytes mediates chloride/formate exchange', Am J Physiol Cell 
Physiol, 278, (1), pp. C207-211. 
Scott, D. A., Wang, R, Kreman, T. M., Sheffield, V. C. and Karniski, L. P. (1999) 
'The Pendred syndrome gene encodes a chloride-iodide transport protein', 
Nat Genet, 21, (4), pp. 440-443. 
Sharma, P., Dudus, L., Nielsen, P. A., Clausen, H., Yankaskas, J. R, 
Hollingsworth, M. A. and Engelhardt, J. F. (1998) 'MUC5B and MUC7 are 
differentially expressed in mucous and serous cells of submucosal glands 
in human bronchial airways', Am. J Respir Cell Mol Bioi, 19, (1), pp. 30-37. 
Shcheynikov, N., Wang, Y., Park, M., Ko, S. B. H., Dorwart, M., Naruse, S., 
Thomas, P. J. and Muallem, S. (2006) 'Coupling modes and stoichiometry 
of CrtHC03- exchange by SLC26A3 and SLC26A6', J Gen Physiol, 127, 
(5), pp. 511-524. 
233 
Shcheynikov, N., Yang, D., Wang, Y., Zeng, W., Karniski, L. P., So, I., Wall, S. M. 
and Muallem, S. (2008) 'The SLC26A4 transporter functions as an 
electroneutral crtr/HC03- exchanger: role of SLC26A4 and SLC26A6 in r 
and HC03- secretion and in regulation of CFTR in the parotid duct', J 
Physio/, 586, (16), pp. 3813-3824. 
Shen, B. a., Finkbeiner, W. E., Wine, J. J., Mrsny, R J. and Widdicombe, J. H. 
(1994) 'Calu-3: a human airway epithelial cell line that shows cAMP-
dependent cr secretion', Am J Physiol Lung Cell Mol Physiol, 266, (5), pp. 
L493-501. 
Sheppard, D. N. and Welsh, M. J. (1999) 'Structure and function of the CFTR 
chloride channel', Physiol Rev, 79, (1), pp. 23-45. 
Shin, J. H., Son, E. J., Lee, H. S., Kim, S. J., Kim, K., Choi, J. Y., Lee, M. G. and 
Yoon, J. H. (2007) 'Molecular and functional expression of anion 
exchangers in cultured normal human nasal epithelial cells', Acta 
Physiologica, 191, (2), pp. 99-110. 
Shumaker, H., Amlal, H., Frizzell, R, Ulrich II, C. D. and Solemani, M. (1999) 
'CFTR drives Na + -nHC03- cotransport in pancreatic duct cells: a basis for 
defective HC03- secretion in CF, Am J Physiol Cell Physiol, 276, (1), pp. 
C16-25. 
Simpson, J. E., Gawenis, L. R, Walker, N. M., Boyle, K. T. and Clarke, L. L. 
(2005) 'Chloride conductance of CFTR facilitates basal Cr/HC03-
exchange in the villous epithelium of intact murine duodenum', Am J 
Physiol Gastrointest Liver Physiol, 288, (6), pp. G1241-1251. 
234 
Singh, M., Krouse, M., Moon, S. and Wine, J. J. (1997) 'Most basal I(SC) in Calu-
3 human airway cells is bicarbonate-dependent cr secretion', Am J 
Physiol Lung Cell Mol Physio/, 272, (4), pp. L690-698. 
Skowron-zwarg, M., Boland, S., Caruso, N., Coraux, C., Marano, F. and Tournier, 
F. (2007) 'Interleukin-13 interferes with CFTR and AQP5 expression and 
localization during human airway epithelial cell differentiation', Exp Cell 
Res, 313, (12), pp. 2695-2702. 
Smith, J. J., Travis, S. M., Greenberg, E. P. and Welsh, M. J. (1996) 'Cystic 
fibrosis airway epithelia fail to kill bacteria because of abnormal airway 
surface fluid', Cell, 85, (2), pp. 229-236. 
Smith, J. J. and Welsh, M. J. (1992) 'cAMP stimulates bicarbonate secretion 
across normal, but not cystic fibrosis airway epithelia', J Clin Invest, 89, 
(4), pp. 1148-1153. 
Soleimani, M. (2006) 'Expression, regulation and the role of SLC26 CrtHC03-
exchangers in kidney and gastrointestinal tract', in Epithelial Anion 
Transport in Health and Disease: The Role of the SLC26 Transporters 
Family. Vol. 273 Novartis Foundation Symposium, pp. 91-106. 
Soleimani, M., Greeley, T., Petrovic, S., Wang, Z., Amlal, H., Kopp, P. and 
Burnham, C. E. (2001) 'Pendrin: an apical CrtOH-/HC03- exchanger in the 
kidney cortex', Am J Physiol Renal Physio/, 280, (2), pp. F356-364. 
Song, Y., Ishiguro, H., Yamamoto, A., Xiang Jin, C. and Kondo, T. (2009) 'Effects 
of SLC26A6 deletion and CFTR inhibition on HC03- secretion by mouse 
pancreatic duct', J Med Invest, 56, (Supplement), pp. 332-335. 
235 
Song, Y., Salinas, D., Nielson, D. W. and Verkman, A. S. (2006) 'Hyperacidity of 
secreted fluid from submucosal glands in early cystic fibrosis', Am J 
Physio! Cell Physio!, 290, (3), pp. C741-749. 
Song, Y. and Verkman, A. S. (2001) 'Aquaporin-5 dependent fluid secretion in 
airway submucosal glands', J Bio! Chem, 276, (44), pp. 41288-41292. 
Songyang, Z., Fanning, A. S., Fu, C., Xu, J., Marfatia, S. M., Chishti, A. H., 
Crompton, A., Chan, A. C., Anderson, J. M. and Cantley, L. C. (1997) 
'Recognition of unique carboxyl-terminal motifs by distinct PDZ domains', 
Science, 275, (5296), pp. 73-77. 
Sprague, R. S., Ellsworth, M. L., Stephenson, A. H., Kleinhenz, M. E. and Lonigro, 
A. J. (1998) 'Deformation-induced ATP release from red blood cells 
requires CFTR activity', Am J Physio! Heart Circ Physio!, 275, (5), pp. 
H1726-1732. 
Stewart, A. K., Chernova, M. N., Kunes, Y. Z. and Alper, S. L. (2001) 'Regulation 
of AE2 anion exchanger by intracellular pH: critical regions of the NH2-
terminal cytoplasmic domain', Am J Physio! Cell Physio!, 281, (4), pp. 
C1344-1354. 
Stewart, A. K., Kurschat, C. E., Burns, D., Banger, N., Vaughan-Jones, R. D. and 
Alper, S. L. (2007) 'Transmembrane domain histidines contribute to 
regulation of AE2-mediated anion exchange by pH', Am J Physio! Cell 
Physio!, 292, (2), pp. C909-918. 
Stewart, A. K., Yamamoto, A., Nakakuki, M., Kondo, T., Alper, S. L. and Ishiguro, 
H. (2009) 'Functional coupling of apical CrlHC03- exchange with CFTR in 
stimulated HC03- secretion by guinea pig interlobular pancreatic duct', Am 
J Physio! Gastrointest Liver Physio!, 296, (6), pp. G1307-1317. 
236 
Stuart-Tilley, A., Sardet, C., Pouyssegur, J., Schwartz, M. A., Brown, D. and 
Alper, S. L. (1994) 'Immunolocalization of anion exchanger AE2 and cation 
exchanger NHE-1 in distinct adjacent cells of gastric mucosa', Am J 
Physiol Cell Physiol, 266, (2), pp. C559-568. 
Stutts, M. J., Canessa, C. M., Olsen, J. C., Hamrick, M., Cohn, J. A., Rossier, B. 
C. and Boucher, R. C. (1995) 'CFTR as a cAMP-dependent regulator of 
sodium channels', SCience, 269, (5225), pp. 847-850. 
Stutts, M. J., Rossier, B. C. and Boucher, R. C. (1997) 'Cystic fibrosis 
transmembrane conductance regulator inverts protein kinase A-mediated 
regulation of epithelial sodium channel single channel kinetics', J Bioi 
Chem, 272, (22), pp. 14037-14040. 
Sun, F., Hug, M. J., Lewarchik, C. M., Yun, C. H. C., Bradbury, N. A. and Frizzell, 
R. A. (2000) 'E3KARP mediates the association of ezrin and protein 
kinase A with the cystic fibrosis transmembrane conductance regulator in 
airway cells', J Bioi Chem, 275, (38), pp. 29539-29546. 
Szalmay, G., Varga, G., Kajiyama, F., Yang, X. S., Lang, T. F., Case, R. M. and 
Steward, M. C. (2001) 'Bicarbonate and fluid secretion evoked by 
cholecystokinin, bombesin and acetylcholine inisolated guinea-pig 
pancreatic ducts', J Physiol, 535, (3), pp. 795-807. 
Szkotak, A. J., Man, S. F. P. and Duszyk, M. (2003) 'The role of the basolateral 
outwardly rectifying chloride channel in human airway epithelial anion 
secretion', Am J Respir Cell Mol Bioi, 29, (6), pp. 710-720. 
Tabcharani, J. A., Chang, X. B., Riordan, J. R. and Hanrahan, J. W. (1992) 'The 
cystic fibrosis transmembrane conductance regulator chloride channel. 
Iodide block and permeation', Biophys J, 62, (1), pp. 1-4. 
237 
Tamada, T., Hug, M. J., Frizzell, R. A. and Bridges, R. J. (2001) 'Microelectrode 
and impedance analysis of anion secretion in Calu-3 cells', J Pancreas, 2, 
(4), pp. 219-228. 
Tamaoki, T. and Nakano, H. (1990) 'Potent and specific inhibitors of protein 
kinase C of microbial origin', Nat Biotech, 8, (8), pp. 732-735. 
Tarran, R (2004) 'Regulation of airway surface liquid volume and mucus 
transport by active ion transport', Proc Am Thorac Soc, 1, (1), pp. 42-46. 
Tarran, R, Button, B., Picher, M., Paradiso, A. M., Ribeiro, C. M., Lazarowski, E. 
R, Zhang, L., Collins, P. L., Pickles, R. J., F red berg , J. J. and Boucher, R 
C. (2005) 'Normal and cystic fibrosis airway surface liquid homeostasis: 
the effects of phasic shear stress and viral infections', J Bioi Chem, 280, 
(42), pp. 35751-35759. 
Tarran, R, Trout, L., Donaldson, S. H. and Boucher, R C. (2006) 'Soluble 
mediators, not cilia, determine airway surface liquid volume in normal and 
cystic fibrosis superficial airway epithelia', J Gen Physiol, 127, (5), pp. 
591-604. 
Taylor, C. J. and Aswani, N. (2002) 'The pancreas in cystic fibrosis', Paediatr 
Respir Rev, 3, (1), pp. 77-81. 
Thastrup, 0., Cullen, P. J., Drabak, B. K., Hanley, M. R and Dawson, A. P. 
(1990) 'Thapsigargin, a tumor promoter, discharges intracellular Ca2+ 
stores by specific inhibition of the endoplasmic reticulum Ca2+ -ATPase', 
Proc Nat Acad Sci U.S.A., 87, (7), pp. 2466-2470. 
238 
Thelin, W. R., Kesimer, M., Tarran, R., Kreda, S. M., Grubb, B. R., Sheehan, 
J .K., Stutts, M. J. and Milgram, S. L. (2005) 'The cystic fibrosis 
transmembrane conductance regulator is regulated by a direct interaction 
with the protein phosphatase 2A', J BioI Chem, 280, (50), pp. 41512-
41520. 
Thiagarajah, J. R., Song, Y., Haggie, P. M. and Verkman, A. S. (2004) 'A small 
molecule CFTR inhibitor produces cystic fibrosis-like submucosal gland 
fluid secretions in normal airways', FASEB J., 18, (7), pp. 875-7. 
Tousson, A., Van Tine, B. A., Naren, A. P., Shaw, G. M. and Schwiebert, L. M. 
(1998) 'Characterization of CFTR expression and chloride channel activity 
in human endothelia', Am J Physiol Cell Physiol, 275, (6), pp. C1555-1564. 
Travis, S. M., Berger, H. A. and Welsh, M. J. (1997) 'Protein phosphatase 2C 
dephosphorylates and inactivates cystic fibrosis transmembrane 
conductance regulator', Proc Nat Acad Sci U. S.A., 94, (20), pp. 11055-
11060. 
Travis, S. M., Singh, P. K. and Welsh, M. J. (2001) 'Antimicrobial peptides and 
proteins in the innate defense of the airway surface', Curr Opin Immunol, 
13, (1), pp. 89-95. 
Trout, L., Corboz, M. R. and Ballard, S. T. (2001) 'Mechanism of substance P-
induced liquid secretion across bronchial epithelium', Am J Physiol Lung 
Cell Mol Physiol, 281, (3), pp. L639-645. 
Trout, L., Gatzy, J. T. and Ballard, S. T. (1998) 'Acetylcholine-induced liquid 
secretion by bronchial epithelium: role of cr and HC03- transport', Am J 
Physiol Lung Cell Mol Physiol, 275, (6), pp. L 1095-1099. 
239 
Ueki, I., German, V. and Nadel, J. (1980) 'Micropipette measurement of airway 
submucosal gland secretion. Autonomic effects.' Am Rev Respir Dis, 121, 
(2), pp. 351-357. 
Urbach, V., Helix, N., Renaudon, B. and Harvey, B. J. (2002) 'Cellular 
mechanisms for apical ATP effects on intracellular pH in human bronchial 
epithelium', J Physio/, 543, (1), pp. 13-21. 
Verlander, J. W., Madsen, K. M., Low, P. S., Allen, D. P. and Tisher, C. C. (1988) 
'Immunocytochemical localization of band 3 protein in the rat collecting 
duct', Am J Physiol Renal Physio/, 255, (1), pp. F115-125. 
Vince, J. W. and Reithmeier, R. A. F. (2000) 'Identification of the carbonic 
anhydrase II binding site in the CrJHC03- anion exchanger AE 1', 
Biochemistry, 39, (18), pp. 5527-5533. 
Wan, H., Winton, H. L., Soeller, C., Stewart, G. A., Thompson, P. J., Gruenert, D. 
C., Cannell, M. B., Garrod, D. R. and Robinson, C. (2000) 'Tight junction 
properties of the immortalized human bronchial epithelial cell lines Calu-3 
and 16HBE14o', Eur Respir J, 15, (6), pp. 1058-1068. 
Wang, Y., Soyombo, A. A., Shcheynikov, N., Zeng, W., Dorwart, M., Marino, C. 
R., Thomas, P. J. and Muallem, S. (2006) 'SLC26A6 regulates CFTR 
activity in vivo to determine pancreatic duct HC03- secretion: relevance to 
cystic fibrosis', EMBO J, 25, pp. 5049-5057. 
Wang, Z., Wang, T., Petrovic, S., Tuo, B., Riederer, B., Barone, S., Lorenz, J. N., 
Seidler, U., Aronson, P. S. and Soleimani, M. (2005) 'Renal and intestinal 
transport defects in SLC26A6-null mice', Am J Physiol Cell Physio/, 288, 
pp. C957 -965. 
240 
Welsh, M. J. (1990) 'Abnormal regulation of ion channels in cystic fibrosis 
epithelia', FASEB J., 4, (10), pp. 2718-2725. 
Wheat, V. J., Shumaker, H., Burnham, C., Shull, G. E., Yankaskas, J. R. and 
Soleimani, M. (2000) 'CFTR induces the expression of DRA along with cr 
IHC03- exchange activity in tracheal epithelial cells', Am J Physiol Cell 
Physiol, 279, (1), pp. C62-71. 
Wine, J. J. and Joo, N. S. (2004) 'Submucosal glands and airway defense', Proc 
Am Thorac Soc, 1, (1), pp. 47-53. 
Wine, J. J. (2007) 'Parasympathetic control of airway submucosal glands: central 
rei exes and the airway intrinsic nervous system', Auton Neurisci, 133, (1), 
pp.35-54. 
Winter, M. C. and Welsh, M. J. (1997) 'Stimulation of CFTR activity by its 
phosphorylated R domain', Nature, 389, (6648), pp. 294-296. 
Wu, J. V., Krouse, M. E., Rustagi, A., Joo, N. S. and Wine, J. J. (2004) 'An 
inwardly rectifying potassium channel in apical membrane of Calu-3 cells', 
J Bioi Chem, 279, (45), pp. 46558-46565. 
Xia, Y., Haws, C. M. and Wine, J. J. (1997). 'Disruption of monolayer integrity 
enables activation of a cystic fibrosis "bypass" channel in human airway 
epithelia', Nat Med, 3, pp. 263-268. 
Xie, Q., Welch, R., Mercado, A., Romero, M. F. and Mount, D. B. (2002) 
'Molecular characterization of the murine SLC26A6 anion exchanger: 
functional comparison with SLC26A 1', Am J Physiol Renal Physiol, 283, 
(4), pp. F826-838. 
241 
Xu, J., Henriksnas, J., Barone, S., Witte, D., Shull, G. E., Forte, J. G., Holm, L. 
and Soleimani, M. (2005) 'SLC26A9 is expressed in gastric surface 
epithelial cells, mediates Cr/HC03- exchange, and is inhibited by NH/', 
Am J Physiol Cell Physiol, 289, (2), pp. C493-505. 
Xu, J., Song, P., Nakamura, S., Miller, M., Barone, S., Alper, S. L., Riederer, B., 
Bonhagen, J., Arend, L. J., Amlal, H., Seidler, U. and Soleimani, M. (2009) 
'Deletion of the chloride transporter SLC26A7 causes distal renal tubular 
acidosis and impairs gastric acid secretion', J Bioi Chern, 284, (43), pp. 
29470-29479. 
Yamaya, M., Finkbeiner, W. E., Chun, S. Y. and Widdicombe, J. H. (1992) 
'Differentiated structure and function of cultures from human tracheal 
epithelium', Am J Physiol Lung Cell Mol Physiol, 262, (6), pp. L713-724. 
Yamaya, M., Ohrui, T., Finkbeiner, W. E. and Widdicombe, J. H. (1993) 'Calcium-
dependent chloride secretion across cultures of human tracheal surface 
epithelium and glands', Am J Physiol Lung Cell Mol Physiol, 265, (2), pp. 
L 170-177. 
Zhang, Y., Chernova, M. N., Stuart-Tilley, A. K., Jiang, L. and Alper, S. L. (1996) 
'The cytoplasmic and transmembrane domains of AE2 both contribute to 
regulation of anion exchange by pH. J Bioi Chern, 271, pp. 5741-5749. 
Zhao, H., Star, R. A. and Muallem, S. (1994) 'Membrane localization of H+ and 
HC03- transporters in the rat pancreatic duct', J Gen Physiol, 104, (1), pp. 
57-85. 
ZGnd, G., Madara, J. L., Dzus, A. L., Awtrey, C. S. and Colgan, S. P. (1996) 
'Interleukin-4 and interleukin-13 differentially regulate epithelial chloride 
secretion', J Bioi Chern, 271, pp. 7460-7464. 
242 
